EXHIBIT 10.10
EXECUTION COPY
AGREEMENT AND PLAN OF ORGANIZATION
by and among
CLARANT, INC.,
RSI I ACQUISITION CORP.,
RSI GROUP, INC.,
RESOURCE SOLUTIONS INTERNATIONAL, LLC
and
XXXXXXX XXXXXXXX,
XXXXXXX XXXXX
and
XXXXX X. XXXXX
Dated: June 1, 1999
TABLE OF CONTENTS
1. THE MERGER...............................................................................................2
1.1 DELIVERY AND FILING OF ARTICLES OF MERGER.......................................................2
1.2 EFFECTIVE TIME..................................................................................2
1.3 CERTIFICATE OF INCORPORATION, BYLAWS AND BOARD OF DIRECTORS OF SURVIVING
CORPORATION.....................................................................................2
1.4 EFFECT OF MERGER................................................................................3
2. CONVERSION OF STOCK, CONVERTIBLE SECURITIES AND OPTIONS..................................................4
2.1 MANNER OF CONVERSION............................................................................4
3. DELIVERY OF MERGER CONSIDERATION.........................................................................5
3.1 TENDER OF CONSIDERATION.........................................................................5
3.2 TENDER OF COMPANY STOCK.........................................................................5
3.3 EARNOUT.........................................................................................5
4. PRECLOSING AND CLOSING...................................................................................6
4.1 PRECLOSING......................................................................................6
4.2 CLOSING.........................................................................................6
5. REPRESENTATIONS AND WARRANTIES OF THE COMPANY AND
STOCKHOLDERS.............................................................................................6
5.1 DUE ORGANIZATION................................................................................7
5.2 AUTHORIZATION...................................................................................7
5.3 CAPITAL STOCK OF THE COMPANY AND THE SUBSIDIARY.................................................8
5.4 AUTHORITY; NO CONFLICT..........................................................................8
5.5 TRANSACTIONS IN CAPITAL STOCK; ORGANIZATION ACCOUNTING. ........................................9
5.6 [Reserved]......................................................................................9
5.7 SUBSIDIARIES....................................................................................9
5.8 PREDECESSOR STATUS; ETC.........................................................................9
5.9 SPINOFF BY THE COMPANY..........................................................................9
5.10 FINANCIAL STATEMENTS...........................................................................10
5.11 LIABILITIES AND OBLIGATIONS....................................................................10
5.12 ACCOUNTS AND NOTES RECEIVABLE..................................................................10
5.13 PATENTS AND OTHER INTELLECTUAL PROPERTY........................................................11
5.14 TRADEMARKS.....................................................................................11
5.15 LITIGATION AND LEGAL PROCEEDINGS...............................................................12
5.16 COMPLIANCE WITH APPLICABLE LAWS; PERMITS.......................................................13
5.17 EMPLOYEE BENEFITS..............................................................................14
5.18 INSURANCE POLICIES.............................................................................18
i
5.19 ENVIRONMENT....................................................................................20
5.20 LABOR AND EMPLOYMENT MATTERS...................................................................21
5.21 PERSONAL PROPERTY..............................................................................22
5.22 SIGNIFICANT CUSTOMERS; MATERIAL CONTRACTS AND COMMITMENTS......................................22
5.23 REAL PROPERTY..................................................................................24
5.24 TAXES..........................................................................................27
5.25 BUSINESS CONDUCT...............................................................................30
5.26 DEPOSIT ACCOUNTS; POWERS OF ATTORNEY...........................................................32
5.28 RELATIONS WITH GOVERNMENTS.....................................................................32
5.29 DISCLOSURE.....................................................................................32
5.31 AFFILIATE TRANSACTIONS.........................................................................34
5.32 MISREPRESENTATION..............................................................................34
5.33 BROKERS........................................................................................34
5.34 AUTHORITY; OWNERSHIP...........................................................................35
5.35 PREEMPTIVE RIGHTS..............................................................................35
5.36 NO INTENTION TO DISPOSE OF CLARANT STOCK.......................................................35
5.37 TENDER.........................................................................................35
5.38 INVESTOR QUESTIONNAIRES........................................................................35
6. REPRESENTATIONS OF CLARANT AND NEWCO....................................................................35
6.1 DUE ORGANIZATION...............................................................................35
6.2 AUTHORIZATION..................................................................................36
6.3 TRANSACTION NOT A BREACH.......................................................................36
6.4 MISREPRESENTATION..............................................................................36
6.5 CAPITAL STOCK..................................................................................36
6.6 SUBSIDIARIES...................................................................................37
6.7 LIABILITIES AND OBLIGATIONS....................................................................37
6.8 CONFORMITY WITH LAW; LITIGATION................................................................37
6.9 VALIDITY OF OBLIGATIONS........................................................................37
6.10 CLARANT COMMON STOCK...........................................................................37
6.11 NO SIDE AGREEMENTS.............................................................................38
6.12 BUSINESS; REAL PROPERTY; MATERIAL AGREEMENTS...................................................38
6.13 NO VIOLATIONS..................................................................................38
6.14 ABSENCE OF CHARGES.............................................................................38
6.15 TAXES..........................................................................................39
7. COVENANTS PRIOR TO CLOSING..............................................................................40
7.1 ACCESS AND COOPERATION; DUE DILIGENCE..........................................................40
7.2 CONDUCT OF BUSINESS PENDING CLOSING............................................................40
7.3 PROHIBITED ACTIVITIES..........................................................................41
7.4 NO SHOP........................................................................................43
7.5 NOTICE TO BARGAINING AGENTS....................................................................43
ii
7.6 AGREEMENTS.....................................................................................43
7.7 NOTIFICATION OF CERTAIN MATTERS................................................................44
7.8 COOPERATION IN PREPARATION OF REGISTRATION STATEMENT...........................................44
7.9 FINAL FINANCIAL STATEMENTS.....................................................................45
7.10 FURTHER ASSURANCES.............................................................................45
7.11 AMENDMENT OF SCHEDULES.........................................................................45
7.12 THIRD PARTY APPROVALS..........................................................................46
7.13 HSR FILING.....................................................................................46
7.14 AUTHORIZED CAPITAL STOCK.......................................................................47
8. CONDITIONS PRECEDENT TO OBLIGATIONS OF THE STOCKHOLDERS AND
THE COMPANY.............................................................................................47
8.1 REPRESENTATIONS AND WARRANTIES.................................................................47
8.2 PERFORMANCE OF OBLIGATIONS.....................................................................47
8.3 NO LITIGATION..................................................................................47
8.4 OPINION OF COUNSEL.............................................................................47
8.5 REGISTRATION STATEMENT.........................................................................48
8.6 CONSENTS AND APPROVALS.........................................................................48
8.7 GOOD STANDING CERTIFICATES.....................................................................48
8.8 SECRETARY'S CERTIFICATE........................................................................48
8.9 HSR ACT........................................................................................48
8.10 CLOSING OF THE IPO.............................................................................48
8.11 EMPLOYMENT AGREEMENTS..........................................................................48
8.12 LISTING........................................................................................49
8.13 TAX OPINION....................................................................................49
9. CONDITIONS PRECEDENT TO OBLIGATIONS OF CLARANT AND NEWCO................................................49
9.1 REPRESENTATIONS AND WARRANTIES.................................................................49
9.2 PERFORMANCE OF OBLIGATIONS.....................................................................49
9.3 NO LITIGATION..................................................................................50
9.4 COMPANY AND STOCKHOLDER REPRESENTATIONS........................................................50
9.5 NO MATERIAL ADVERSE EFFECT.....................................................................50
9.6 TERMINATION OF RELATED PARTY AGREEMENTS........................................................50
9.7 OPINION OF COUNSEL.............................................................................50
9.8 CONSENTS AND APPROVALS.........................................................................50
9.9 GOOD STANDING CERTIFICATES.....................................................................50
9.10 REGISTRATION STATEMENT.........................................................................51
9.11 EMPLOYMENT AGREEMENTS..........................................................................51
9.12 CLOSING OF IPO.................................................................................51
9.13 FIRPTA CERTIFICATE.............................................................................51
9.14 [Reserved].....................................................................................51
9.15 SATISFACTION...................................................................................51
iii
9.16 HSR ACT........................................................................................51
9.17 INVESTOR QUESTIONNAIRE.........................................................................51
9.18 THE STOCKHOLDERS' RELEASE......................................................................51
10. COVENANTS OF CLARANT AND THE STOCKHOLDERS AFTER CLOSING.................................................51
10.1 PRESERVATION OF TAX AND ACCOUNTING TREATMENT...................................................51
10.2 TAX MATTERS....................................................................................52
10.3 DIRECTORS AND OFFICERS.........................................................................53
10.4 DIRECTORS' AND OFFICERS' INSURANCE.............................................................53
10.5 LOAN GUARANTIES................................................................................53
11. INDEMNIFICATION.........................................................................................53
11.1 INDEMNIFICATION BY STOCKHOLDERS................................................................53
11.2 INDEMNIFICATION BY CLARANT.....................................................................54
11.3 INDEMNIFICATION PROCEDURE THIRD PARTY CLAIMS...................................................55
11.4 TAX CONTESTS...................................................................................57
11.5 INDEMNIFICATION PROCEDURE OTHER CLAIMS........................................................58
11.6 FAILURE TO GIVE TIMELY NOTICE..................................................................58
11.7 REDUCTION OF LOSS..............................................................................58
11.8 SUBROGATION....................................................................................58
11.9 ARBITRATION....................................................................................58
11.10 EXCLUSIVE REMEDY...............................................................................59
11.11 LIMITATION AND EXPIRATION. ....................................................................59
11.12 SURVIVAL OF REPRESENTATIONS WARRANTIES AND COVENANTS. .........................................61
12. TERMINATION OF AGREEMENT................................................................................61
12.1 TERMINATION....................................................................................61
12.2 LIABILITIES IN EVENT OF TERMINATION............................................................61
13. NONCOMPETITION..........................................................................................61
13.1 PROHIBITED ACTIVITIES..........................................................................61
13.2 DAMAGES........................................................................................62
13.3 REASONABLE RESTRAINT...........................................................................63
13.4 SEVERABILITY; REFORMATION......................................................................63
13.5 INDEPENDENT COVENANT...........................................................................63
13.6 MATERIALITY....................................................................................63
14. NONDISCLOSURE OF CONFIDENTIAL INFORMATION...............................................................64
14.1 STOCKHOLDERS...................................................................................64
14.2 CLARANT AND NEWCO..............................................................................64
14.3 DAMAGES........................................................................................65
14.4 SURVIVAL.......................................................................................65
iv
15. TRANSFER RESTRICTIONS...................................................................................65
15.1 TRANSFER RESTRICTIONS..........................................................................65
16. FEDERAL SECURITIES ACT REPRESENTATIONS..................................................................66
16.1 NONREGISTRATION OF CLARANT COMMON STOCK........................................................66
16.2 COMPLIANCE WITH LAW............................................................................66
16.3 ECONOMIC RISK; SOPHISTICATION..................................................................67
17. REGISTRATION RIGHTS.....................................................................................67
17.1 PIGGYBACK REGISTRATION RIGHTS..................................................................67
17.2 REGISTRATION PROCEDURES........................................................................68
17.3 UNDERWRITING AGREEMENT.........................................................................68
17.4 AVAILABILITY OF RULE 144.......................................................................68
17.5 MARKET STANDOFF................................................................................68
18. DEFINITIONS....................................................................................69
19. GENERAL.................................................................................................77
19.1 COOPERATION....................................................................................77
19.2 SUCCESSORS AND ASSIGNS.........................................................................77
19.3 ENTIRE AGREEMENT...............................................................................77
19.4 COUNTERPARTS...................................................................................78
19.5 EXPENSES.......................................................................................78
19.6 NOTICES........................................................................................79
19.7 GOVERNING LAW..................................................................................80
19.8 EXERCISE OF RIGHTS AND REMEDIES................................................................80
19.9 TIME...........................................................................................80
19.10 REFORMATION AND SEVERABILITY...................................................................80
19.11 STOCKHOLDERS' REPRESENTATIVE...................................................................80
19.12 CAPTIONS.......................................................................................81
19.13 SURVIVAL.......................................................................................81
19.14 ACCOUNTING TERMS...............................................................................81
v
EXHIBITS AND SCHEDULES
EXHIBIT 1.1 Articles of Merger
EXHIBIT 1.3 Surviving Corporation Charter Documents
EXHIBIT 2.1(a) Consideration
EXHIBIT 3.3 Contingent Consideration
EXHIBIT 5.2 Member and Manager Approvals
EXHIBIT 5.29(a) Directors and Officers Questionnaire
EXHIBIT 5.29(b) Investor Questionnaires
EXHIBIT 6.1 Clarant Charter Documents
EXHIBIT 8.11 Form of Employment Agreement
EXHIBIT 18 Knowledge
EXHIBIT 19.6 Stockholders' Addresses and Counsel/Wire Instructions
SCHEDULE 5.1 Charter Documents and Officers and Directors of the Company and
the Subsidiary
SCHEDULE 5.3 Capital Structure of the Company
SCHEDULE 5.4 Consents
SCHEDULE 5.8 Predecessor Status
SCHEDULE 5.10 Financial Statements
SCHEDULE 5.11 Liabilities and Obligations
SCHEDULE 5.12 Accounts Receivable
SCHEDULE 5.13 Intellectual Property
SCHEDULE 5.14 Trademarks
SCHEDULE 5.15 Litigation
SCHEDULE 5.16 Compliance with Laws/Permits
SCHEDULE 5.17 Company Plans
SCHEDULE 5.18 Insurance
SCHEDULE 5.19 Environmental
SCHEDULE 5.20 Employees
SCHEDULE 5.21 Personal Property
SCHEDULE 5.22 Material Contracts
SCHEDULE 5.23 Real Property
SCHEDULE 5.24(g) List of Tax Returns
SCHEDULE 5.24(q) Tax Elections
SCHEDULE 5.24(w) Qualified Subchapter S Subsidiaries
SCHEDULE 5.25 Business Conduct
SCHEDULE 5.26 Deposit Accounts/Powers of Attorney
SCHEDULE 5.27 Y2K
SCHEDULE 5.30 Warranties
SCHEDULE 5.31 Affiliate Transactions
vi
SCHEDULE 6.5 Clarant Securities
SCHEDULE 6.7 Liabilities & Obligations
SCHEDULE 6.8 Conformity with Law
SCHEDULE 6.9 Litigation
SCHEDULE 6.12 Property
SCHEDULE 6.13 Consents
SCHEDULE 9.11 Employment Agreements
SCHEDULE 10.4 D&O Insurance
SCHEDULE 11.1(f) Additional Indemnification Matters
SCHEDULE 18.1 Registration Statement
vii
AGREEMENT AND PLAN OF ORGANIZATION
THIS AGREEMENT AND PLAN OF ORGANIZATION (this "Agreement") is made as
of June 1, 1999, by and among CLARANT, INC., a Delaware corporation ("Clarant"),
RSI I ACQUISITION CORP., a Texas corporation ("Newco"), RSI GROUP, INC., a Texas
corporation (the "Company") RESOURCE SOLUTIONS INTERNATIONAL, LLC, a Texas
limited liability company ("the Subsidiary"), and XXXXXXX XXXXXXXX, XXXXXXX
XXXXX, and XXXXX X. XXXXX (each individually a "Stockholder" and collectively,
the "Stockholders").
WHEREAS, Newco is a corporation duly organized and existing under the
laws of the State of Texas, having been incorporated on May 3, 1999, solely for
the purpose of completing the transactions set forth herein, and is a
wholly-owned subsidiary of Clarant;
WHEREAS, the Company provides is in the business of providing
professional data processing services to businesses wishing to market through
the Internet (the "Business");
WHEREAS, the respective Boards of Directors of Newco and the Company
and the members of the Subsidiary (which together are hereinafter collectively
referred to as "Constituent Corporations") deem it advisable and in the best
interests of the Constituent Corporations and their respective stockholders
and/or members that Newco merge with and into the Company pursuant to this
Agreement and the applicable provisions of the laws of the State of Texas (the
"Merger"), and in furtherance thereof have approved the Merger; and, as
applicable, have recommended approval of the Merger to their constituent
stockholders;
WHEREAS, the Stockholders of the Company and the members of the
Subsidiary have unanimously approved the Merger;
WHEREAS, Xxxxx X. Xxxxx, as the owner of twenty percent (20%) of the
membership interests of the Subsidiary (the "Grant Interest"), and Clarant
desire, simultaneously with the consummation of the Merger, to have Xxxxx X.
Xxxxx contribute all of the Grant Interest to Clarant in exchange for Clarant
Common Stock and cash;
WHEREAS, it is the intent of Clarant, Newco, the Company and each of
the Stockholders that upon the completion of the Merger, the Company shall be
the Surviving Corporation existing as a wholly owned subsidiary of Clarant;
WHEREAS, the Subsidiary desires to join in this Agreement for the
purposes of making certain representations, warranties and covenants to Clarant
relating to the transactions contemplated by this Agreement;
WHEREAS, Clarant plans to enter into other separate agreements
substantially similar to this Agreement (the "Other Agreements") with Align
Solutions Corp., Young & Rubicam, Inc., Free Range Media, Inc., Interactive8,
Inc., Integrated Consulting, Inc., Multimedia Resources, LLC, and Potomac
Partners Management Consulting, LLC (collectively, the "Other Founding
Companies" and together with the Company, the "Founding Companies"), and their
respective principal owners in order to acquire additional Internet consulting
organizations.
WHEREAS, this Agreement and the Other Agreements constitute the
"Clarant Plan of Organization";
WHEREAS, the Boards of Directors of Clarant and the Company and the
members of the Subsidiary have approved and adopted the Clarant Plan of
Organization as an integrated plan to transfer the capital stock as membership
interests, as the case may be, of the Company and each of the Other Founding
Companies to Clarant under Section 351 of the Internal Revenue Code of 1986, as
amended (the "Code");
WHEREAS, in consideration of the agreements of the Other Founding
Companies pursuant to the Other Agreements, the Stockholders and the Board of
Directors of the Company and the stockholders and the boards of directors of
each of Clarant and Newco have approved the Merger, this Agreement and the
transactions contemplated hereby.
NOW, THEREFORE, in consideration of the premises and of the mutual
agreements, representations, warranties, provisions and covenants herein
contained, the parties hereto hereby agree as follows:
1. THE MERGER
1.1 DELIVERY AND FILING OF ARTICLES OF MERGER. The Constituent
Corporations will cause the Articles of Merger in substantially the form
attached hereto as EXHIBIT 1.1 to be signed, verified and filed with the
Secretary of State of the State of Texas and stamped receipt copies of each such
filing to be delivered to Clarant on or before the Closing Date.
1.2 EFFECTIVE TIME. At the Effective Time and subject to the terms and
conditions of this Merger and the applicable provisions of the applicable laws
governing mergers in the State of Texas (the "State Corporation Law"), Newco
shall be merged with and into the Company in accordance with the Articles of
Merger, the separate existence of Newco shall cease, and the Company shall be
the surviving party in the Merger. At the Effective Time, the effect of the
Merger otherwise shall be as provided in the applicable provisions of the State
Corporation Law.
1.3 CERTIFICATE OF INCORPORATION, BY-LAWS AND BOARD OF DIRECTORS OF
SURVIVING CORPORATION. At the Effective Time:
2
(a) the Articles of Incorporation of the Surviving Corporation
shall be amended and restated as permitted under the laws of the State of Texas
and shall read substantially in the form attached hereto as EXHIBIT 1.3;
(b) the By-laws of Newco then in effect shall be the By-laws
of the Surviving Corporation until amended as provided by law;
(c) Xxxxxxxxx X. Xxxxxx, the Chief Executive Officer of
Clarant ("Xx. Xxxxxx") shall be the sole director of the Surviving Corporation
until his successor is elected or appointed and qualified in accordance with the
terms of the By-laws of the Surviving Corporation; and
(d) Xx. Xxxxxx shall be the President and Chief Executive
Officer of the Surviving Company. The President of the Company, or the
Subsidiary, immediately prior to the Effective Time shall be a Vice President of
the Surviving Company and the other officers of the Company, except for Xx.
Xxxxxxxx and Xx. Xxxxx, immediately prior to the Effective Time shall continue
as officers of the Surviving Corporation in the same capacity or capacities.
1.4 EFFECT OF MERGER. Except as herein specifically set forth, the
identity, existence, purposes, powers, objects, franchises, privileges, rights
and immunities of each Constituent Corporation Company shall continue unaffected
and unimpaired by the Merger, and the Surviving Corporation shall be fully
vested therewith. At the Effective Time, the separate existence of Newco shall
cease and, in accordance with the terms of this Agreement, the Surviving
Corporation shall possess all the rights, privileges, immunities, powers and
franchises, of a public as well as of a private nature, and all property, real,
personal and mixed, and all debts due on whatever account, including
subscriptions to shares, and all other choses in action, and all and every other
interest of or belonging to or due to the Company or Newco shall be taken and
deemed to be transferred to, and vested in, the Surviving Corporation without
further act or deed; and all property, rights and privileges, powers and
franchises and all and every other interest shall be thereafter as effectually
the property of the Surviving Corporation as they were of the Company and Newco;
and the title to any real estate, or interest therein, whether by deed or
otherwise, under the laws of the state of incorporation vested in the Company
and Newco, shall not revert or be in any way impaired by reason of the Merger.
The Surviving Corporation shall thenceforth be responsible and liable for all
the liabilities and obligations of the Company and Newco and any claim existing,
or action or proceeding pending, by or against the Company or Newco may be
prosecuted as if the Merger had not taken place, or the Surviving Corporation
may be substituted in its place. Neither the rights of creditors nor any liens
upon the property of the Company or Newco shall be impaired by the Merger, and
all debts, liabilities and duties of the Company and Newco shall attach to the
Surviving Corporation, and may be enforced against it to the same extent as if
said debts, liabilities and duties had been incurred or contracted by it.
3
2. CONVERSION OF STOCK, CONVERTIBLE SECURITIES AND OPTIONS
2.1 MANNER OF CONVERSION. For purposes of converting the issued and
outstanding shares of capital stock of the Company ("Company Stock") under this
Agreement, the Stockholders shall be divided into two classes: (A) the first
class being Stockholders who qualify as "accredited investors" under Rule 501(a)
of Regulation D promulgated under the 1933 Act ("Accredited Stockholders") and
(B) the second class being Stockholders who do not qualify as "accredited
investors" under Rule 501(a) of Regulation D promulgated under the 1933 Act
("Non-accredited Stockholders"). Pursuant to the provisions of this Section 2.1,
each of the Accredited Stockholders and Non-accredited Stockholders shall
receive his or her pro rata share of the Merger Consideration distributed
according to the terms of this Section 2.1.
(a) At the Effective Time, by virtue of the Merger and without
any further action on the part of the holder thereof, each of the shares of
capital stock or membership interests as the case may be, of the Constituent
Corporations shall be automatically canceled, extinguished and converted or
otherwise treated as follows:
(i) each share of issued and outstanding Company
Stock owned by an Accredited Stockholder immediately prior to the Effective Time
shall be converted into the right to receive (A) that number of shares of
Clarant Common Stock as set forth on EXHIBIT 2.1(a), and (B) the amount of cash
as set forth on EXHIBIT 2.1(a);
(ii) each share of issued and outstanding Company
Stock owned by an Non-accredited Stockholder immediately prior to the Effective
Time shall be converted into the right to receive the amount of cash as set
forth on EXHIBIT 2.1(a);
(iii) each share Company Stock that is owned directly
or indirectly by the Company shall be canceled and retired and shall cease to
exist and no stock of Clarant or other consideration shall be delivered in
exchange therefor; and
(iv) each share of issued and outstanding Newco Stock
shall continue to be issued and outstanding and shall be converted automatically
into one share of validly issued, fully paid and non-assessable common stock in
the Surviving Corporation. Each stock certificate of Newco evidencing ownership
of any such shares shall evidence ownership of the shares of capital stock of
the Surviving Corporation converted pursuant to this Agreement.
(v) each issued and outstanding membership interest
of the Subsidiary shall continue to be issued and outstanding without change,
except that Clarant shall become the owner of the Grant Interest.
(b) [Reserved]
4
(c) All Clarant Common Stock received by the Stockholders
pursuant to this Agreement shall, except for restrictions on resale or transfer
described in Sections 15 and 16 hereof, have the same rights as all the other
shares of outstanding Clarant Common Stock by reason of the provisions of the
Certificate of Incorporation of Clarant or as otherwise provided by the Delaware
General Corporation Law. All voting rights of Clarant Common Stock received by
the Stockholders shall be fully exercisable by the Stockholders, and the
Stockholders shall not be deprived nor restricted in exercising those rights
after the Effective Time of the Merger.
(d) From and after the Effective Time, all shares of Company
Stock, Convertible Securities and Options of the Company shall no longer be
outstanding and shall cease to exist, and each certificate or agreement
previously representing any such securities shall represent only the right to
receive the consideration determined according to the formulas provided on
EXHIBIT 2.1(a).
3. DELIVERY OF MERGER CONSIDERATION
3.1 TENDER OF CONSIDERATION. At the Closing Clarant shall deliver to
the Stockholders the consideration allocable pro rata to each Stockholder (the
"Merger Consideration") as follows:
(a) upon the surrender by each of the Stockholders his or her
certificates for shares of Company Stock (i) each of the Accredited Stockholders
shall receive (A) the number of shares of Clarant Common Stock allocable to such
Accredited Stockholder pursuant to EXHIBIT 2.1(a) and (B) the amount of cash
allocable to such Accredited Stockholder pursuant to EXHIBIT 2.1(a); and (ii)
each of the Non-accredited Stockholders shall receive the amount of cash
allocable to such Non-accredited Stockholder pursuant to EXHIBIT 2.1(a);
(b) The cash portion of the Merger Consideration allocable to
each Accredited Stockholder or Non-accredited Stockholder, as the case may be,
shall be paid by wire transfer to the account listed on EXHIBIT 19.6.
3.2 TENDER OF COMPANY STOCK. The Stockholders shall deliver in trust to
Xxxxxx, Xxxxxx & Xxxxxxxxx, counsel to Clarant, at the Pre-Closing the
certificates representing Company Stock, duly endorsed in blank by each of the
Stockholders, or accompanied by stock powers duly endorsed in blank, with
signatures guaranteed by a national or state chartered bank or other financial
institution, and with all necessary transfer tax and other revenue stamps,
acquired at the Stockholders' expense, affixed and canceled. The Stockholders
agree promptly to cure any deficiencies with respect to the endorsement of the
stock certificates or other documents of conveyance with respect to such Company
Stock or with respect to the stock powers accompanying any Company Stock.
5
3.3 EARN-OUT. In addition to the Merger Consideration and subject to
the terms of this Section 3.3, Clarant shall deliver contingent consideration
determined according to the formula stated in EXHIBIT 3.3 (the "Contingent
Consideration") to each Stockholder on a pro rata basis. Each Accredited
Stockholder as of the Closing Date shall be eligible to receive his or her pro
rata share of Contingent Consideration in a combination of Clarant Common Stock
and cash. Each Non-accredited Stockholder as of the Closing Date shall be
eligible to receive his or her pro rata share of Contingent Consideration in
cash as provided in EXHIBIT 3.3.
4. PRE-CLOSING AND CLOSING
4.1 PRE-CLOSING. At or prior to the Pre-Closing, the parties shall take
all actions necessary to prepare to (a) effect the Merger (including, if
permitted by applicable state law, the advance filing with the appropriate state
authorities of the Certificate and Articles of Merger and/or Plan of Merger, as
applicable (collectively, the "Merger Documents"), which shall become effective
at the Effective Time) and (b) deliver the Clarant Common Stock and Company
Stock, as the case may be, referred to in Article 3 hereof; provided, that such
actions shall not include the actual completion of the Merger for purposes of
this Agreement or the delivery of such stock and transmission of funds by wire
referred to in Article 3 hereof, each of which actions shall only be taken upon
the Closing Date as herein provided. In the event that there is no Closing Date
and this Agreement terminates, Clarant hereby covenants and agrees to do all
things required by the State Corporation Law and all things which counsel for
the Company advise Clarant are required by the State Corporation Law in order to
rescind actions effected by the advance filing of the Merger Documents as
described in this Section. The taking of the actions described in clauses (a)
and (b) above (the "Pre-Closing") shall take place the day following the date
that the Registration Statement shall be declared effective by the Securities
and Exchange Commission (the "Pre-Closing Date") at the offices of Xxxxxx,
Xxxxxx & Xxxxxxxxx, 0000 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000.
4.2 CLOSING. On the Closing Date: (a) the Merger Documents shall be or
shall have been filed with the appropriate state authorities so that they shall
be or, as of 8:00 a.m. New York City time on the Closing Date, shall become
effective and the Merger shall thereby be effected, (b) all transactions
contemplated by this Agreement, including the delivery of Clarant Common Stock
and Company Stock, as the case may be, the transmission of funds by wire in an
amount equal to the cash portion of the consideration to be paid according to
EXHIBIT 2.1(a), and (c) all conditions to closing as set forth in Articles 8 and
9 of this Agreement shall have been satisfied. The date on which the actions
described in this Section 4.2 occur shall be referred to as the "Closing Date."
This Agreement shall terminate if the Closing Date has not occurred within
fifteen (15) business days of the Pre-Closing Date. Time is of the essence. The
"Effective Time" shall be the same date as the "Closing Date."
5. REPRESENTATIONS AND WARRANTIES OF THE COMPANY AND STOCKHOLDERS
6
(A) REPRESENTATIONS AND WARRANTIES OF THE COMPANY AND THE STOCKHOLDERS.
The Company, the Subsidiary and each of the Stockholders jointly and
severally represents and warrants to Clarant and Newco that all of the following
representations and warranties in this Section 5(A) are true at the date of this
Agreement, shall be true, accurate and complete at the Pre-Closing Date and the
Closing Date, in each case as modified by any applicable Schedule amendments or
supplements pursuant to Section 7.11, and each of the Stockholders further
represents and warrants that, except as contemplated hereby or as affected by
the transaction contemplated hereby, such representations and warranties shall
survive the Closing Date as provided in Article 11:
5.1 DUE ORGANIZATION. Each of the Company and the Subsidiary is duly
organized, validly existing, and in good standing under the laws of the state of
its incorporation and has all requisite power and authority to carry on its
operations as they are now being conducted, to own or use the properties and
assets it purports to own or use, and to perform all of its obligations under
the Material Contracts. Each of the Company and the Subsidiary is duly qualified
to conduct business and own its property and assets as a foreign entity in good
standing under the laws of each state in which either the ownership or use of
properties and assets owned or used by it, or the nature of the activities
conducted by it, requires such qualification and where failure to do so would
have a Material Adverse Effect. True and complete copies of the Certificate or
Articles of Incorporation and By-laws, each as amended, of the Company and the
Subsidiary (the "Charter Documents") are all attached to SCHEDULE 5.1. Neither
the Company nor the Subsidiary is in violation of any Charter Documents. The
minute books and stock records of the Company, as heretofore made available to
Clarant, are complete in all material respects and reflect all transactions of
the Company. The most recent minutes of each of the Company and the Subsidiary,
which are dated no earlier than ten (10) business days prior to the date hereof,
affirm and ratify all prior acts of each of the Company and the Subsidiary and
of its officers and directors on behalf of the Company and the Subsidiary in
respect of the transactions contemplated hereby. SCHEDULE 5.1 contains a
complete and accurate list of the directors and officers of the Company and the
Subsidiary.
5.2 AUTHORIZATION. The officers of each of the Company and the
Subsidiary executing this Agreement are duly authorized to execute and deliver
this Agreement and to perform the obligations hereunder. The execution and
delivery of this Agreement by the Company and the Subsidiary and performance by
the Company and the Subsidiary of their obligations under this Agreement and the
consummation by the Company and the Subsidiary of the transactions contemplated
hereby have been duly authorized by all necessary corporate action in accordance
with applicable law and the Charter Documents on the part of the Company, the
Subsidiary the Stockholders of the Company and the members of the Subsidiary and
copies of the respective approvals of the board of directors and the
Stockholders of the Company and the members of the Subsidiary (certified by the
Secretary of the Company to be true, accurate and complete) are
7
attached hereto as EXHIBIT.5.2. This Agreement constitutes the valid and binding
obligations of the Company and the Stockholders, enforceable against the
Company, the Subsidiary and the Stockholders in accordance with its terms,
subject to bankruptcy, reorganization, receivership and other laws affecting
creditors' rights generally and the application of equitable principles.
5.3 CAPITAL STOCK OF THE COMPANY AND THE SUBSIDIARY. The respective
designations and numbers of outstanding shares and voting rights of each class
of outstanding capital stock or membership interests, as the case may be, and
securities convertible, exercisable or redeemable for capital stock or
membership interests, as the case may be, (collectively, "Convertible
Securities"), or rights, warrants, puts, calls or options relating to capital
stock or membership interests, as the case may be, (collectively, "Options") of
the Company and of the Subsidiary as of the date of this Agreement are as set
forth on SCHEDULE 5.3 hereto. The Company and the Subsidiary have no issued and
outstanding Convertible Securities or Options. All of the issued and outstanding
shares of capital stock of the Company and membership interests of the
Subsidiary are owned by the Persons listed on SCHEDULE 5.3 and in the amounts
set forth thereon, and, except as set forth on SCHEDULE 5.3, are owned free and
clear of all Encumbrances, and no other Person (other than Clarant) has any
right to acquire any capital stock of the Company or membership interest in the
Subsidiary. All of the issued and outstanding shares of capital stock of the
Company and membership interests of the Subsidiary have been duly authorized and
validly issued, are fully paid and nonassessable, are owned of record and
beneficially by the Stockholders and were offered, issued, sold and delivered by
the Company or the Subsidiary, as the case may be in compliance with all
applicable state and Federal securities laws concerning the offering and sale or
grant of securities, and a complete list of the Company's stockholders and the
Subsidiary's members and their respective holdings of Company Stock and
membership interests in the Subsidiary are set forth on SCHEDULE 5.3. Set forth
on SCHEDULE 5.3 is a complete list of all the Subsidiary's and the Company's
stockholders' agreements, buy-sell agreements, security subscription agreements,
registration rights agreements, voting agreements, option plans and agreements
and other similar agreements (collectively, "Securities Agreements"), and a copy
of each such agreement is attached thereto. To the Knowledge of the Company, the
Subsidiary and the Stockholders, there are no breaches or defaults by the
Company, the Subsidiary or the Stockholders under any of the Company's or the
Subsidiary's Securities Agreements.
5.4 AUTHORITY; NO CONFLICT. Except to the extent consents or approvals
are required from third parties or Governmental Authorities (the "Consents"),
the execution, delivery or performance of this Agreement by the Company will
not:
(a) violate or conflict with or result in a breach of any
provision of any Law, permit, judgment, or other decision of any court or other
tribunal or any Governmental Authority binding on the Company or any Subsidiary,
or any of its respective Affiliates, or conflict with or result in the breach of
any of the terms, conditions or provisions thereof;
8
(b) violate, conflict with or constitute a default under any
of the Charter Documents of the Company or the Subsidiary or of any Material
Contract;
(c) constitute an event that would permit any Person to
terminate any Material Contract or accelerate the maturity of any material
indebtedness or other material obligation;
(d) result in the creation or imposition of any Encumbrance
upon the properties or assets of the Company or the Subsidiary; or
(e) require any authorization, consent, approval, exemption or
other action by, or notice to any court or other tribunal or Governmental
Authority (each a "Governmental Consent").
SCHEDULE 5.4 describes each third party and Governmental Authority Consent.
5.5 TRANSACTIONS IN CAPITAL STOCK; ORGANIZATION ACCOUNTING. Except as
set forth on SCHEDULE 5.3, (a) no Option, Convertible Security, or commitment of
any kind exists which obligates the Company or the Subsidiary to issue any of
its authorized but unissued capital stock or its treasury stock; and (b) neither
the Company nor the Subsidiary has any obligation (contingent or otherwise) to
purchase, redeem or otherwise acquire any of its Company Stock, Convertible
Securities or Options, the membership interests or any interests therein or to
pay any dividend or make any distribution in respect thereof.
5.6 [Reserved]
5.7 SUBSIDIARIES. The sole subsidiary of the company is the Subsidiary.
Neither the Company nor the Subsidiary presently own, of record or beneficially,
or control, directly or indirectly, any capital stock, securities convertible
into capital stock or any other equity interest in any corporation, association
or business entity (other than the Subsidiary) nor is the Company or the
Subsidiary, directly or indirectly, a participant in any joint venture,
partnership, limited liability company or other non-corporate entity. The
Subsidiary has no subsidiaries.
5.8 PREDECESSOR STATUS; ETC. Set forth on SCHEDULE 5.8 is a list of all
names of all predecessor companies of the Company and the Subsidiary, including
the names of any entities acquired by the Company (by stock purchase, merger or
otherwise) or owned by the Company or from which the Company previously acquired
material assets. Except as disclosed on SCHEDULE 5.8, the Company has not been a
subsidiary or division of another company or a part of an acquisition that was
later rescinded.
5.9 SPIN-OFF BY THE COMPANY. There has not been any sale, spin-off, or
split-up of material properties or assets of either the Company, the Subsidiary
or any other person or entity
9
that directly, or indirectly through one or more intermediaries, controls, or is
controlled by, or is under common control with, the Company ("Affiliates") since
January 1, 1997.
5.10 FINANCIAL STATEMENTS.
(a) Except as set forth on SCHEDULE 5.10, the Company and the
Subsidiary have delivered to Clarant (as SCHEDULE 5.10) copies of the following
financial statements (the "Financial Statements"): audited consolidated Balance
Sheets, income statements, statements of stockholders' equity and statements of
cash flows at and for the fiscal years ended December 31, 1996, 1997 and 1998
and unaudited consolidated Balance Sheets, income statements, statements of
stockholders' equity and statements of cash flows at and for the interim periods
ended March 31, 1999.
(b) Each of the Financial Statements fairly presents the
Company's consolidated financial condition, assets and liabilities as of their
respective dates and the results of operations and cash flows for the periods
related thereto in accordance with GAAP, consistently applied among the periods
which are the subject of the Financial Statements, except unaudited interim
financial statements which were or are subject to normal and recurring year-end
adjustments which were not and are not expected to be material in amount or to
require the addition of required footnotes thereto.
5.11 LIABILITIES AND OBLIGATIONS. The Company and the Subsidiary have
delivered to Clarant an accurate list (which is set forth on SCHEDULE 5.11) as
of the Balance Sheet Date of (a) all liabilities of the Company in excess of
$10,000 which are not reflected on the Balance Sheet at the Balance Sheet Date
or otherwise reflected in the Company Financial Statements at the Balance Sheet
Date, (b) all loan agreements, notes and other material debt obligations
(whether secured or unsecured), indemnity or guaranty agreements, bonds,
mortgages, liens, pledges or other security agreements to which the Company or
the Subsidiary is a party. Except as set forth on SCHEDULE 5.11, since the
Balance Sheet Date, neither the Company nor the Subsidiary has incurred any
material liabilities of any kind, character and description, whether accrued,
absolute, secured or unsecured, contingent or otherwise, other than liabilities
incurred in the Ordinary Course of Business that will not have a Material
Adverse Effect.
5.12 ACCOUNTS AND NOTES RECEIVABLE. The Company and the Subsidiary have
delivered to Clarant an accurate list (which is set forth on SCHEDULE 5.12) of
the accounts and notes receivable of the Company and the Subsidiary as of the
Balance Sheet Date, including any such amounts which are not reflected on the
Balance Sheet at the Balance Sheet Date, and including receivables from and
advances to employees and the Stockholders. Within ten (10) days prior to
Closing, the Company and the Subsidiary shall provide Clarant (a) an accurate
list of all outstanding receivables obtained subsequent to the Balance Sheet
Date and (b) an aging of all such accounts and notes receivable showing amounts
due in 30 day aging categories (the "A/R Aging Reports"). Except to the extent
reflected on SCHEDULE 5.12 or as disclosed by the
10
Company to Clarant in a writing accompanying the A/R Aging Reports, as the case
may be, the Company, the Subsidiary and the Stockholders have no reason to
believe that any such account, note or other receivable is not or shall not be,
collectible in the amounts shown on SCHEDULE 5.12 (in the case of the accounts
and notes receivable set forth on SCHEDULE 5.12, net of reserves reflected in
the balance sheet at the Balance Sheet Date) and as of the date of the A/R Aging
Reports, respectively.
5.13 PATENTS AND OTHER INTELLECTUAL PROPERTY.
(a) The Company owns or licenses all Intellectual Property
necessary and desirable for the Company to conduct its business in the manner
presently conducted, and all material Intellectual Property (other than
Trademarks) owned or used by the Company and/or the Subsidiary or in which or to
which it has any rights, licenses or immunities are described and set forth with
reasonable particularity in SCHEDULE 5.13 along with material information as to
the ownership thereof or licenses, rights or immunities therein and
registrations thereof;
(b) Except as disclosed in SCHEDULE 5.13:
(i) to the Knowledge of the Stockholders, the
Subsidiary and the Company, the Company and the Subsidiaries have the right and
authority to use all Intellectual Property as is necessary to enable it to
conduct and to continue to conduct all phases of its business in the manner
presently conducted and the Company and the Subsidiary has never infringed on,
misappropriated, or otherwise conflicted with, is not now infringing on,
misappropriating or otherwise conflicting with, and will not conflict with,
infringe on or misappropriate any patent or other intellectual property right
belonging to any Person;
(ii) neither the Company nor the Subsidiary is a
party to any license agreement or arrangement, whether as licensee, licensor or
otherwise, with respect to any Intellectual Property not set forth in SCHEDULE
5.13;
(iii) [Reserved]
(iv) none of the Stockholders, or any of their
Affiliates, owns any of the Intellectual Property used by the Company or the
Subsidiary; and
(v) to the Knowledge of the Stockholders, the Company
and the Subsidiary, there is no unauthorized use, infringement or
misappropriation by any third party of any Intellectual Property owned by the
Company or the Subsidiary.
5.14 TRADEMARKS. Except as disclosed in SCHEDULE 5.14:
11
(a) all trademarks, service marks, trade dress, and trade
names (including computer software and data) ("Trademarks") used by the Company
and/or the Subsidiary in the conduct of the Business are described and set forth
with reasonable particularity in SCHEDULE 5.14, along with material information
as to the ownership thereof;
(b) all such Trademarks are owned by the Company and/or the
Subsidiary, except for such as are licensed under licenses referred to in
SCHEDULE 5.14;
(c) all such Trademarks are valid and in good standing, free
and clear of any Encumbrances other than in the Ordinary Course of Business and,
to the Knowledge of the Company, the Subsidiary and the Stockholders, are not
being overtly challenged in any way;
(d) to the Knowledge of the Company, the Subsidiary and the
Stockholders, neither the Company nor the Subsidiary has infringed on is now
infringing on any Trademark of or belonging to another Person; and
(e) to the Knowledge of the Stockholders, the Subsidiary and
the Company, there is no claim pending or Threatened against the Company or the
Subsidiary with respect to alleged infringement of any Trademark owned by any
Person nor does the operation or any aspect to its business in the manner in
which it has heretofore been operated or is presently operated give rise to any
such infringement.
5.15 LITIGATION AND LEGAL PROCEEDINGS.
(a) Except as set forth in SCHEDULE 5.15:
(i) there is no suit, private proceeding, action,
liability or claim (collectively, "Actions") pending or, to the Company's, the
Subsidiary's or the Stockholders' Knowledge, Threatened, against the Company,
the Subsidiary or any Company Plan or any fiduciary of any such Company Plan or
to which the Company or the Subsidiary is otherwise a party or which may have a
Material Adverse Effect on the Company.
(ii) to the Knowledge of the Stockholders and the
Company, the Company and the Subsidiary have given all required notice of such
Actions to the appropriate insurance carrier(s) and/or all such Actions have in
the judgment of the Company's Chief Financial Officer, been fully reserved for
on the Financial Statements. SCHEDULE 5.15 lists the insurer for each Action
covered by insurance or designates each Action, or portion of each Action, as
uninsured and the individual and aggregate policy limits for the insurance
covering each insured Action and the applicable policy deductibles for each
insured Action;
12
(iii) no litigation matter (other than workers
compensation claims) to which the Company or the Subsidiary was a party was
resolved, settled or closed during the three years preceding the date of this
Agreement;
(iv) there is no pending Proceeding that has been
commenced by or against the Company or the Subsidiary that relates to or may
materially affect the Business, and, to the Knowledge of the Stockholders, the
Subsidiary and the Company, no such Proceeding has been Threatened; and
(v) neither the Company nor the Subsidiary is subject
to any judgment, Order, or decree of any court or Governmental Authority and, to
the Knowledge of the Company, the Subsidiary and the Stockholders, none is
Threatened. Except as disclosed in SCHEDULE 5.15, neither the Company or the
Subsidiary is engaged in any legal action to recover money due it or for damages
sustained by it.
(b) Matters disclosed in SCHEDULE 5.15 shall include the
following information, where applicable:
(i) a summary description of the Action together with
the following:
(1) a list all relevant documentation;
(2) if known, amounts claimed and any other
action or relief sought; and
(3) name of claimant and, if known, all
other parties to the Action.
(ii) the name of each court or agency before which
such Action is pending; and
(iii) the date such Action was instituted.
5.16 COMPLIANCE WITH APPLICABLE LAWS; PERMITS.
(a) Except as set forth on SCHEDULE 5.16, the Company and the
Subsidiary have complied in all material respects with all laws, rules,
regulations, writs, injunctions, decrees, and Orders applicable to it or to the
operation of the Business (collectively, "Laws") and has not received any notice
of any alleged claim or threatened claim, violation of, liability or potential
responsibility under, any such Law which has not heretofore been cured and for
which there is no remaining liability other than those not having a Material
Adverse Effect.
13
(b) The Company and the Subsidiary hold all licenses, permits
and other governmental authorizations (the "Permits") the absence of any of
which could have a Material Adverse Effect, and the Company has delivered to
Clarant an accurate list and summary description (which is set forth on SCHEDULE
5.16) of all such Permits. To the Knowledge of the Company, the Subsidiary and
the Stockholders, the Permits listed on SCHEDULES 5.16 are valid, and neither
the Company nor the Subsidiary has received any written notice that any
Governmental Authority intends to cancel, terminate or not renew any such
Permit. The Company and the Subsidiary have conducted and are conducting their
Business in compliance with the requirements, standards, criteria and conditions
set forth in the Permits listed on SCHEDULE 5.16 and are not in violation of any
of the foregoing except where such non-compliance or violation would not have a
Material Adverse Effect. Except as specifically provided in SCHEDULE 5.16, the
transactions contemplated by this Agreement will not result in a default under
or a breach or violation of, or adversely affect the rights and benefits
afforded to the Company and the Subsidiary by, any of the Permits listed on
SCHEDULE 5.16.
5.17 EMPLOYEE BENEFITS.
(a) As used in this Section 5.17, the following terms have the
meanings set forth below:
"COBRA" means Sections 601-608 of ERISA and Section
4980(B)(8) of the Code.
"Company Other Benefit Obligation" means an Other Benefit
Obligation the Company sponsors or maintains or with respect to which the
Company has or may have liability, in each case with respect to any present or
former employees or directors of the Company.
"Company Plan" means all Plans of which the Company is a Plan
Sponsor, or to which the Company otherwise contributes, or in which the
Company's employees have participated, or for which the Company has or may have
any liability (including with respect to previously terminated Plans).
"Company VEBA" means a VEBA whose members include employees of
the Company or any ERISA Affiliate.
"ERISA" means the Employee Retirement Income Security Act of
1974 as amended.
"ERISA Affiliate" means, with respect to the Company, any
other trade or business, whether or not incorporated, that, together with the
Company, would be treated as a single employer under Section 414 of the Code or
ERISA Section 4001.
"Multiemployer Plan" has the meaning given in ERISA
Section 3(37)(A).
14
"Other Benefit Obligations" means all obligations or
arrangements to provide benefits to present or former employees or directors
(other than obligations or arrangements that are Plans). Other Benefit
Obligations include (unless they are Plans) employment agreements, severance
agreements, executive compensation arrangements, incentive programs or
arrangements, sick leave, vacation pay, sabbaticals, severance pay policies,
plant closing benefits, salary continuation for disability, consulting, or
other compensation arrangements, workers' compensation, retirement, deferred
compensation, bonus, stock option or purchase, medical insurance, life
insurance, tuition reimbursement or scholarship programs, employee discount
programs, meals, travel, or vehicle allowances, any plans subject to Section
125 of the Code, and any plans providing benefits or payments in the event of
a change of control, change in ownership or effective control, or sale of a
substantial portion of the assets of any business or portion thereof, in each
case with respect to any present or former employees or directors and
excluding any arrangements that, in the aggregate, do not reflect liability
of the Company for more than $25,000.
"Pension Plan" has the meaning given in ERISA Section
3(2)(A).
"Plan" has the meaning given in ERISA Section 3(3),
including plans exempted by ERISA Section 4(b)(5) or excluded from coverage
under ERISA by 29 CFR Section 2510.3-3(b) as a plan covering only partners,
members, or sole properties.
"Plan Sponsor" has the meaning given in ERISA Section
3(16)(B).
"Qualified Plan" means any Company Plan that is intended to
meet the requirements of Section 401(a) of the Code.
The "Service" means the Internal Revenue Service.
"VEBA" means a voluntary employees' beneficiary association
under Section 501(c)(9) of the Code.
(b) (i) There are no Company VEBAs; and
(ii) neither the Company nor any ERISA Affiliate sponsors,
maintains or contributes to or has any actual or potential liability with
respect to any now or formerly existing (1) Multiemployer Plan or (2) Pension
Plan subject to Title IV of ERISA or Section 412 of the Code.
(c) (i) SCHEDULE 5.17 contains a complete and accurate list of
all material Company Plans and material Company Other Benefit Obligations; and
15
(ii) SCHEDULE 5.17 contains a complete and accurate list
of all ERISA Affiliates.
(d) Stockholders have provided to Clarant all of the following
documents relating to Company Plans and Company Other Benefit
Obligations:
(i) all the documents, if any, that set forth the
terms of each Company Plan and Company Other Benefit Obligation and of any
related trust, including (1) the most recent summary plan descriptions of
Company Plans for which the Company is required to distribute summary plan
descriptions, (2) the most recent, if any, summaries and descriptions furnished
to participants and beneficiaries regarding Company Plans and Company Other
Benefit Obligations for which a summary plan description is not required (and
all forms of COBRA notices), and (3) amendments, if any, to each of the
foregoing;
(ii) all personnel and employment manuals and
policies;
(iii) a written description of any Company Plan or
Company Other Benefit Obligation that is not otherwise in writing and that is
listed on SCHEDULE 5.17;
(iv) the Form 5500 or 5500 C/R, if any, filed in each
of the most recent two plan years (or three, if the most recent two 5500C/Rs do
not include a 5500C) with respect to each Company Plan, including all schedules
thereto;
(v) all material notices that were given, with
respect to a Company Plan or Other Company Benefit Obligation, by the Service,
Department of Labor, or other governmental agency to the Company or any Company
Plan within the two years preceding the date of this Agreement (and any earlier
material notices relating to matters not resolved as of the date of this
Agreement); and
(vi) with respect to Qualified Plans, (I) the most
recent determination regarding qualification and, if different, the most recent
determination letter that covered the qualification of the entire plan, or (II)
if applicable, the most recent opinion letter issued by the Service with respect
to such Qualified Plan.
(e) With respect to Plans and Other Benefit Obligations:
(i) the Company has performed all of its material
obligations under all Company Plans and Company Other Benefit Obligations;
(ii) the Company, with respect to all Company Plans
and Company Other Benefit Obligations is, and each Company Plan and Company
Other Benefit Obligation is, in material compliance with ERISA, the Code,
federal and state securities laws and other
16
applicable Laws and with the terms of each Company Plan and Company Other
Benefit Obligation;
(iii) no transaction prohibited by ERISA Section
406 and no "prohibited transaction" under Section 4975(c) of the Code have
occurred with respect to any Company Plan that could give rise to liability
against the Company in excess of $25,000;
(iv) the Company has no liability to the Service with
respect to any Plan that would have a Material Adverse Effect;
(v) the Company has no liability with respect to any
Plan under ERISA Section 502(i) that would have a Material Adverse Effect;
(vi) a determination letter, or, if applicable, an
opinion letter, has been issued by the Service with respect to each Qualified
Plan;
(vii) since December 31, 1998, there has been no
establishment or amendment of any Company Plan or Company Other Benefit
Obligation that would increase the liability of the Company by more than
$25,000;
(viii) other than routine claims for benefits
submitted by participants or beneficiaries, no claim against, or legal
proceeding involving, any Company Plan or Company Other Benefit Obligation is
pending or, to Stockholders' or the Company's Knowledge, is Threatened. No
Company Plans or Company Other Benefit Obligations are, to the Company's
Knowledge, presently under audit or examination (nor has notice been received of
a potential audit or examination) by the Service, the Department of Labor, or
any other governmental agency, and no matters are pending with respect to any
Company Plan under the Service's Employee Plans Compliance Resolutions System or
any successor or predecessor program;
(ix) no Company Plan or Company Other Benefit
Obligation provides benefits, including without limitation death or medical
benefits (whether or not insured), with respect to current or former employees
after retirement or other termination of service other than (1) coverage
mandated by applicable law, (2) death benefits or retirement benefits under any
Company Plan that is a Pension Plan, (3) deferred compensation benefits in the
form of cash, (4) benefits, the full cost of which is borne by the current or
former employee (or his beneficiary), or (5) insured disability benefits;
(x) no Company Plan or Company Other Benefit
Obligation contains any provision that would prohibit the transactions
contemplated by this Agreement or that would give rise to any acceleration or
vesting of benefits, severance, termination or other payments or liabilities as
a result of the transactions contemplated by this Agreement; and the Company has
17
not declared or paid any bonus or incentive compensation in contemplation of the
transactions contemplated by this Agreement;
(xi) all group health plans of the Company and its
ERISA Affiliates have been operated in material compliance with the requirements
of COBRA and Section 5000 of the Code and the Health Insurance Portability and
Accountability Act.
(xii) the only Qualified Plans are the Qualified
Plans identified on SCHEDULE 5.17. The Company has never maintained or
contributed to other Qualified Plans. No Company Plan contains any security
issued by the Company or any ERISA Affiliate; each Qualified Plan of the
Company is and has always been in substantial compliance with Section 401(a)
of the Code;
(xiii) the Company has paid all amounts it is
required to pay as contributions to the Company Plans as of the last day of the
most recent fiscal year of each of the plans ended before the date of this
Agreement; all benefits accrued under any unfunded Company Plan or Company Other
Benefit Obligation will have been paid, accrued, or otherwise adequately
reserved to the extent required by GAAP as of the date of this Agreement;
(xiv) no payment that is owed or may become due to
any director, officer, or employee of the Company will be non-deductible to
the Company or subject to tax under Section 280G or Section 4999 of the
Code; nor will the Company be required to "gross up" or otherwise compensate
any such Person because of the imposition of any excise or income tax on a
payment to such Person.
5.18 INSURANCE POLICIES.
(a) The Company and the Subsidiary have made available to
Clarant:
(i) true and complete copies of all policies of
insurance to which the Company or the Subsidiary is a party or any officer or
director of the Company or the Subsidiary is or has been covered at the expense
of the Company or the Subsidiary;
(ii) true, accurate and complete copies of all
pending applications by the Company or the Subsidiary for policies of insurance;
and
(iii) any written statement by the auditor of the
Company's Financial Statements with regard to the adequacy of such entity's
coverage or of the reserves for claims.
(b) SCHEDULE 5.18 describes:
18
(i) any self-insurance arrangement by or affecting
the Company and the Subsidiary, including any reserves established thereunder;
(ii) any workers' compensation schemes applicable to
the Company or the Subsidiary;
(iii) any contract or arrangement, other than a
policy of insurance, for the transfer or sharing of any risk by the Company and
the Subsidiary; and
(iv) all obligations of the Company and the
Subsidiary to third parties with respect to insurance (including such
obligations under leases and service agreements).
(c) SCHEDULE 5.18 sets forth, by year, for the current policy
year and each of the preceding two policy years:
(i) a summary of the loss experience under each
policy;
(ii) a statement describing each claim under an
insurance policy for an amount in excess of $50,000, which sets forth:
(A) the name of the claimant;
(B) a description of the policy by insurer,
type of insurance, and period of coverage; and
(C) the amount and a brief description of
the claim; and
(iii) a statement describing the loss experience for
all claims that were self- insured, including the number and aggregate cost of
such claims.
(d) Except as set forth in SCHEDULE 5.18:
(i) all insurance policies to which the Company or
the Subsidiary is a party or that provide coverage to Stockholders, or any
director or officer of the Company or the Subsidiary:
(A) are valid, outstanding, and enforceable;
(B) are issued by an insurer that the
Company and the Subsidiary believe is financially sound and reputable;
19
(C) taken together, in the Company's belief,
provide adequate insurance for the properties, assets and the Business of the
Company and the Subsidiary for all risks normally insured against by a Person
carrying on the same or similar business or businesses as the Company;
(D) comply with the insurance requirements
of all Laws and Contracts to which the Company and/or the Subsidiary is a party
or by which it is bound; and
(E) do not provide for any retrospective
premium adjustment or other experience-based liability on the part of the
Company and/or the Subsidiary;
(ii) neither the Company nor the Subsidiary has
received (A) any refusal of coverage or any notice that a defense will be
afforded with reservation of rights, or (B) any notice of cancellation or any
other indication that any insurance policy is no longer in full force or effect
or will not be renewed or that the issuer of any policy is not willing or able
to perform its obligations thereunder;
(iii) each of the Company and the Subsidiary has paid
all premiums due and has otherwise performed all of its obligations under each
policy to which the Company or the Subsidiary is a party or that provides
coverage to the Company, the Subsidiary, or director or member thereof; and
(iv) except as set forth in SCHEDULE 5.18 the Company
and the Subsidiary have given notice to the insurer of all claims that may be
insured thereby.
5.19 ENVIRONMENT.
(a) Except as set forth in SCHEDULE 5.19:
(i) the Company and the Subsidiary, and at all times
have been, in material compliance with, and has not been, and is not, in
material violation of, or materially liable under, any Environmental Law; and
(ii) with respect to Permits required by, and all
notices or applications required by, the Environmental Laws, the Company and the
Subsidiary possess all such Permits and has filed all such notices and
applications the absence of which would have a Material Adverse Effect on the
Company or the Subsidiary.
(b) Except as disclosed in SCHEDULE 5.19:
(i) neither the Company nor the Subsidiary has been
subject to, or received any, notice of any Action or intended Action relating to
the presence or alleged presence
20
of Hazardous Materials in, under, or upon any real estate currently or formerly
owned, leased or used by (A) the Company or the Subsidiary, or (B) any other
Person with respect to Hazardous Materials disposed of by or on behalf of the
Company;
(ii) the Company, the Subsidiary and Stockholders
have no Knowledge of any basis for any such notice or Action; and
(iii) there are no pending or, to the Knowledge of
the Stockholders, the Subsidiary and the Company, Threatened, Actions or
proceedings (or notice of potential actions or proceedings) from any
Governmental Authority or any other entity against or applicable to the Company
or the Subsidiary regarding any matter relating to health or protection of the
Environment.
(c) There are, and have been, no past or present events,
conditions, circumstances, activities, practices, incidents, or actions that
could reasonably be expected to interfere with or prevent the Company's or the
Subsidiary's continued compliance with any Environmental Law, give rise to any
legal obligation or liability, or otherwise form the basis of any Action,
hearing or investigation against or involving the Company or the Subsidiary or
any real estate presently or previously owned or used by the Company or the
Subsidiary under any of the Environmental Law or related common law theories,
except as identified in SCHEDULE 5.19.
(d) To the Knowledge of the Stockholders, the Subsidiary and
the Company, SCHEDULE 5.19 sets forth the name and principal place of business
of every off-site waste disposal organization, and each of the haulers,
transporters or cartage organizations engaged now or in the preceding three
years by the Business to dispose of Hazardous Materials to any off-site waste
disposal location on behalf of the Company or the Subsidiary.
5.20 LABOR AND EMPLOYMENT MATTERS.
With respect to employees of and service providers to the Company and
the Subsidiary:
(a) [Reserved]
(b) the Company and the Subsidiary are complying and has
complied in all material respects with all applicable laws respecting employment
and employment practices, terms and conditions of employment and wages and
hours, including without limitation any such laws respecting employment
discrimination, workers' compensation, family and medical leave, the Immigration
Reform and Control Act, and occupational safety and health requirements, and no
claims or investigations are pending or, to the Company's Knowledge, Threatened
with respect to such laws, either by private individuals or by Governmental
Authority;
21
(c) neither the Company nor the Subsidiary has not and is not
engaged in any unfair labor practice, and there is not now, nor within the past
three years has there been, any unfair labor practice complaint against the
Company or the Subsidiary pending or, to the Company's Knowledge, Threatened,
before the National Labor Relations Board or any other comparable authority;
(d) no labor union represents or has ever represented the
Company's or the Subsidiary's employees and no collective bargaining agreement
is or had been binding against the Company. Neither the Company nor the
Subsidiary is not currently negotiating to enter into such agreements. No
grievance or arbitration proceeding arising out of or under collective
bargaining agreements or employment relationships is pending, and no claims
therefor exist or have, to the Company's Knowledge, been Threatened;
(e) no labor strike, lock-out, slowdown, or work stoppage is
or has ever been pending or Threatened against or directly affecting the Company
or the Subsidiary;
(f) all Persons who are or were performing services for the
Company or the Subsidiary and are or were classified as independent contractors
do or did satisfy and have satisfied the requirements of law to be so
classified, and the Company and the Subsidiary has fully and accurately reported
their compensation on the Service's Form 1099 when required to do so; and
(g) SCHEDULE 5.20 hereto sets forth an accurate list, as of
the date hereof, of all employees of the Company and the Subsidiary who earned
more than $75,000 in 1998 or are expected to earn that level in 1999, and lists
all employment agreements with such employees, and the officers and directors
and the rate of compensation (and the portions thereof attributable to salary,
bonus, and other compensation respectively) of each such Person as of (a) the
Balance Sheet Date and (b) the date hereof.
5.21 PERSONAL PROPERTY.
(a) The Company and the Subsidiary have delivered to Clarant
(a) an accurate list (which is set forth on SCHEDULE 5.21) of (i) all personal
property included (or that will be included) in "depreciable plant, property and
equipment" (or similarly named line item) on the balance sheet of the Company at
the Balance Sheet Date, (ii) all other personal property owned by the Company or
the Subsidiary with a value individually in excess of $10,000 (A) at the Balance
Sheet Date and (B) acquired since the Balance Sheet Date, and (iii) all leases
and agreements in respect of personal property, together with a listing of the
capital costs of all such properties and assets which are subject to capital
leases.
(b) Except as set forth on SCHEDULE 5.21, (i) all personal
property with a value individually in excess of $10,000 used by the Company or
the Subsidiary in its business is either
22
owned by the Company or any Subsidiary or leased by the Company or the
Subsidiary pursuant to a lease included on SCHEDULE 5.21, (ii) all of the
personal property listed on SCHEDULE 5.21 is in good working order and
condition, ordinary wear and tear excepted, and (iii) all leases and agreements
included on SCHEDULE 5.21 are in full force and effect and constitute valid and
binding agreements of the Company or the Subsidiary, and to the Company's and
the Stockholders' Knowledge, of the parties (and their successors) thereto in
accordance with their respective terms.
5.22 SIGNIFICANT CUSTOMERS; MATERIAL CONTRACTS AND COMMITMENTS.
(a) The Company and the Subsidiary have delivered to Clarant
an accurate list (which is set forth on SCHEDULE 5.22) of all Significant
Customers, it being understood and agreed that a "Significant Customer," for
purposes of this Agreement, means a customer (or Person) representing 5% or more
of the Company's and the Subsidiary's annual revenues as of the Balance Sheet
Date. Except to the extent set forth on SCHEDULE 5.22, none of the Company's or
the Subsidiary's Significant Customers has canceled or substantially reduced or,
to the Knowledge of the Company or any Stockholder, is currently attempting or
threatening to cancel a contract or substantially reduce utilization of the
services provided by the Company or the Subsidiary.
(b) The Company and the Subsidiary have made available to
Clarant a true and complete copy (or in the case of oral arrangements, a
detailed summary) of each Material Contract, including all amendments or other
modifications thereto. Except as set forth on SCHEDULE 5.22, each Material
Contract is a valid and binding obligation of the Company or the Subsidiary
enforceable in accordance with its terms, and is in full force and effect,
subject to bankruptcy, reorganization, receivership and other laws affecting
creditors' rights generally and the application of equitable principles. Except
as set forth on SCHEDULE 5.22, the Company or the Subsidiary have performed all
obligations required to be performed by it under each Material Contract, and it
is not, nor, to the Knowledge of the Company or any Stockholder, is any other
party to any Material Contract (with or without the lapse of time or the giving
of notice, or both) in breach or default in any material respect thereunder.
Neither the Company nor the Subsidiary has been notified that any party to a
Material Contract intends to cancel, terminate, not renew, or exercise an option
under any Material Contract, whether in connection with the transactions
contemplated hereby or otherwise.
(c) Except as listed or described on SCHEDULE 5.22, the
Company and the Subsidiary have no Contracts of the types described below:
(i) any collective bargaining arrangement with any
labor union or any such agreements currently in negotiation or proposed;
23
(ii) any contract for capital expenditures or the
acquisition or construction of fixed assets for or in respect to real property
other than in the Ordinary Course of Business in excess of $50,000;
(iii) any contract with a term in excess of one year
for the purchase, maintenance, acquisition, sale or furnishing of materials,
supplies, merchandise, machinery, equipment, parts or other property or services
(except that the Company and the Subsidiary need not list any such contract made
in the Ordinary Course of Business which requires aggregate future payments of
less than $50,000, and in lieu of providing each individual contract, the
Company and the Subsidiary have provided to Clarant its standard subcontractor
form and a list of each subcontractor).
(iv) any contract relating to the borrowing of money,
or the guaranty of another Person's borrowing of money, including, without
limitation, all notes, mortgages, indentures and other obligations, agreements
and other instruments for or relating to any lending or borrowing, including
assumed indebtedness;
(v) any contract granting any Person an Encumbrance
on any of the properties or assets of the Company or the Subsidiary, in whole or
in part;
(vi) any contract for the cleanup, abatement or other
actions in connection with Hazardous Materials, the remediation of any existing
environmental liabilities, violation of Environmental Laws or relating to the
performance of any environmental audit or study;
(vii) any contract granting to any Person a
first-refusal, first-offer or similar preferential right to purchase or acquire
any material property or asset of the Business of the Company or the Subsidiary,
other than in the Ordinary Course of Business;
(viii) any contract having an original value in
excess of $50,000 under which the Company or the Subsidiary is:
(A) a lessee or sublessee of any machinery,
equipment, vehicle or other tangible personal property or real property, or
(B) a lessor of any real property or
machinery, equipment, vehicle or other tangible personal property owned by the
Company or the Subsidiary;
(ix) any contract providing for the indemnification
of any officer, director, employee or other Person where such indemnification
may exceed the sum of $50,000;
(x) any joint venture or partnership contract;
24
(xi) any contract that prohibits the use or
publication by the Company, the Subsidiary, Clarant or Newco of the name of any
other party to such contract or prohibits or restricts the Company or any
Subsidiary from freely providing services to any other customer or potential
customer of the Company or the Subsidiary, Clarant, Newco or any Other Founding
Company; or
(xii) a governmental contract subject to price
redetermination or renegotiation.
5.23 REAL PROPERTY.
(a) SCHEDULE 5.23 contains a complete and accurate listing of
all real property owned by the Company and the Subsidiary including the street
address, legal description, property tax identification numbers of each parcel
of real property at the Balance Sheet Date and acquired since the Balance Sheet
Date (the "Real Property"). The Company and the Subsidiary have good and
insurable title to the Real Property subject to no Encumbrance, except for:
(i) liens reflected on SCHEDULE 5.11 as securing
specified liabilities (with respect to which no default by the Company or its
Subsidiary exists);
(ii) liens for current taxes not yet due and payable
and assessments not in default;
(iii) easements for utilities serving the Real
Property only; and
(iv) easements, covenants and restrictions and other
exceptions to title shown of record in the office of the County Clerks in the
jurisdictions in which the Real Property properties, assets and leasehold
estates are located which do not adversely affect the current use of the Real
Property.
(b) Except as set forth on SCHEDULE 5.23:
(i) to the Company's and the Stockholders' Knowledge,
the Company or the Subsidiary, as the case may be, has good and valid rights of
ingress and egress to and from all Real Property from and to the public street
systems for all usual street, road and utility purposes;
(ii) to the Knowledge of the Company and the
Stockholders, all structures and all structural, mechanical and other physical
systems thereof that constitute part of the Real Property, including but not
limited to the walls, roofs and structural elements thereof and the heating,
ventilation air conditioning, plumbing, electrical, mechanical, sewer, waste
water, storm water, paving and parking equipment, systems and facility included
therein, and other material items at the Real Property, are free of defects and
in good operating condition and repair (for purposes of this section, a defect
shall mean a condition relating to the structure or any
25
structural, mechanical or physical system which requires an expenditure of
more than $1,000 to correct);
(iii) to the Knowledge of the Company and the
Stockholders, all water, sewer, gas, electric, telephone and drainage
facilities, and all other utilities required by any applicable law or by the
use and operation of the Real Property are installed to the property lines of
the Real Property, are connected pursuant to valid permits to municipal or
public utility services or proper drainage facilities, are fully operable and
are adequate to service the Real Property in the operation of the Business
and to permit full compliance with the requirements of all laws in the
operation of the business;
(iv) the Real Property and all present uses and
operations of the Real Property by the Company or the Subsidiary comply with all
applicable Laws, covenants, conditions, restrictions, easements, disposition
agreements and similar matters affecting the Real Property and the Company and
the Subsidiary have obtained all approvals of Governmental Authorities
(including certificates of use and occupancy, licenses and permits) required in
connection with the use, occupation and operation of the Real Property;
(v) to the Knowledge of the Company and the
Stockholders, there are no pending or Threatened condemnation, fire, health,
safety, building, zoning or other land use regulatory proceedings, lawsuits or
administrative actions relating to any portion of the Real Property or any other
matters which do or may adversely effect the current use, occupancy or value
thereof, nor has the Company or the Subsidiary received notice of any pending or
Threatened special assessment proceedings affecting any portion of the Real
Property;
(vi) there are no parties other than the Company or
the Subsidiary in possession of any of the Real Property or any portion thereof,
and there are no leases, subleases, licenses, concessions or other agreements,
written or oral, granting to any party or parties the right of use or occupancy
of any portion of the Real Property or any portion thereof; and
(vii) all real property taxes and assessments that
are due and payable by the Company or the Subsidiary with respect to the Real
Property have been paid or will be paid at or prior to Closing.
(c) Attached to SCHEDULE 5.23 are true, complete and correct
copies of all title reports, title insurance policies and the most recent
property tax bills for each parcel of Real Property.
(d) SCHEDULE 5.23 sets forth a complete and accurate list of
real property leased by the Company or its Subsidiaries (the "Leased Real
Property") and an indication as to which such properties, if any, are currently
owned, or were formerly owned, by Stockholders or Affiliates of the Company, any
Subsidiary, or a Stockholder. The Company has provided Clarant with true,
complete and correct copies of all leases and agreements (the "Leases") in
respect of such real property leased by the Company or its Subsidiaries.
SCHEDULE 5.23 sets forth the
26
applicable monthly rental, expiration, and renewal terms for each Lease. Except
as set forth on SCHEDULE 5.23, all Leases are in full force and effect and
constitute valid and binding agreements of the Company or its Subsidiaries and,
to the Company's and the Stockholders' Knowledge, of the parties (and their
successors) thereto in accordance with their respective terms. None of the
Leases requires the consent or approval of any party thereto in connection with
the consummation of the transactions contemplated by this Agreement.
(e) the Leased Real Property and all present uses and
operations of the Leased Real Property by the Company comply with all applicable
Laws, covenants, conditions, restrictions, easements, disposition agreements and
similar matters affecting the Leased Real Property and the Company has obtained
all approvals of Governmental Authorities (including certificates of use and
occupancy, licenses and permits) required in connection with the use, occupation
and operation of the Leased Real Property.
5.24 TAXES
(a) Neither the Company nor any Subsidiary is or has been a
member of any affiliated, consolidated, combined, unitary or similar group,
other than a group of which the Company is the common parent;
(b) All Returns required to have been filed by or with respect
to the Company and each of the Subsidiaries, including Returns of any
affiliated, combined, consolidated, unitary or similar group including the
Company or any Subsidiary (each a "Relevant Group"), have been duly filed, and
each such Return correctly and completely reports the Tax liability and all
other material information required to be reported thereon. All Taxes (whether
or not shown on any Return) owed by the Company, each Subsidiary and each
Relevant Group that are due and payable have been paid;
(c) The amount of the liability of the Company and the
Subsidiaries for unpaid Taxes as of the Balance Sheet Date did not exceed the
current liability accruals for Taxes (excluding any reserves for deferred Taxes)
set forth on the Company Financial Statements dated as of the Balance Sheet
Date. The amount of the liability of the Company and the Subsidiaries for unpaid
Taxes as of the date of any financial statements provided pursuant to Section
5.10 will not exceed the current liability accruals for Taxes (excluding any
reserves for deferred Taxes) set forth on such financial statements. The amount
of the liability of the Company and the Subsidiaries for unpaid Taxes as of the
Closing Date will not exceed the current liability accruals for Taxes (excluding
any reserves for deferred Taxes) set forth on the financial statements provided
pursuant to Section 5.10, or if there are no such financial statements, the
Company Financial Statements dated as of the Balance Sheet Date, as such
accruals are adjusted on the books and records of the Company and the
Subsidiaries through the Closing Date in accordance with past custom and
practice;
27
(d) Neither the Company, any Subsidiary nor any Relevant Group
is a party or subject to any agreement extending the time within which to file
any Return. No claim has ever been made by any Taxing Authority in any
jurisdiction in which the Company or any Subsidiary does not file Returns that
it is or may be subject to taxation by that jurisdiction;
(e) The Company and each Subsidiary has withheld and paid over
all Taxes required to have been withheld and paid over, and complied with all
information reporting and record-keeping requirements with respect to, any
amounts paid or owing to any employee, creditor, independent contractor or other
third party;
(f) No Tax Proceedings are presently pending with regard to
any Tax Returns or Taxes of the Company, any Subsidiary or any Relevant Group,
and no notice has been received (whether in writing or verbally) of the expected
commencement of a Tax Proceeding. No issues have been raised in any audit or
examination by or with respect to the Company, any Subsidiary or any member of
any Relevant Group which, by application of similar principles, could reasonably
be expected to result in a proposed deficiency for any other period not so
examined;
(g) SCHEDULE 5.24(g) attached hereto lists all material
federal, state, local and foreign income and franchise Tax Returns filed by or
with respect to the Company, each Subsidiary and each Relevant Group for all
Taxable Periods ended on or after January 1, 1991. With respect to each Return,
SCHEDULE 5.24(g) indicates whether the Return that has been examined and closed,
is presently subject to examination or is a Return with respect to which the
period for assessment under applicable law, after giving effect to extensions or
waivers, has expired. The Stockholders have made available to Clarant complete
and correct copies of all federal, state, local and foreign income and franchise
Tax Returns filed by or with respect to, and all Tax examination reports and
statements of deficiencies assessed against or agreed to by, the Company, each
Company Subsidiary and each Relevant Group since January 1, 1991;
(h) Neither the Company nor any Subsidiary nor any Relevant
Group has waived any statute of limitations in respect of Taxes or agreed to any
extension of time with respect to any Tax assessment or deficiency;
(i) Neither the Company nor any Subsidiary has made any
payments, is obligated to make any payments or is a party to any agreement that
could require it to make any payments that are not deductible pursuant to
Section 280G of the Code;
(j) Neither the Company nor any Subsidiary (i) is a party to
any Tax allocation, Tax indemnity, tax sharing agreement, or any similar
arrangement pursuant to which it has agreed to be liable for Taxes of any other
Person or (ii) has any liability for Taxes of any other Person (A) as a
transferee or successor or (B) under Section 1.1502-6 of the Treasury
regulations (or any similar provision of state, local or foreign law);
28
(k) None of the assets owned or used by the Company or any
Subsidiary constitutes tax exempt bond financed property or tax-exempt use
property within the meaning of Section 168 of the Code. Neither the Company nor
any Subsidiary is a party to any "safe harbor lease" that is subject to the
provisions of Section 168(f)(8) of the Code as in effect prior to the Tax Reform
Act of 1986, or to any "long term contract" within the meaning of Section 460 of
the Code;
(l) Neither the Company nor any Subsidiary has disposed of any
property in a transaction being accounted for under the installment method
pursuant to Section 453 of the Code;
(m) Neither the Company nor any Subsidiary is a "consenting
corporation" within the meaning of Section 341(f)(1) of the Code or comparable
provisions of any state statutes, and none of the assets of the Company or any
Subsidiary is subject to an election under Section 341(f) of the Code or
comparable provisions of any state statutes;
(n) Neither the Company nor any Subsidiary is a party to any
joint venture or partnership other than with respect to the fact that the
Subsidiary is a limited liability company;
(o) Neither the Company nor any Subsidiary will be required to
include any adjustment in taxable income in any Taxable Period ending after the
Closing Date under Section 481 of the Code (or any similar provision of the Tax
laws of any jurisdiction) as a result of any change in any method of accounting
occurring in a Taxable Period ending on or before the Closing Date. No Taxing
Authority has proposed any such change in any accounting method. The Company and
each Subsidiary presently use the accrual method of accounting for income Tax
purposes;
(p) Neither the Company nor any Subsidiary nor any member of
any Relevant Group has received any written ruling of a Taxing Authority
relating to Taxes or has entered into any closing agreement or similar written
binding agreement with a Taxing Authority relating to Taxes;
(q) SCHEDULE 5.24(q) sets forth all elections affecting the
Company or any Subsidiary with respect to (1) the qualified subchapter S status
of the Company, (2) the qualified subchapter S subsidiary status of any
Subsidiary, (3) any election made under Section 338 of the Code, (4) the
classification of the Company or any Subsidiary under Treasury Regulations
Section 301.7701-3, (5) any material change in method of accounting, and (6) net
operating and loss limitations as a result of any member leaving a consolidated
group;
(r) There are no liens or other encumbrances on any of the
assets of the Company or any Subsidiary relating or attributable to Taxes (other
than liens for Taxes not yet delinquent);
29
(s) The Company is not an investment company as defined in
Section 351(e)(1) of the Code;
(t) None of the Stockholders is a party to or bound by any
agreement or arrangement pursuant to which such Stockholder will transfer or
otherwise dispose of beneficial ownership of the Clarant Stock received by such
Stockholder pursuant to this Agreement;
(u) None of the Stockholders is under the jurisdiction of a
court in a Title 11 or similar case within the meaning of Section 351(e)(2) of
the Code.
(v) The Company (and any predecessor of the Company) has been
a validly electing S corporation within the meaning of Code ss.ss.1361 and 1362
at all times since its formation; and
(w) SCHEDULE 5.24(w) identifies each Subsidiary that is a
"qualified subchapter S subsidiary" within the meaning of Code ss.1361(b)(3)(B).
Each subsidiary so identified has been a qualified subchapter S subsidiary at
all times since the date shown on such Schedule.
5.25 BUSINESS CONDUCT. Except as set forth on SCHEDULE 5.25, since the
Balance Sheet Date, the Company and the Subsidiary have conducted the Business
only in the Ordinary Course of Business and have incurred no liabilities other
than in the Ordinary Course of Business. Except as forth on SCHEDULE 5.25, since
the Balance Sheet Date, there has not been any:
(a) change in the Company's or the Subsidiary's business,
operations, financial condition, operating results, assets or liabilities that
would have a Material Adverse Effect on the Company or the Subsidiary;
(b) damage, destruction or loss of any real or personal
property or assets owned or leased by the Company or the Subsidiary or used in
the operation of the Business, whether or not covered by insurance, having a
replacement cost in excess of $50,000;
(c) voluntary or involuntary sale, transfer, surrender,
abandonment or other disposition of any kind by the Company or the Subsidiary of
any assets or property rights (real or personal, tangible or intangible), having
a replacement cost or fair market value in excess of $50,000, except in each
case the sale of inventory and collection of accounts in the Ordinary Course of
Business;
(d) strike, picketing, boycott, work stoppage, union
organizational activity, allegation, charge or complaint of employment
discrimination, other labor dispute or similar occurrence that might reasonably
be expected to have a Material Adverse Effect;
30
(e) material loan or advance by the Company or the Subsidiary
to any party other than sales to customers on credit or travel advances to
employees made in the Ordinary Course of Business;
(f) notice (formal or otherwise) of any material liability,
potential liability or claimed liability relating to the Environment;
(g) declaration, setting aside, or payment of any dividend or
other distribution in respect to the Company's capital stock, Convertible
Securities or Options, any direct or indirect redemption, purchase, or other
acquisition of such stock, or the payment of principal or interest on any note,
bond, debt instrument or debt other than as required to be paid under the terms
of such instrument;
(h) incurrence of debts, liabilities or obligations (except
current liabilities incurred in connection with or for services rendered or
goods supplied in the Ordinary Course of Business, liabilities on account of
Taxes and governmental charges (but not penalties, interest or fines in respect
thereof), and obligations or liabilities incurred by virtue of the execution of
this Agreement);
(i) issuance by the Company or the Subsidiary of any notes,
bonds, or other debt securities or instruments or any equity securities or
securities convertible into or exchangeable for any equity securities;
(j) cancellation, waiver or release by the Company or the
Subsidiary of any material debts, liabilities, obligations, rights or claims,
except in each case in the Ordinary Course of Business;
(k) amendment of the Company's Charter Documents;
(l) amendment or termination of any Material Contract, other
than expiration of such contract in accordance with its terms;
(m) change in accounting principles, methods or practices
(including, without limitation, any change in depreciation or amortization
policies or rates) utilized by the Company or the Subsidiary;
(n) discharge or satisfaction of any material liability,
encumbrance or payment of any material obligation or liability, other than
current liabilities paid in the Ordinary Course of Business or cancellation of
any debts or claims;
(o) sale or assignment by the Company or the Subsidiary of any
properties or assets other than in the Ordinary Course of Business;
31
(p) capital expenditures or commitments therefor by the
Company or the Subsidiary other than in the Ordinary Course of Business or in
excess of $100,000 in the aggregate;
(q) charitable contributions or pledges by the Company or the
Subsidiary in excess of $25,000 in the aggregate;
(r) mortgage, pledge or other encumbrance of any property or
asset of the Company or the Subsidiary other than in the Ordinary Course of
Business;
(s) adoption, amendment or termination of any employee
benefit or pension plan; or
(t) increase in the benefits provided under any employee
benefit pension plan;
5.26 DEPOSIT ACCOUNTS; POWERS OF ATTORNEY.
(a) The Company has delivered to Clarant an accurate schedule
(which is set forth on SCHEDULE 5.26) as of the date of this Agreement of:
(i) the name of each financial institution in which
the Company or the Subsidiary has accounts or safe deposit boxes;
(ii) the names in which the accounts or boxes are
held;
(iii) the type of account and account number; and
(iv) the name of each Person authorized to draw
thereon or have access thereto.
(b) SCHEDULE 5.26 also sets forth the name of each Person,
corporation, firm or other entity holding a general or special power of attorney
from the Company or the Subsidiary and a description of the terms of such power
of attorney.
5.27 YEAR 2000 COMPLIANCE. The Company and the Subsidiary have
investigated and reviewed the areas within its business and operations and
determined, after due inquiry, that, except as set forth on SCHEDULE 5.27, all
computer systems, software and hardware used in or relied on for the business
and operations of the Company are able to accurately process date data,
including calculating, comparing and sequencing from, into and between the
twentieth century without human intervention (through year 1999), the year 2000,
and the twenty-first century, including leap year calculations ("Year 2000
Compliant"). To the Knowledge of the Company and the Stockholders, the Company's
and the Subsidiary's Significant Customers, and any other customer, vendor or
business partner of the Company whose failure to perform under any contract,
agreement or other understanding with the Company or the Subsidiary could have a
Material Adverse Effect, are or will be Year 2000 Compliant before December 31,
1999.
32
5.28 RELATIONS WITH GOVERNMENTS. Neither the Company nor the Subsidiary
has made, offered or agreed to offer anything of value to any governmental
official, political party or candidate for government office nor has it
otherwise taken any action which would cause the Company or the Subsidiary to be
in violation of the Foreign Corrupt Practices Act of 1977, as amended, or any
law of similar effect.
5.29 DISCLOSURE.
(a) This Agreement, including the schedules hereto, together
with the completed Directors and Officers Questionnaires and Investor
Questionnaires attached hereto respectively as EXHIBIT 5.29(a) and EXHIBIT
5.29(b) and all other documents and information made available to Clarant and
its representatives in writing pursuant hereto or thereto, present fairly the
Business of the Company and the Subsidiary for the time periods with respect to
which such information was requested. The Company's rights under the documents
delivered pursuant hereto would not be materially adversely affected by, and no
statement made herein would be rendered untrue in any material respect by, any
other document to which the Company, any Subsidiary or any officer, director or
Stockholder is a party, or to which its properties or assets are subject, or by
any other fact or circumstance regarding the Company and the Subsidiary (which
fact or circumstance was, or should reasonably, after due inquiry, have been
known to the Company or a Stockholder) that is not disclosed pursuant hereto or
thereto. If, prior to the 25th day after the date of the final prospectus of
Clarant utilized in connection with the IPO, the Company or the Stockholders
become aware of any fact or circumstance which would change (or, if after the
Closing Date, would have changed) a representation or warranty of the Company or
the Stockholders in this Agreement or would affect any document delivered
pursuant hereto in any material respect, the Company and the Stockholders shall
immediately give notice of such fact or circumstance to Clarant. However,
subject to the provisions of Section 7.11, such notification shall not relieve
either the Company or the Stockholders of their respective obligations under
this Agreement, and, at the sole option of Clarant, the truth and accuracy of
any and all warranties and representations of the Company, the Subsidiary or on
behalf of the Company, the Subsidiary and of the Stockholders at the date of
this Agreement by Clarant and Newco and on the Pre-Closing Date and on the
Closing Date, shall be a precondition to the consummation of this transaction.
(b) The Company, the Subsidiary and the Stockholders
acknowledge and agree: (i) that there exists no firm commitment, binding
agreement, or promise or other assurance of any kind, whether express or
implied, oral or written, that a Registration Statement will become effective or
that the IPO pursuant thereto will occur at a particular price or within a
particular range of prices or occur at all; (ii) that neither Clarant or any of
its officers, directors, agents or representatives nor any Underwriter shall
have any liability to the Company, the Subsidiary, the Stockholders or any other
Person affiliated or associated with the Company or the Subsidiary for any
failure of the Registration Statement to become effective, the IPO to occur at a
particular price or within a particular range of prices or to occur at all; and
(iii) that the decision of the Stockholders to enter into this Agreement, or to
vote in favor of or consent to the proposed
33
Merger, has been or will be made independent of, and without reliance upon, any
statements, opinions or other communications, or due diligence investigations
which have been or will be made or performed by any prospective Underwriter,
agent of Clarant or the prospective IPO; provided however that the Company, the
Subsidiary and the Stockholders retain the right to require as a condition to
Closing that the price of Clarant Common Stock sold in the IPO be no lower than
the minimum price specified on EXHIBIT 5.29(a).
5.30 WARRANTIES; PRODUCTS. SCHEDULE 5.30 sets forth a description of
all the product and service warranties and guarantees given by the Company or
the Subsidiary to any customer in connection with the sale or distribution of
its products and services. Except as described on SCHEDULE 5.30, (i) no claims
have been made or are, to the Knowledge of the Company, Threatened under the
Company's or the Subsidiary's product or service warranties, (ii) to the
Knowledge of the Company and the Subsidiary, there exists no event or
circumstance, which after notice or the passage of time or both, might create or
result in liabilities or obligations under the Company's or the Subsidiary's
product warranties in excess of the liabilities and obligations incurred by the
Company or the Subsidiary, on average, during the past two years, and (iii) to
the Knowledge of the Company, there is no design or other defect in any type of
product or service of the Company or the Subsidiary, including, without
limitation, any software programming that would cause the products or services
delivered by the Company or the Subsidiary to not be Year 2000 Compliant. The
warranty reserves reflected on the Company Financial Statements are set forth on
SCHEDULE 5.30 and are reasonable for all warranty claims.
5.31 AFFILIATE TRANSACTIONS. SCHEDULE 5.31 sets forth the parties to
and the date, nature and amount of (a) each transaction involving the transfer
of any cash, securities, property, assets or rights in which the amount involved
individually or collectively exceeded $60,000 to or from the Company or the
Subsidiary from, to, or for the benefit of any officer, director or family
member thereof or any other Affiliate or former Affiliate of the Company or the
Subsidiary ("Affiliate Transactions") during the period commencing January 1,
1996, through the date hereof and (b) any existing commitments of the Company or
the Subsidiary to engage in the future in any Affiliate Transactions. Each
Affiliate Transaction was effected on terms equivalent to those which would have
been established in an arms-length negotiation, except as disclosed on SCHEDULE
5.31.
5.32 MISREPRESENTATION. To the Knowledge of the Company and the
Stockholders none of the representations and warranties set forth in this
Agreement or in any of the certificates, schedules, exhibits, lists, documents
or other instruments delivered, or to be delivered, by the Company, the
Subsidiary or the Stockholders as contemplated by any provision hereof, contains
any untrue statement of a material fact or omits to state a material fact
necessary to make the statements contained herein or therein not misleading.
5.33 BROKERS. Neither the Company, the Subsidiary nor the Stockholders
have any liability or obligation to pay any fees or commissions to any broker,
finder, or agent with respect
34
to the transactions contemplated by this Agreement for which Clarant, Newco or
the Surviving Corporation could become liable or obligated.
(B) REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDERS
Each Stockholder severally represents and warrants to Clarant and Newco
that the representations and warranties set forth in this Section 5(B) are true,
accurate and complete as of the date of this Agreement and, shall be true,
accurate and complete at the time of the Pre-Closing and on the Closing Date,
and, subject to Section 7.11, that the representations and warranties set forth
in Sections 5.34, 5.35 and 5.36 shall survive the Closing Date as provided in
Article 11:
5.34 AUTHORITY; OWNERSHIP. Such Stockholder has the full legal right,
power and authority to enter into this Agreement and constitutes the valid and
binding obligation of each Stockholder, enforceable in accordance with its
terms. Such Stockholder owns beneficially and of record all of the shares of the
Company Stock identified on SCHEDULE 5.3 as being owned by such Stockholder,
and, except as set forth on SCHEDULE 5.3, such Company Stock is owned free and
clear of all Encumbrances.
5.35 PREEMPTIVE RIGHTS. Such Stockholder does not have, or hereby
waives, any preemptive or other right to acquire shares of Company Stock or
Clarant Stock that such Stockholder has or may have had other than rights of any
Stockholder to acquire Clarant Stock pursuant to (i) this Agreement or (ii) any
Option granted by Clarant.
5.36 NO INTENTION TO DISPOSE OF CLARANT STOCK. No Stockholder has any
current plan or intention, or is under any binding commitment or contract, to
sell, exchange or otherwise dispose of Company Stock, Convertible Securities or
Options or any Clarant Stock to be received or received pursuant to Section 3.1
or 3.3.
5.37 TENDER. Such Stockholder has full power and authority to tender,
sell, assign, and transfer the Company Stock owned by such Stockholder to
Clarant pursuant to this Agreement, that there is no Person who holds any right
of first offer, right of first refusal, right under any stockholder's agreement
or otherwise that can prevent, or otherwise delay, the transfer of Company Stock
owned by the Stockholder to Clarant under this Agreement, and that, when the
Company Stock is accepted by Clarant, Clarant will acquire good and unencumbered
title thereto, free and clear of all liens, restrictions, charges and
encumbrances and not subject to any adverse claims.
5.38 INVESTOR QUESTIONNAIRES. Such Stockholder has executed and
delivered to Clarant an Investor Questionnaire in the form attached hereto as
EXHIBIT 5.29(b), and such form is true complete and accurate in all material
respects.
35
6. REPRESENTATIONS OF CLARANT AND NEWCO
Clarant and Newco jointly and severally represent and warrant to the
Stockholders that all of the following representations and warranties in this
Article 6 are true, accurate and complete at the date of this Agreement and
shall be true, accurate and complete at the time of the Pre-Closing and on the
Closing Date, and that such representations and warranties shall survive the
Closing Date.
6.1 DUE ORGANIZATION. Clarant and NEWCO are each corporations duly
organized, validly existing and in good standing under the laws of the State of
Delaware and each is duly authorized and qualified to do business under all
applicable laws to carry on its business in the places and in the manner as now
conducted, except where the failure to be so authorized or qualified would not
have a Material Adverse Effect on Clarant. True, complete and correct copies of
the Certificate of Incorporation and By-laws, each as amended to date, of
Clarant and Newco (the "Clarant Charter Documents") are all attached hereto as
EXHIBIT 6.1.
6.2 AUTHORIZATION. The respective officers of Clarant and Newco
executing this Agreement are duly authorized to execute and deliver this
Agreement, and Clarant and Newco have the corporate right, power and authority
to enter into this Agreement and the Merger.
6.3 TRANSACTION NOT A BREACH. Neither the execution and delivery of
this Agreement or the Other Agreements, nor their performance will violate,
conflict with, or result in a breach of any provision of any Law, rule,
regulation, order, permit, judgment, injunction, decree or other decision of any
court or other tribunal or any Governmental Authority binding on Clarant or
Newco or conflict with or result in the breach of any of the terms, conditions
or provisions of the Clarant Charter Documents or of any contract, agreement,
mortgage or other instrument or obligation to which Clarant or Newco is a party
or by which Clarant or Newco is bound.
6.4 MISREPRESENTATION. None of the representations and warranties set
forth in this Agreement or in any of the certificates, schedules, exhibits,
lists, documents, or other instruments (including the most recent draft of the
Registration Statement) delivered, or to be delivered, to the Company or the
Stockholders as contemplated by any provision hereof, contains any untrue
statement of a material fact or omits to state a material fact necessary to make
the statements contained herein or therein not misleading.
6.5 CAPITAL STOCK. As of the Effective Time, the authorized capital
stock of Clarant will consist of One Hundred Million (100,000,000) shares of
common stock, par value $.10 per share (the "Clarant Common Stock") and Ten
Million (10,000,000) shares of preferred stock, par value $.10 per share
("Clarant Preferred Stock") (collectively, the "Clarant Common Stock" and
"Clarant Preferred Stock" referred to as "Clarant Stock"), and the issued and
outstanding Clarant Stock, Convertible Securities and Options of Clarant will be
as set forth on SCHEDULE 6.5. SCHEDULE 6.5 also sets forth the authorized and
outstanding Clarant Stock, Convertible Securities
36
and Options as of the date of this Agreement. As of the date of this Agreement,
one hundred percent of the issued and outstanding capital stock of Newco is
owned by Clarant. Except as part of the IPO that will take place on the Closing
Date as contemplated by this Agreement and the Other Agreements and as disclosed
in the Registration Statement, there are no outstanding options, rights
(preemptive or otherwise), warrants, calls, convertible securities or
commitments or any other arrangements to which Clarant is a party requiring
issuance, sale or transfer of any equity securities of Clarant or any securities
convertible directly or indirectly into equity securities of Clarant, or
evidencing the right to subscribe for any equity securities of Clarant, or
giving any Person other than the Founding Companies any rights with respect to
the capital stock of Clarant. At the Effective Time, Clarant shall have
outstanding only one class of capital stock (the Clarant Common Stock, and the
shares of Clarant Common Stock issued on the Closing Date pursuant to this
Agreement and the Other Agreements and to Persons who purchase shares in the IPO
will in the aggregate possess at least 80% of the total voting power of the
Clarant Common Stock that is entitled to vote and is outstanding as of the
Closing Date (after taking into account the dilution of the holdings of Clarant
Common Stock of the current Clarant stockholders). Except as will be disclosed
in the Registration Statement and as of the Closing Date, there are no voting
agreements, voting trusts, other agreements (including cumulative voting
rights), commitments or understandings with respect to the capital stock of
Clarant.
6.6 SUBSIDIARIES. Clarant has no subsidiaries except for the companies
identified as "ACQUISITION CORP." in the Other Agreements. Except as disclosed
in the Registration Statement, Clarant does not currently own, of record or
beneficially, or control, directly or indirectly, any capital stock, securities
convertible into capital stock or any other equity interest in any corporation,
association or business entity, and Clarant, directly or indirectly, is not a
participant in any joint venture, partnership or other non-corporate entity.
6.7 LIABILITIES AND OBLIGATIONS. Except as set forth on SCHEDULE 6.7 or
disclosed in the Registration Statement, Clarant has no material liabilities,
contingent or otherwise, except as set forth in or contemplated by this
Agreement and the Other Agreements and except for fees incurred in connection
with the transactions contemplated hereby and thereby.
6.8 CONFORMITY WITH LAW; LITIGATION. Except to the extent set forth on
SCHEDULE 6.8 or disclosed in the Registration Statement, Clarant is not in
violation of any Law or Order of any Governmental Authority having jurisdiction
over it which would have a Material Adverse Effect on Clarant; and except to the
extent set forth in SCHEDULE 6.9, there are no material Actions pending or, to
the Knowledge of Clarant, threatened, against or affecting Clarant, or before or
by any Governmental Authority having jurisdiction over it and no written notice
of any Action has been received by Clarant. Clarant has conducted and is
conducting its businesses in substantial compliance with applicable Laws and is
not in violation of any of the foregoing which might have a Material Adverse
Effect on Clarant.
37
6.9 VALIDITY OF OBLIGATIONS. The execution and delivery of this
Agreement by Clarant and the performance of the transactions contemplated herein
have been duly and validly authorized by the Board of Directors of Clarant and
this Agreement has been duly and validly authorized by all necessary corporate
action and is a legal, valid and binding obligation of Clarant.
6.10 CLARANT COMMON STOCK. At the time of issuance thereof, the Clarant
Common Stock to be delivered to the Stockholders pursuant to this Agreement will
constitute valid and legally issued shares of Clarant, fully paid and
nonassessable, and with the exception of restrictions upon resale set forth in
Article 15 hereof, will be identical in all substantive respects (which do not
include the form of certificate upon which it is printed or the presence or
absence of a CUSIP number on any such certificate) to the Clarant Common Stock
issued and outstanding as of the date hereof. The shares of Clarant Common Stock
to be issued to the Stockholders pursuant to this Agreement will not be
registered under the 1933 Act, except as provided in Article 17 hereof.
6.11 NO SIDE AGREEMENTS, Except as may be disclosed in the Registration
Statement, Clarant has not entered or, as of the Effective Time, will not have
entered into any material agreement with any of the Founding Companies or any of
the stockholders of the Founding Companies other than (i) the Other Agreements
and the agreements contemplated by the Other Agreements, including the
employment agreements referred to therein and (ii) other employment agreements
entered into in the ordinary course of business.
6.12 BUSINESS; REAL PROPERTY; MATERIAL AGREEMENTS. Clarant was
organized on August 21, 1998, and has conducted limited operations since that
time. Clarant has not conducted any material business since the date of its
inception, except in connection with this Agreement, the Other Agreements and
the IPO. Clarant does not own and has not at any time owned any real property or
any material personal property and is not a party to any other material
agreement, except as listed on SCHEDULE 6.12 and except that Clarant is a party
to the Other Agreements and the agreements contemplated thereby and to such
agreements as will be disclosed in, or filed as exhibits to, the Registration
Statement.
6.13 NO VIOLATIONS. Clarant is not in violation of any Clarant Charter
Document. None of Clarant, or, to the Knowledge of Clarant, any other party
thereto, is in default under any lease, instrument, agreement, license, or
permit to which Clarant is a party, or by which Clarant or any of its
properties, are bound (collectively, the "Clarant Documents"). The rights and
benefits of Clarant under the Clarant Documents will not be adversely affected
by the transactions contemplated hereby and will not result in any material
violation or breach or constitute a default under, any of the terms or
provisions of the Clarant Documents or the Clarant Charter Documents. Except as
set forth on SCHEDULE 6.13, none of the Clarant Documents requires notice to, or
the consent or approval of, any governmental agency or other third party with
respect to any of the transactions contemplated hereby in order to remain in
full force and
38
effect, and the consummation of the transactions contemplated hereby will not
give rise to any right to termination, cancellation or acceleration or loss of
any right or benefit.
6.14 ABSENCE OF CHARGES. Since March 31, 1999, except as set forth in
the Registration Statement, and except as contemplated by this Agreement and the
Other Agreements, there has not been:
(a) any change in the financial condition, assets, liabilities
(contingent or otherwise) income or business or Clarant that would have of
Material Adverse Effect on Clarant;
(b) any damage destruction or loss (whether or not covered by
insurance) materially adversely affecting the properties or business of Clarant;
(c) any change in the authorized capital of Clarant or its
outstanding securities or any change in its ownership interests or any grant of
any options, warrants, calls, conversion rights or commitments;
(d) any declaration or payment of any dividend or distribution
in respect of the capital stock or any direct or indirect redemption, purchase
or other acquisition of any of the capital stock of Clarant;
(e) any work interruptions, labor grievances or claims filed,
or any event or condition of any character, materially adversely affecting the
business of Clarant;
(f) any sale or transfer, or any agreement to sell or
transfer, any material assets, property or rights of Clarant to any person;
(g) any cancellation or agreement to cancel, any indebtedness
or other obligation owing Clarant;
(h) any plan, agreement or arrangement granting any
preferential rights to purchase or acquire any interest in any of the assets,
property or rights of Clarant or requiring consent of any party to the transfer
and assignment of any such assets, property or rights;
(i) any waiver of any material rights or claims of Clarant;
(j) any amendment or termination of any material contract,
agreement, license, permit or other right to which Clarant is a party;
(k) any transaction by Clarant outside the Ordinary Course of
Business; or
39
(l) any other distribution of property or assets by Clarant
other than in the Ordinary Course of Business;
6.15 TAXES. All Returns required to have been filed by or with respect
to Clarant have been duly filed. No Tax Proceedings are presently pending with
regard to any Tax Returns or Taxes of Clarant, and no notice has been received
(whether in writing or verbally) of the expected commencement of such a Tax
Proceeding. All Taxes (whether or not shown on any Return) owed by Clarant have
been paid.
7. COVENANTS PRIOR TO CLOSING
7.1 ACCESS AND COOPERATION; DUE DILIGENCE.
(a) Between the date of this Agreement and the Closing Date,
the Company and the Subsidiary will afford to the officers, directors and
authorized representatives of Clarant reasonable access during normal business
hours to all of the Company's and its Subsidiaries' sites, properties, books and
records and will furnish Clarant with such additional financial and operating
data and other information as to the Business and properties and assets of the
Company and its Subsidiaries as Clarant may from time to time reasonably
request. The Company and the Subsidiary will cooperate with Clarant and its
representatives, including Clarant's auditors and counsel, in the preparation of
any documents or other material (including the Registration Statement) which may
be required in connection with the transactions contemplated by this Agreement.
Clarant, Newco, the Stockholders and the Company and its Subsidiaries will treat
all information obtained in connection with the negotiation and performance of
this Agreement or the due diligence investigations conducted with respect to the
Other Founding Companies as confidential in accordance with the provisions of
Article 14 hereof. In addition, Clarant will cause each of the Other Agreements,
binding each of the Other Founding Companies, to contain a provision similar to
this Section 7.1 requiring each such Other Founding Company, its stockholders,
directors, officers, representatives, employees and agents to keep confidential
any information obtained by such Other Founding Company.
(b) Between the date of this Agreement and the Closing Date,
Clarant will afford to the officers and authorized representatives of the
Company and the Subsidiary access to all of Clarant's and Newco's sites,
properties, books and records and will furnish the Company and the Subsidiary
with such additional financial and operating data and other information as to
the Business and properties of Clarant and Newco as the Company and the
Subsidiary may from time to time reasonably request. Clarant and Newco will
cooperate with the Company, the
40
Subsidiary, its representatives, auditors and counsel in the preparation of any
documents or other material which may be required in connection with the
transactions contemplated by this Agreement. The Company, the Subsidiary and the
Stockholders will cause all information obtained in connection with the
negotiation and performance of this Agreement to be treated as confidential in
accordance with the provisions of Article 14 hereof.
7.2 CONDUCT OF BUSINESS PENDING CLOSING. Between the date of this
Agreement and the Closing Date, the Company and the Subsidiary will:
(a) carry on in the Ordinary Course of Business substantially
as conducted heretofore and not introduce any new method of management,
operation or accounting;
(b) maintain its properties, assets and facilities, including
those held under leases, in as good working order and condition as at present,
ordinary wear and tear excepted;
(c) perform in all material respects its obligations under
agreements relating to or affecting the Business;
(d) keep in full force and effect present insurance policies
or other comparable insurance coverage;
(e) use their commercially reasonable best efforts to maintain
and preserve its business organization intact and use its best efforts to retain
its present management, key employees and relationships with suppliers,
customers and others having business relations with the Company or the
Subsidiary;
(f) maintain compliance in all material respects with all
Permits, Laws, rules and regulations, consent orders, and all other orders of
applicable courts, regulatory agencies and similar Governmental Authorities; and
(h) maintain present debt and lease instruments in accordance
with their respective terms and not enter into new or amended debt or lease
instruments, except as disclosed on SCHEDULE 5.25, provided that debt and/or
lease instruments may be replaced if such replacement instruments are on terms
at least as favorable to the Company or the Subsidiary as the instruments being
replaced.
7.3 PROHIBITED ACTIVITIES. Between the date hereof and the Closing
Date, neither the Company nor the Subsidiary will, without the prior written
consent of Clarant:
(a) make any change in its Charter Documents;
41
(b) grant or issue any securities, Options, conversion rights
or commitments of any kind relating to its securities of any kind other than in
connection with the exercise of Options listed on SCHEDULE 5.3;
(c) declare or pay any dividend, or make any distribution in
respect of its securities whether now or hereafter outstanding, or purchase,
redeem or otherwise acquire or retire for value any securities or engage in any
transaction that will significantly affect the cash reflected on the Balance
Sheet of the Company at the Balance Sheet Date;
(d) enter into any contract or commitment or incur or agree to
incur any liability or make any capital expenditure, except if it is in the
Ordinary Course of Business and involves an amount not in excess of $50,000;
(e) create, assume or permit to exist any Encumbrance upon any
assets or properties whether now owned or hereafter acquired, except (i) with
respect to purchase money liens incurred in connection with the acquisition of
equipment with an aggregate cost not in excess of $10,000 necessary or desirable
for the conduct of the Business of the Company and the Subsidiary, (ii) (1)
liens for Taxes either not yet delinquent or being contested in good faith and
by appropriate proceedings (and for which adequate reserves have been
established and are being maintained) or (2) materialmen's, mechanics',
workers', repairmen's, employees' or other like liens arising in the Ordinary
Course of Business (the liens set forth in clause (ii) being referred to herein
as "Statutory Liens"), or (iii) liens set forth on SCHEDULE 5.11 OR 5.23 hereto;
(f) sell, assign, lease or otherwise transfer or dispose of
any property, assets or equipment except in the Ordinary Course of Business;
except that, at the request of either Xx. Xxxxxxxx or Xx. Xxxxx, as the case may
be, the Company may assign to either Xx. Xxxxxxxx or Xx. Xxxxx, as the case may
be, certain [LIST POLICIES] whole and term life insurance policies taken out by
the Company for the benefit of Xx. Xxxxxxxx and Xx. Xxxxx and provided that the
cash portion of the Merger Consideration to be paid to Xx. Xxxxxxxx or Xx. Xxxxx
shall be reduced by the cash value of such insurance policies if Xx. Xxxxxxxx or
Xx. Xxxxx, as the case may be, request the assignment of such life insurance
policies.
(g) negotiate for the acquisition of any business or the
start-up of any new business;
(h) merge or consolidate or agree to merge or consolidate with
or into any other entity;
(i) waive any material right or claim of the Company or the
Subsidiary, provided that the Company and the Subsidiary may negotiate and
adjust bills in the course of good faith disputes with customers in a manner
consistent with past practice, provided, further,
42
that such adjustments shall not be deemed to be included on SCHEDULE 5.12 unless
specifically listed thereon;
(j) commit a material breach or amend or terminate any
Material Contract to which the Company or the Subsidiary is a party or as to
which it is a beneficiary;
(k) enter into any other transaction outside the Ordinary
Course of Business or prohibited hereunder;
(l) except in the Ordinary Course of Business or as required
by Law or contractual obligations or other understandings or arrangements
existing on the date hereof, neither the Company nor the Subsidiary will (A)
increase in any manner the base compensation of, or enter into any new bonus or
incentive agreement or arrangement with, any of the officers, directors or
employees engaged in the Company's or the Subsidiary's Business, (B) pay or
agree to pay any additional pension, retirement allowance or other employee
benefit to any such officers, directors or employee, whether past or present,
(C) enter into any new employment, severance, consulting, or other compensation
agreement with any existing officers, directors or employee engaged in the
Company's or the Subsidiary's Business, (D) amend or enter into a new Plan or
Other Benefit Obligation (except as required by Law) or amend or enter into a
new collective bargaining agreement (except as required by this Agreement), or
(E) engage in any Affiliate Transactions;
(m) make or change any Tax election, amend any Tax Return or
take or omit to take any other action not in the Ordinary Course of Business and
consistent with past practice that would have the effect of increasing any Taxes
of Clarant, the Company or any Subsidiary for any Taxable Period ending after
the Closing Date; or
(n) without the express prior written consent of Clarant,
amend, modify, repeal or otherwise alter the approvals by the Company's board of
directors by the Company's stockholders, and by the members of the Subsidiary
attached hereto as EXHIBIT 5.2.
7.4 NO SHOP. In consideration of the substantial expenditure of time,
effort and expense undertaken by Clarant in connection with its due diligence
review and the preparation and execution of this Agreement, the Company, the
Subsidiary and the Stockholders agree that neither they nor their
representatives, agents or employees will, after the execution of this Agreement
until the earlier of (a) the termination of this Agreement or (b) the Closing,
directly or indirectly, solicit, encourage, negotiate or discuss with any third
party (including by way of furnishing any information concerning the Company or
the Subsidiary) any acquisition proposal relating to or affecting the Company or
the Subsidiary or any part of it, or any direct or indirect interests in the
Company or the Subsidiary, whether by purchase of assets or stock, purchase of
interests, merger or other transaction, and further agree that the Company and
the Subsidiary will promptly advise Clarant of the terms of any communications
any of the Stockholders, the
43
Company or the Subsidiary may receive or become aware of relating to any bid for
all or any part of the Company or the Subsidiary.
7.5 NOTICE TO BARGAINING AGENTS. Prior to the Closing Date, the Company
and the Subsidiary shall satisfy any requirement for notice of the transactions
contemplated by this Agreement under applicable collective bargaining
agreements, and shall deliver to Clarant at the Pre-Closing, any and all proof
that any such required notice has been sent.
7.6 AGREEMENTS. On or prior to the Closing Date and effective as of the
Effective Time, the Company and the Subsidiary shall cause the termination of
and obtain a written waiver of rights from any beneficiary under (and shall
deliver evidence of such terminations and waivers to Clarant prior to Closing)
(a) all Securities Agreements, (b) any employment agreements between the
Company, the Subsidiary and any employee who is listed on SCHEDULE 9.11 hereto,
and (c) any existing agreement between the Company or the Subsidiary and any
Stockholders or other security holders.
7.7 NOTIFICATION OF CERTAIN MATTERS.
(a) The Stockholders, the Company and the Subsidiary shall
give prompt notice to Clarant of (i) the occurrence or non-occurrence of any
event the occurrence or non-occurrence of which would be likely to cause any
representation or warranty of the Company, the Subsidiary or the Stockholders
contained herein to be untrue or inaccurate in any material respect; (ii) any
material failure of any Stockholder, the Company or the Subsidiary to comply
with or satisfy any covenant, condition or agreement to be complied with or
satisfied by such Person hereunder and (iii) the exercise by any Person of any
Option or Convertible Security listed on SCHEDULE 5.3 or any enforceable request
for the Company or the Subsidiary to purchase, redeem or otherwise acquire any
of its Company Stock, Convertible Securities or Options;
(b) Clarant and Newco shall give prompt notice to the Company
and the Subsidiary of (i) the occurrence or non-occurrence of any event the
occurrence or non-occurrence of which would be likely to cause any
representation or warranty of Clarant or Newco contained herein to be untrue or
inaccurate in any material respect and (ii) any material failure of Clarant or
Newco to comply with or satisfy any covenant, condition or agreement to be
complied with or satisfied by it hereunder;
(c) The delivery of any notice pursuant to this Section 7.7
shall not be deemed to (i) modify the representations or warranties hereunder of
the party delivering such notice, which modification may only be made pursuant
to Section 7.11, (ii) modify the conditions set forth in Articles 8 and 9, or
(iii) limit or otherwise affect the remedies available hereunder to the party
receiving such notice.
44
7.8 COOPERATION IN PREPARATION OF REGISTRATION STATEMENT.
(a) The Company, the Subsidiary and Stockholders shall furnish
or cause to be furnished to Clarant and the Underwriters all of the information
concerning the Company, the Subsidiaries and the Stockholders requested by
Clarant or the Underwriters for inclusion in, and will cooperate with Clarant
and the Underwriters in the preparation of, the Registration Statement and the
prospectus included therein (including audited and unaudited financial
statements, prepared in accordance with generally accepted accounting
principles, in form suitable for inclusion in the Registration Statement). The
Company, the Subsidiary and the Stockholders agree promptly to advise Clarant if
at any time during the period in which a prospectus relating to the offering is
required to be delivered under the Securities Act, any information contained in
the prospectus concerning the Company, the Subsidiary or the Stockholders
contains any untrue statement of a material fact or omits to state a material
fact required to be stated therein or necessary to make the statements therein
not misleading, and to provide the information needed to correct such
inaccuracy. Insofar as the information relates solely to the Company, the
Subsidiary or the Stockholders, the Company and the Subsidiary represents and
warrants as to such information with respect to itself and the Subsidiary, and
each Stockholder represents and warrants, as to such information with respect to
the Company, the Subsidiary and himself or herself, that the Registration
Statement at its effective date, at the date of the final Prospectus, each
preliminary prospectus and each amendment to the Registration Statement, and at
each closing date with respect to the IPO under the Underwriting Agreement
(including with respect to any over-allotment option) will not include an untrue
statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein not misleading.
(b) Clarant agrees that it will use its commercially
reasonable best efforts to provide to the Company and its counsel copies of
drafts of the Registration Statement as they are prepared and give the Company,
the Subsidiary and the Stockholders a reasonable period of time to review and
comment upon such documents prior to filing with the SEC. Any objections posed
by the Company or its counsel shall be in writing and state with specificity the
material in question, the reason for the objection, and the Company's and the
Stockholders' proposed alternative. If the objection is founded upon a rule
promulgated under the Securities Act, the objection shall cite the rule.
Notwithstanding the foregoing, during the three business days immediately
preceding the date scheduled for the effective date of the IPO, the Company and
the Stockholders agree that two hours from the time the proposed changes are
transmitted to the Company and the Company's counsel is sufficient time to
review and respond to proposed changes.
7.9 FINAL FINANCIAL STATEMENTS. The Company shall provide prior to the
Closing Date, and Clarant shall have had sufficient time prior thereto to
review, the unaudited consolidated Balance Sheets of the Company as of the end
of all fiscal quarters following the Balance Sheet Date, and the unaudited
consolidated income statements, statements of cash flows and retained earnings
of the Company for all fiscal quarters ended after the Balance Sheet Date. Such
Financial Statements shall have been prepared in accordance with GAAP applied on
a consistent
45
basis throughout the periods indicated and in a manner consistent with the
Financial Statements (except as noted therein). Except as noted in such
Financial Statements, all of such Financial Statements will present fairly the
results of operations of the Company for the periods indicated thereon.
7.10 FURTHER ASSURANCES. The parties hereto agree to execute and
deliver, or cause to be executed and delivered, such further instruments or
documents or take such other action as may be reasonably necessary or convenient
to carry out the transactions contemplated hereby.
7.11 AMENDMENT OF SCHEDULES. Each party hereto agrees that, with
respect to the representations and warranties of such party contained in this
Agreement, such party shall have the continuing obligation, until 24 hours prior
to the anticipated effectiveness of the Registration Statement, to supplement or
amend promptly the Schedules hereto with respect to any matter hereafter arising
or discovered which, if existing or known at the date of this Agreement, would
have been required to be set forth or described in the Schedules, provided
however, that supplements and amendments to Schedules 5.11 (Liabilities and
Obligations), 5.12 (Accounts and Notes Receivable) and 5.22 (Significant
Customers; Material Contracts and Commitments) must be delivered only at the
Closing Date, unless such Schedule is to be amended to reflect an event
occurring other than in the Ordinary Course of Business; and further provided
that all matters identified by the Company on any Schedule supplement or
amendment shall also be included on SCHEDULE 11.1(f). Notwithstanding the
foregoing sentence, no amendment or supplement to a Schedule prepared by the
Company that constitutes or reflects an event or occurrence that would have a
Material Adverse Effect on the Company may be made unless Clarant and a majority
of the Founding Companies other than the Company consent to such amendment or
supplement; and provided further, that no amendment or supplement to a Schedule
prepared by Clarant or Newco that constitutes or reflects an event or occurrence
that would have a Material Adverse Effect on Clarant and Newco may be made
unless a majority of the Founding Companies consent to such amendment or
supplement. For all purposes of this Agreement, including without limitation for
purposes of determining whether the conditions set forth in Sections 8.1 and 9.1
have been fulfilled, the Schedules hereto shall be deemed to be the Schedules as
amended or supplemented pursuant to this Section 7.11. In the event that one of
the Other Founding Companies seeks to amend or supplement a Schedule pursuant to
this Section 7.11 of one of the Other Agreements, and such amendment or
supplement constitutes or reflects an event or occurrence that would have a
Material Adverse Effect on such Other Founding Company, Clarant shall give the
Company notice promptly after it has knowledge thereof. If Clarant and a
majority of the Founding Companies consent to such amendment or supplement,
which consent shall have been deemed given by Clarant or any Founding Company if
no response is received within 24 hours following receipt of notice of such
amendment or supplement (or sooner if required by the circumstances under which
such consent is requested), but the Company does not give its consent, the
Company may terminate this Agreement pursuant to Section 12.1(d). In the event
that the Company seeks to amend or supplement a Schedule pursuant to this
Section 7.11, and Clarant and a majority of the Other Founding Companies do not
consent to such amendment or supplement, this Agreement shall be deemed
terminated by
46
mutual consent as set forth in Section 12.1(a). No amendment of or supplement to
a Schedule shall be made later than 24 hours prior to the anticipated
effectiveness of the Registration Statement.
7.12 THIRD PARTY APPROVALS. Prior to the Closing Date, the Company and
the Subsidiary shall satisfy any requirement for notice and approval of the
transactions contemplated by this Agreement under applicable agreements with
third parties, including any contract with any Governmental Authority.
7.13 HSR FILING. To the extent the Merger is a transaction subject to
the filing requirements of the HSR Act, each of the Company, the Stockholders
and Clarant shall use its commercially reasonable best efforts to (a) file all
information required to be filed by it pursuant to the HSR Act and (b) provide
the other party with all information reasonably requested and required by it to
satisfy any filing requirements it may have under the HSR Act.
7.14 AUTHORIZED CAPITAL STOCK. Through the Closing Date, Clarant shall
maintain its authorized capital stock as set forth in the Registration Statement
filed with the SEC except for such changes as are made to respond to comments
made by the SEC or requirements of any exchange or automated trading system for
which application is made to register the Clarant Common Stock.
8. CONDITIONS PRECEDENT TO OBLIGATIONS OF THE STOCKHOLDERS
AND THE COMPANY
The obligations of the Stockholders, the Company and the Subsidiary
with respect to actions to be taken on the Pre-Closing Date and, to the extent
specified in this Article 8, on the Closing Date are subject to the satisfaction
or waiver on or prior to the Pre-Closing Date and/or the Closing Date, as the
case may be, of all of the conditions set forth in this Article 8. As of the
Pre-Closing Date or the Closing Date, as the case may be, all conditions not
satisfied shall be deemed to have been waived by the Company, the Subsidiary and
the Stockholders unless such parties have objected by notifying Clarant in
writing of such objection on or before the Pre-Closing Date or consummation of
the transactions on the Closing Date, respectively, except that no such waiver
shall be deemed to affect the survival of the representations and warranties of
Clarant and Newco contained in Article 6 hereof.
8.1 REPRESENTATIONS AND WARRANTIES. All representations and warranties
of Clarant and Newco contained in Article 6 shall be true and correct in all
material respects as of the Pre-Closing Date and the Closing Date as though such
representations and warranties had been made as of that time; and a certificate
to the foregoing effect dated the Pre-Closing Date and the Closing Date and
signed by the President, any Vice President or the Secretary of Clarant shall
have been delivered to the Stockholders.
47
8.2 PERFORMANCE OF OBLIGATIONS. All of the terms, covenants and
conditions of this Agreement to be complied with and performed by Clarant and
Newco on or before each of the Pre-Closing Date and the Closing Date shall have
been duly complied with and performed in all material respects on or before each
of the Pre-Closing Date and the Closing Date, as the case may be; and
certificates to the foregoing effect dated each of the Pre-Closing Date and the
Closing Date and signed by the President, any Vice President or the Secretary of
Clarant shall have been delivered to the Stockholders.
8.3 NO LITIGATION. No Action or Proceeding before a court or any other
governmental agency or body shall have been instituted or Threatened to restrain
or prohibit the Merger or the IPO and no Governmental Authority shall take any
other action with respect to the transactions hereunder which would have a
Material Adverse Effect on Clarant.
8.4 OPINION OF COUNSEL. The Company shall have received an opinion from
counsel for Clarant, dated the Pre-Closing Date in form and substance of the
type customarily given by counsel to an acquiring company in transactions
similar to that contemplated by this Agreement and acceptable to the Company
(and the Underwriters shall have received a copy of the same opinion addressed
to them), and at the Closing the Company shall have received a statement from
such counsel that the opinion is true as of the Closing Date.
8.5 REGISTRATION STATEMENT. The Registration Statement shall have been
declared effective by the SEC and no stop order suspending the effectiveness of
the Registration Statement shall be in effect and no proceeding therefor shall
have been instituted or shall be pending or contemplated under the 1933 Act, and
the Underwriters shall have agreed to acquire on a firm commitment basis,
subject to the conditions set forth in the Underwriting Agreement, shares of
Clarant Common Stock for a price no lower than the minimum price specified on
EXHIBIT 2.1(a).
8.6 CONSENTS AND APPROVALS. All necessary consents of and filings
required to be obtained or made by Clarant or Newco with any Governmental
Authority or agency relating to the consummation of the transactions
contemplated herein shall have been obtained and made.
8.7 GOOD STANDING CERTIFICATES. Clarant and Newco each shall have
delivered to the Company a certificate, dated as of a date no earlier than ten
(10) days prior to the Pre-Closing Date, duly issued by the Delaware Secretary
of State and in each state in which Clarant or Newco is authorized to do
business, showing that each of Clarant and Newco is in good standing and
authorized to do business and that all state franchise and/or income tax returns
and taxes for Clarant and Newco, respectively, for all periods prior to the
Closing have been filed and paid.
8.8 SECRETARY'S CERTIFICATE. The Company shall have received a
certificate or certificates, dated the Pre-Closing Date and the Closing Date and
signed by the secretary of Clarant and of Newco, certifying the truth and
correctness of attached copies of the Clarant's and
48
Newco's respective Certificates of Incorporation (including amendments thereto),
By-Laws (including amendments thereto), and resolutions of the boards of
directors and, if required, the Stockholders of Clarant and Newco approving
Clarant's and Newco's entering into this Agreement and the consummation of the
transactions contemplated hereby.
8.9 HSR ACT. The waiting period applicable to the consummation of the
transaction contemplated by this Agreement under the HSR Act shall have expired
or been terminated.
8.10 CLOSING OF THE IPO. The Closing of the sale of the Clarant Common
Stock to the Underwriters in the IPO shall have occurred simultaneously with the
Closing Date hereunder.
8.11 EMPLOYMENT AGREEMENTS. Each of the persons listed on SCHEDULE 9.11
shall have been afforded the opportunity to enter into an employment agreement
substantially in the form of EXHIBIT 8.11.
8.12 LISTING. Clarant shall cause the Clarant Common Stock to be listed
on the Nasdaq National Stock Market, subject to official notice of issuance.
8.13 TAX OPINION. Clarant shall have received an opinion upon which the
Company and the Stockholders will be entitled to rely (the "Tax Opinion") from
Xxxxxx, Xxxxxx & Xxxxxxxxx, tax counsel for Clarant, or such other tax counsel
reasonably acceptable to Clarant and the Company ("Tax Counsel") that the
Clarant Plan of Organization will qualify as a tax-free transfer of property
under Section 351(a) of Code and that the Stockholders will not recognize gain
to the extent the Stockholders exchange Company Stock or membership interests,
as the case may be, for Clarant Common Stock (but not cash or other property)
pursuant to the Clarant Plan of Organization, and in rendering such Tax Opinion,
Tax Counsel shall be entitled to rely on customary written representations
acceptable to Tax Counsel and received from (i) Clarant and (ii) the Company,
(ii) the Company, (iii) each Other Founding Company, and (iv) each Stockholder
and each contributor, stockholder or member of the Other Founding Companies who
will receive Clarant Common Stock under the Clarant Plan of Organization.
9. CONDITIONS PRECEDENT TO OBLIGATIONS OF CLARANT AND NEWCO
The obligations of Clarant and Newco with respect to actions to be
taken on the Pre-Closing Date and on the Closing Date, are subject to the
satisfaction or waiver on or prior to the Pre-Closing Date and/or the Closing
Date, as the case may be, of all of the conditions set forth in this Article 9.
As of the Pre-Closing Date or the Closing Date, as the case may be, all
conditions not satisfied shall be deemed to have been waived by Clarant and
Newco unless such parties have objected by notifying the Company and the
Stockholders in writing of such objection on or before the Pre-Closing Date or
consummation of the transactions on the Closing Date, respectively, except that
no such waiver shall be deemed to affect the survival of the
49
representations and warranties of the Company, the Subsidiary and the
Stockholders contained in Article 5 hereof.
9.1 REPRESENTATIONS AND WARRANTIES. All the representations and
warranties of the Stockholders, the Company and the Subsidiary contained in this
Agreement shall be true and correct in all material respects as of the
Pre-Closing Date and the Closing Date with the same effect as though such
representations and warranties had been made on and as of such date; and the
Stockholders shall have delivered to Clarant certificates dated the Pre-Closing
Date and the Closing Date and signed by them to such effect.
9.2 PERFORMANCE OF OBLIGATIONS. All of the terms, covenants and
conditions of this Agreement to be complied with or performed by the
Stockholders, the Company and the Subsidiary on or before each of the
Pre-Closing Date and the Closing Date shall have been duly performed or complied
with in all material respects on or before each of the Pre-Closing Date and the
Closing Date, as the case may be; and the Stockholders shall have delivered to
Clarant certificates dated the Pre-Closing Date and the Closing Date,
respectively, and signed by them to such effect.
9.3 NO LITIGATION. No Action or Proceeding before a court or any other
Governmental Authority or body shall have been instituted or Threatened to
restrain or prohibit the Merger or the IPO and no Governmental Authority or body
shall have taken any other action or made any request of Clarant as a result of
which the management of Clarant deems it inadvisable to proceed with the
transactions hereunder.
9.4 COMPANY AND STOCKHOLDER REPRESENTATIONS. The Company and the
Stockholders who will receive Clarant Common Stock shall have provided Tax
Counsel with the written representations requested pursuant to Section 8.13.
9.5 NO MATERIAL ADVERSE EFFECT. As of the Pre-Closing Date and as of
the Closing Date, no event or circumstance shall have occurred which would
constitute a Material Adverse Effect.
9.6 TERMINATION OF RELATED PARTY AGREEMENTS. All existing agreements
between the Company or the Subsidiary and the Stockholders shall have been
canceled effective prior to or as of the Closing Date and the Company shall have
obtained all of the terminations and waivers required under Section 7.6.
9.7 OPINION OF COUNSEL. Clarant shall have received an opinion from
counsel to the Company, dated the Pre-Closing Date, in form and substance of the
type customarily given by counsel to a founding company in transactions similar
to that contemplated by this Agreement and acceptable to Clarant (and the
Underwriters shall have received a copy of the same opinion
50
addressed to them), and at the Closing Clarant shall have received a statement
from such counsel that the opinion is true as of the Closing Date.
9.8 CONSENTS AND APPROVALS. All necessary Consents of and filings with
any governmental authority or agency relating to the consummation of the
transactions contemplated herein shall have been obtained and made and all
Consents of third parties listed on SCHEDULE 5.4 shall have been obtained.
9.9 GOOD STANDING CERTIFICATES. The Company and the Subsidiary shall
have delivered to Clarant a certificate, dated as of a date no earlier than ten
(10) days prior to the Pre-Closing Date, duly issued by the appropriate
governmental authority in the Company's state of incorporation and, unless
waived by Clarant, in each state in which the Company or the Subsidiary is
authorized to do business, showing the Company and the Subsidiary are each in
good standing and authorized to do business and that all state franchise and/or
income tax returns and taxes for the Company and the Subsidiary for all periods
prior to the date of the certificate have been filed and paid.
9.10 REGISTRATION STATEMENT. The Registration Statement shall have been
declared effective by the SEC and no stop order suspending the effectiveness of
the Registration Statement shall be in effect and no proceeding therefor shall
have been instituted or shall be pending or contemplated under the 1933 Act, and
the Underwriters shall have agreed to acquire on a firm commitment basis,
subject to the conditions set forth in the Underwriting Agreement, shares of
Clarant Common Stock.
9.11 EMPLOYMENT AGREEMENTS. Each of the Persons listed on SCHEDULE 9.11
shall have entered into an employment agreement satisfactory to Clarant.
9.12 CLOSING OF IPO. The closing of the sale of the Clarant Common
Stock to the Underwriters in the IPO shall have occurred simultaneously with the
Closing Date hereunder.
9.13 FIRPTA CERTIFICATE. Each Stockholder shall have delivered to
Clarant a certificate to the effect that he or she is not a foreign Person
pursuant to Section 1.1445-2(b) of the Treasury regulations.
9.14 [Reserved]
9.15 SATISFACTION. All actions, proceedings, instruments and documents
required to carry out this Agreement or incidental hereto and all other related
legal matters shall have been approved by counsel to Clarant.
9.16 HSR ACT. The waiting period applicable to the transactions
contemplated by this Agreement under the HSR Act shall have expired or been
terminated.
51
9.17 INVESTOR QUESTIONNAIRE. Each Stockholder shall have provided an
executed Investor Questionnaire in the form of EXHIBIT 5.29(b).
9.18 THE STOCKHOLDERS' RELEASE. The Stockholders shall have delivered
to Clarant and the Company an instrument dated the Closing Date releasing
Clarant and the Company (including all subsidiaries) from (i) any and all claims
of the Stockholders against the Company and Clarant and (ii) any and all
obligations of the Company and Clarant to the Stockholders, except for (x) any
obligations arising after the Closing Date to a Stockholder relating to his or
her employment by the Company or Clarant and (y) obligations arising under this
Agreement or the transactions contemplated hereby.
10. COVENANTS OF CLARANT AND THE STOCKHOLDERS AFTER CLOSING
10.1 PRESERVATION OF TAX AND ACCOUNTING TREATMENT. Except as
contemplated by this Agreement or the Registration Statement, after the Closing
Date, Clarant shall not and shall not permit any of its subsidiaries to
undertake any act that would jeopardize the tax-free status of the organization.
10.2 TAX MATTERS.
(a) Clarant shall prepare or cause to be prepared and file or
cause to be filed all Returns that are required to be filed with respect to the
Company and the Subsidiary (i) for Taxable Periods ending on or before the
Closing Date that are due after the Closing Date (other than Returns of any
Relevant Group of which the Company is not the common parent), and (ii) for
Taxable Periods beginning on or before and ending after the Closing Date
("Straddle Periods"). All such Returns shall be prepared on a basis consistent
with past Returns of the Company and the Subsidiaries unless otherwise required
by applicable law.
(b) Upon the latter of (i) five (5) business days following
the receipt of a request therefor, (ii) five (5) business days prior to the due
date of any payment to the relevant Taxing Authority, or (iii) five (5) business
days following resolution of any dispute covered by Section 10.2(c), the
Stockholders shall pay to Clarant all Taxes shown as due on the Tax Returns
prepared and filed pursuant to Section 10.2(a) that relate to a Pre-Closing
Period to the extent that such Taxes exceed the reserves for such Taxes
(excluding any reserves for deferred Taxes) set forth on the financial
statements provided pursuant to Section 5.10.
(c) Any federal or state income Tax Returns prepared by
Clarant pursuant to Section 10.2(a) shall be delivered to the Stockholders at
least 30 days before the due date of such Return including any extension. If the
Stockholders reasonably object in writing to any material item on such Return at
least 10 days before their due date, the parties shall reasonably negotiate to
resolve such dispute. If such dispute cannot be resolved within 10 days of the
receipt by the
52
Company of such written notice, (i) the Company may in its sole discretion file
such Return and (ii) the dispute shall be referred to a national independent
accounting firm agreeable to the parties for resolution. The party whose
position is not adopted in such resolution by an independent accounting firm
shall pay all expenses of the successful party in resolving the dispute.
(d) For purposes of apportioning any Taxes to the portion of a
Straddle Period that ends on the Closing Date, the determination shall be made
based on a closing of the books as of the close of the Closing Date; provided,
that real property, personal property and intangible property Taxes shall be
apportioned ratably on a daily basis between the portions of the Straddle Period
in question.
(e) Each party hereto shall, and shall cause its Subsidiaries
and Affiliates to, provide to each of the other parties hereto such cooperation
and information as any of them reasonably may request in filing any Return,
amended Return or claim for refund, determining a liability for Taxes or a right
to refund of Taxes or in conducting any Tax Proceeding. Such cooperation and
information shall include providing copies of all relevant portions of relevant
Returns, together with relevant accompanying schedules and relevant work papers,
relevant documents relating to rulings or other determinations by Taxing
Authorities and relevant records concerning the ownership and Tax basis of
property, which such party may possess. Each party shall make its employees
reasonably available on a mutually convenient basis at its cost to provide
explanation of any documents or information so provided. Subject to the
preceding sentence, each party required to file Returns pursuant to this
Agreement shall bear all costs of filing such Returns.
(f) Each of the Company, Newco, Clarant and each Stockholder
shall comply with the tax reporting requirements of Section 1.351-3 of the
Treasury Regulations promulgated under the Code, and shall treat the transaction
as a transfer of property under Section 351(a) of the Code.
10.3 DIRECTORS AND OFFICERS. The Persons named in the Registration
Statement shall be elected as directors and elected as officers of Clarant, as
and to the extent set forth in the Registration Statement.
10.4 DIRECTORS' AND OFFICERS' INSURANCE. Clarant and the Surviving
Corporation shall use their commercially reasonable best efforts to maintain for
not less than four years from the Effective Time the policies of directors' and
officers' liability insurance maintained by the Company and its Subsidiaries as
of the date hereof to the extent set forth on SCHEDULE 10.4, provided that
Clarant and the Surviving Corporation may substitute policies of at least
equivalent coverage containing terms and conditions no less advantageous to
those covered in all material respects so long as no lapse in coverage occurs as
a result of such substitution, and covering the time period before and up to the
Effective Time. If a claim is asserted or made within the four year period
contemplated by this Section 10.4, Clarant and the Surviving Corporation shall
use
53
their commercially reasonable best effects to cause such insurance to be
continued until final resolution of any such pending claim. SCHEDULE 10.4 sets
forth a summary description of all such policies, including premium rates.
10.5 LOAN GUARANTIES. Clarant covenants and agrees that it shall use
commercially reasonable efforts to obtain the release of Xx. Xxxxxxxx as a
personal guarantor of the Company's revolving debt facility with Compass Bank.
The parties agree that it is not commercially reasonable for any officer or
director of Clarant to become a substitute personal guarantor of the Company's
revolving debt facility with Compass Bank.
11. INDEMNIFICATION
11.1 INDEMNIFICATION BY STOCKHOLDERS. Subject to the limitations of
Section 11.11, the Stockholders shall jointly and severally indemnify, defend
and hold harmless Clarant, Newco, the Company, and the Surviving Corporation and
their respective officers, directors, employees, agents, representatives and
Affiliates (other than the Stockholders) (each, a "Clarant Indemnified Party"),
at all times from and after this Agreement harmless from and against, and
promptly pay to a Clarant Indemnified Party or reimburse a Clarant Indemnified
Party for, any and all liabilities, obligations, deficiencies, demands, claims,
suits, actions, or causes of action, assessments, losses, costs, expenses,
filing fees, interest, fines, penalties, or damages or costs or expenses of any
and all investigations, proceedings (including appeals, arbitration and
mediation), judgments, environmental analyses, remediations, settlements and
compromises (including reasonable fees and expenses of attorneys, accountants
and other experts) (individually and collectively, the "Losses") sustained or
incurred by any Clarant Indemnified Party resulting from or arising out of (a)
any breach of the representations and warranties of the Stockholders or the
Company set forth herein or on the schedules, exhibits or certificates delivered
in connection herewith, (b) any breach of any covenant or agreement on the part
of the Stockholders or the Company under this Agreement, (c) any liability under
the 1933 Act, the 1934 Act, or other Federal or state law or regulation, at
common law or otherwise, arising out of or based upon any untrue statement or
alleged untrue statement of a material fact relating to the Company or the
Stockholders, and provided to Clarant or its counsel by the Company or the
Stockholders (but in the case of the Stockholders, only if such statement was
provided in writing) contained in the Registration Statement or any prospectus
forming a part thereof, or any amendment thereof or supplement thereto, or
arising out of or based upon any omission or alleged omission to state therein a
material fact relating to the Company or the Stockholders required to be stated
therein or necessary to make the statements therein not misleading, (d) any
Claim or Action arising out of or relating to any purchase or redemption of
Company Stock, Convertible Securities or Options by the Company prior to the
date of this Agreement; (e) except to the extent reserved for (other than as a
deferred Tax item) on the most recent financial statements provided pursuant to
Section 7.9, or if no such financial statements are provided, the Company
Financial Statements dated as of the Balance Sheet Date, any liability of the
Company or any Subsidiary for Taxes for
54
any Pre-Closing Period; or (f) any matter identified on SCHEDULE 11.1(F);
provided, however, (i) that in the case of any indemnity arising pursuant to
clause (c) such indemnity shall not inure to the benefit of Clarant, Newco, the
Company or the Surviving Corporation to the extent that such untrue statement
(or alleged untrue statement) was made in, or omission (or alleged omission)
occurred in, any preliminary prospectus and the Stockholders provided in writing
corrected information to Clarant counsel and to Clarant for inclusion in the
final prospectus, and such information was not so included or properly
delivered, and (ii) that no Stockholder shall be liable for any indemnification
obligation pursuant to this Section 11.1 to the extent attributable to a breach
of any representation, warranty or agreement made herein individually by any
other Stockholder.
11.2 INDEMNIFICATION BY CLARANT. Clarant covenants and agrees that it
will indemnify, defend, protect and hold harmless the Stockholders at all times
from and after the date of this Agreement until the Clarant Expiration Date,
from and against Losses sustained or incurred by any Stockholder resulting from
or arising out of (a) any breach by Clarant or Newco of its representations and
warranties set forth herein or on the schedules, exhibits or certificates
delivered in connection herewith, (b) any breach of any covenant or agreement on
the part of Clarant or Newco under this Agreement, (c) any liability which the
Stockholders may incur due to Clarant's or Newco's failure to be responsible for
the liabilities and obligations of the Company as provided in Article 1 hereof
(except to the extent that Clarant or Newco has claims against the Stockholders
by reason of such liabilities); or (d) any liability under the 1933 Act, the
1934 Act or other Federal or state law or regulation, at common law or
otherwise, arising out of or based upon any untrue statement or alleged untrue
statement of a material fact relating to Clarant, Newco or any of the Other
Founding Companies for inclusion in the Registration Statement or any prospectus
forming a part thereof, or any amendment thereof or supplement thereto, or
arising out of or based upon any omission or alleged omission to state therein a
material fact relating to Clarant or Newco or any of the Other Founding
Companies required to be stated therein or necessary to make the statements
therein not misleading. Provided the Closing occurs, each of the Stockholders
waives any right of contribution or indemnification or other similar right
against Clarant, Newco or the Surviving Corporation arising out of the Company's
representations, warranties, covenants and agreements contained herein, and each
of the Stockholders further agrees that any claims of Clarant and any Clarant
Indemnified Party or the Company hereunder, whether for indemnification or
otherwise, may be asserted directly and fully against the Stockholders without
the need for any claim against or joinder of the Surviving Corporation.
11.3 INDEMNIFICATION PROCEDURE --THIRD PARTY CLAIMS.
(a) In the event that subsequent to the Closing any Person
entitled to indemnification under this Agreement (an "Indemnified Party")
receives notice of the assertion of any claim , obligation, deficiency, demand,
suit, cause of action, assessment or expense of any kind (each, a "Claim") or of
the commencement of any action or proceeding by an entity who is
55
not a party to this Agreement or an Affiliate of such a party (including, but
not limited to any domestic or foreign court, government, or Governmental
Authority or instrumentality, federal state or local) (a "Third Party Claim")
against such Indemnified Party, against which a party to this Agreement is
required to provide indemnification under this Agreement (an "Indemnifying
Party"), the Indemnified Party shall give written notice together with a
statement of any available information regarding such claim to the Indemnifying
Party within sixty (60) days after learning of such Claim (or within such
shorter time as may be necessary to give the Indemnifying Party a reasonable
opportunity to respond to such Claim. The Indemnifying Party shall have the
right, upon written notice to the Indemnified Party (the "Defense Notice")
within thirty (30) days after receipt from the Indemnified Party of notice of
such Claim, which notice by the Indemnifying Party shall specify the counsel it
will appoint to defend such Claim ("Defense Counsel"), to conduct at its expense
the defense against such Claim in its own name, or if necessary in the name of
the Indemnified Party; provided, however, that the Indemnified Party shall have
the right to approve the Defense Counsel, which approval shall not be
unreasonably withheld, and in the event the Indemnifying Party shall propose an
alternate Defense Counsel, which shall be subject again to the Indemnified
Party's approval.
(b) In the event that the Indemnifying Party shall fail to
give such notice, it shall be deemed to have elected not to conduct the defense
of the subject Claim, and in such event the Indemnified Party shall have the
right to conduct such defense in good faith and to compromise and settle the
Claim without prior consent of the Indemnifying Party and the Indemnifying Party
will be liable for all costs, expense, settlement amounts or other Losses paid
or incurred in connection therewith.
(c) In the event that the Indemnifying Party does elect to
conduct the defense of the subject Claim, the Indemnified Party will cooperate
with and make available to the Indemnifying Party such assistance and materials
as may be reasonably requested by it, all at the expense of the Indemnifying
Party, and the Indemnified Party shall have the right at its expense to
participate in the defense assisted by counsel of its own choosing, provided
that the Indemnified Party shall have the right to compromise and settle the
Claim only with the prior written consent of the Indemnifying Party, which
consent shall not be unreasonably withheld or delayed. Without the prior written
consent of the Indemnified Party, the Indemnifying Party will not enter into any
settlement of any Third Party Claim or cease to defend against such Claim, if
pursuant to or as a result of such settlement or cessation, (i) injunctive or
other equitable relief would be imposed against the Indemnified Party, or (ii)
such settlement or cessation would lead to liability or create any financial or
other obligation on the part of the Indemnified Party for which the Indemnified
Party is not entitled to indemnification hereunder. The Indemnifying Party shall
not be entitled to control, and the Indemnified Party shall be entitled to have
sole control over, the defense or settlement of any Claim to the extent that
Claim seeks an order, injunction or other equitable relief against the
Indemnified Party which, if successful, could materially interfere with the
Business, assets, properties condition (financial or otherwise) or prospects of
the Indemnified Party (and the cost of such defense shall constitute an Loss for
56
which the Indemnified Party is entitled to indemnification hereunder). If a firm
decision is made to settle a Third Party Claim, which offer the Indemnifying
Party is permitted to settle under this Section 11.3 and the Indemnifying Party
desires to accept and agree to such offer, the Indemnifying Party will give
written notice to the Indemnified Party to that effect. If the Indemnified Party
fails to consent to such firm offer within thirty (30) calendar days after its
receipt of such notice, the Indemnified Party may continue to contest or defend
such Third Party Claim and, in such event, the maximum liability of the
Indemnifying Party as to such Third Party Claim will not exceed the amount of
such settlement offer, plus costs and expenses paid or incurred by the
Indemnified Party through the end of such thirty (30) day period.
(d) Any judgment entered or settlement agreed upon in the
manner provided herein shall be binding upon the Indemnifying Party, and shall
conclusively be deemed to be an obligation with respect to which the Indemnified
Party is entitled to prompt indemnification hereunder.
11.4 TAX CONTESTS.
(a) If any party receives written notice from any governmental
authority of a Tax Proceeding with respect to any Tax for which the other party
is obligated to provide indemnification under this Agreement, such party shall
within sixty (60) days thereof give written notice to the other party (or within
such shorter time as may be necessary to give the Indemnifying Party a
reasonable opportunity to respond to such notice); provided, however, that the
failure to give such notice shall not affect the indemnification provided
hereunder except to the extent that the failure to give such notice materially
prejudices the Indemnifying Party as provided in Section 11.6.
(b) Upon written notice to Clarant within thirty (30) days
after receipt of notification pursuant to Section 11.4(a), the Stockholders
shall have the right, at their own expense, to control and make all decisions
with respect to any Tax Proceeding relating to Taxes of the Company or any
Subsidiary for any Taxable Period ending on or before the Closing Date. Clarant
shall have the right to approve the counsel selected by the Stockholders to
conduct any such Tax Proceeding, which approval shall not be unreasonably
withheld, and to participate fully at its own expense with counsel of its own
choosing in all aspects of the prosecution or defense of such Tax Proceeding.
The Stockholders shall not take any action or position in any such Tax
Proceeding if that action or position could reasonably be expected to increase
the past, present or future Tax liability of Clarant or any of its Affiliates,
or any Tax liability of the Company or any Subsidiary for any Taxable Period or
portion thereof beginning after the Closing Date without the prior written
consent of Clarant, which consent shall not be unreasonably withheld. The
Stockholders shall not settle or otherwise terminate any such Tax Proceeding
without the prior written consent of Clarant, which consent shall not be
unreasonably withheld.
57
(c) Upon written notice to Clarant within thirty (30) days
after receipt of notification pursuant to Section 11.4(a), the Stockholders
shall have the right, at their own expense, to jointly control and participate
with Clarant in the conduct of any Tax Proceeding relating to Taxes of the
Company or the Subsidiary for a Straddle Period. If Sellers exercise such right,
neither party shall settle or otherwise terminate any such Tax Proceeding
without the prior written consent of the other, which consent shall not be
unreasonably withheld.
(d) If the Stockholders do not exercise their right to assume
control of or participate in any Tax Proceeding as provided under this Section
11.4, Clarant may defend or settle the same in such manner as it may deem
appropriate in its sole and absolute discretion, without in any way limiting its
rights of indemnification hereunder.
(e) Except as otherwise provided in this Section 11.4, Clarant
shall control all Tax Proceedings relating to Taxes and Tax Returns of the
Company and the Subsidiary.
(f) In the event that the provisions of this Section 11.4 and
the provisions of Section 11.3 hereof conflict or otherwise each apply by their
terms, this Section 11.4 shall exclusively govern all matters concerning Tax
Proceedings.
11.5 INDEMNIFICATION PROCEDURE -- OTHER CLAIMS. A claim for
indemnification for any matter not involving a Third-Party Claim (a "Direct
Claim") may be asserted by giving the Indemnifying Party reasonably prompt
written notice thereof, and the Indemnifying Party will have a period of thirty
(30) calendar days within which to satisfy such Direct Claim. If the
Indemnifying Party does not so respond within such thirty (30) calendar day
period, the Indemnifying Party will be deemed to have rejected such Direct
Claim, in which event the Indemnitee will be free to pursue such remedies as may
be available to the Indemnitee under this Article 11.
11.6 FAILURE TO GIVE TIMELY NOTICE. A failure by an Indemnified Party
to give timely, complete or accurate notice as provided in Sections 11.3, 11.4
and 11.5 will not affect the rights or obligations of any party hereunder except
and only to the extent that, as a result of such failure, any party entitled to
receive such notice was deprived of its right to recover any payment under its
applicable insurance coverage or was otherwise directly and materially damaged
as a result of such failure to give timely notice.
11.7 REDUCTION OF LOSS. To the extent any Loss of an Indemnified Party
is reduced by receipt of payment (a) under insurance policies which are not
subject to retroactive adjustment or other reimbursement to the insurer in
respect of such payment, or (b) from third parties not Affiliated with the
Indemnified Party, such payments (net of the expenses of the recovery thereof)
(such net payment being referred to herein as a "Reimbursement") shall be
credited against such Loss; provided, however, (x) the pendency of such payments
shall not delay or reduce the obligation of the Indemnifying Party to make
payment to the Indemnified Party in
58
respect of such Loss, and (y) the Indemnified Party shall have no obligation,
hereunder or otherwise, to pursue payment under or from any insurer or third
party in respect of such loss. If any Reimbursement is obtained subsequent to
payment by an Indemnifying Party in respect of a Loss, such Reimbursement shall
be promptly paid over to the Indemnifying Party.
11.8 SUBROGATION. The Indemnifying Party shall be subrogated to the
Indemnified Party's rights of recovery to the extent of any Loss satisfied by
the Indemnifying Party. The Indemnified Party shall execute and deliver such
instruments and papers as are necessary to assign such rights and assist in the
exercise thereof, including access to books and records of the Acquired Party.
11.9 ARBITRATION. Excluding the right of a party to seek injunctive
relief, all claims (pursuant to Federal or state statutes or by common law),
controversies, differences or disputes between Clarant or Newco and the
Stockholders arising out of or relating to this Agreement or related or
referenced exhibits or the alleged breach thereof including, but not limited to,
indemnification claims under Sections 11.1 and/or 11.2 shall be settled by
arbitration in accordance with the rules then in effect of the American
Arbitration Association at the time of the dispute. After an award is rendered
by the arbitrator(s), a judgment may be entered in any court of competent
Jurisdiction. The arbitration shall occur in Dallas, Texas to the exclusion of
all other locations. The arbitrators cannot add to or subtract from the terms of
this Agreement. The parties agree that the arbitrators may include provisions
for the payment of costs and expenses, including reasonable attorneys' fees as
part of any ruling or award made thereunder. The parties acknowledge that
arbitration shall be the sole, final, binding and exclusive remedy of the
parties with respect to any such matter for which arbitration is undertaken
hereunder. In preparation for the arbitration process described herein, the
parties shall be given at least one hundred twenty (120) days for discovery and
each party may utilize all methods of discovery authorized by the procedural
rules and statutes of the State of Texas for civil litigation and may enforce
the right to obtain such discovery in the manner provided by such rules and
statutes.
11.10 EXCLUSIVE REMEDY. Except as provided in Section 11.11(d) or
Section 14.3 of this Agreement, the indemnification provided for in this Article
11 shall (except as prohibited by ERISA) be the exclusive remedy in any action
seeking damages or any other form of monetary relief brought by any party to
this Agreement against another party; provided, however, that nothing herein
shall be construed to limit the right of a party, in a proper case, to seek
injunctive relief for a breach of this Agreement or to seek relief for a breach
of any employment agreement with, or any security issued by, Clarant.
11.11 LIMITATION AND EXPIRATION. Notwithstanding the foregoing
provisions of this Article 11:
(a) with respect to the indemnification obligations of the
Stockholders under Section 11.1 --
59
(i) there shall be no liability unless, and solely to
the extent that, the aggregate amount of Losses sustained by the Clarant
Indemnified Parties exceeds one percent (1%) of the Merger Consideration (the
"Indemnification Threshold") which Indemnification Threshold shall be treated as
a deductible; PROVIDED, HOWEVER, that the Indemnification Threshold shall not
apply to (w) Losses arising out of breaches of the covenants of the Stockholders
set forth in this Agreement to be performed after the Closing Date or the
representations and warranties made in Sections 5.3 (capital stock of the
Company), 5.17 (employee benefits), 5.24 (taxes), (x) Losses described in
Section 11.1(c), (y) Losses arising out of intentional fraud; or (z) any matters
identified on SCHEDULE 11.1(f);
(ii) [Reserved]
(b) the indemnification obligations of the Stockholders under
Section 11.1, or under any certificate or writing furnished in connection
herewith, shall terminate at the date that is the later of clause (i) or (ii) of
this Section 11.11(b):
(i) (A) with respect to claims arising out of
breaches of the representations and warranties made in Sections 5.17 (employee
benefits), 5.19 (environment) and 5.24 (taxes), the date that is six (6) months
after the expiration of the longest applicable federal or state statute of
limitation (including extensions thereof);
(B) with respect to Losses described in
clause (c) of Section 11.1, the date that is six (6) months after the expiration
of the longest applicable federal or state statute of limitation (including
extensions thereof); or
(C) with respect to all claims other than
those referred to in clause (i)(A) or (B) of this Section 11.11(b), eighteen
(18) months after the Effective Time; or
(ii) the final resolution of claims or demands
pending as of the relevant dates described in clause (i) of this
Section 11.11(b);
(c) with respect to the indemnification obligations of Clarant
under Section 11.2 --
(i) there shall be no liability unless, and solely to
the extent that, the aggregate amount of Losses sustained by the Stockholders
exceeds the Indemnification Threshold; PROVIDED, HOWEVER, that the
Indemnification Threshold shall not apply to Losses arising out of breaches of
the covenants of Clarant set forth in this Agreement to be performed after the
Closing Date or the representations and warranties made in Section 6.5 (Capital
Stock) and 6.15 (Taxes), (y) Losses described in Section 11.2(c), or (z) Losses
arising out of intentional fraud; and
(ii) the aggregate amount of Clarant's liability
under this Article 11 shall not exceed the Merger Consideration.
60
(d) [Reserved]
(e) Indemnity obligations hereunder may be satisfied through the
payment of cash or the delivery of Clarant Common Stock, or a combination
thereof. For purposes of calculating the value of the Clarant Common Stock
received or delivered by the Stockholder (for purposes of determining the
Indemnification Threshold and the amount of any indemnity paid), Clarant Common
Stock shall be valued at its fair market value, which shall be the average
closing price for Clarant Common Stock on the Nasdaq national market system for
the ten trading days ending two business days immediately prior to the date of
payment.
(f) Notwithstanding any other term of this Agreement (except the
proviso to this sentence), a Stockholder's liability under this Article 11 shall
be limited to the total amount of proceeds received or payable to the
Stockholder under this Agreement, which total shall be equal to the sum of (i)
the cash paid to the Stockholder (ii) the Contingent Consideration, if any,
earned and payable to such Stockholder (iii) the Additional Contingent
Consideration, if any, earned and payable to such Stockholder and (iv) the value
of the Clarant Common Stock delivered to such Stockholder on the Closing Date at
the initial public offering price.
11.12 SURVIVAL OF REPRESENTATIONS WARRANTIES AND COVENANTS. All
representations, warranties and covenants made by the Company, the Stockholders
and Clarant in or pursuant to this Agreement or in any document delivered
pursuant hereto shall be deemed to have been made on the date of this Agreement
(except as otherwise provided herein), as of the Pre-Closing Date and, if a
Closing occurs, as of the Closing Date. The representations and warranties of
the Company and the Stockholders will survive the Closing and will remain in
effect until, and will expire upon, the termination of the indemnification
obligations as provided in Section 11.11(b). The representations and warranties
of Clarant will survive the Closing and will remain in effect until, and will
expire upon, the Clarant Expiration Date.
12. TERMINATION OF AGREEMENT
12.1 TERMINATION. This Agreement may be terminated at any time prior to
the Closing Date solely: (a) by mutual consent written consent of the boards of
directors of Clarant and the Company; (b) by either the Stockholders or the
Company (acting through its board of directors), on the one hand, or by Clarant
(acting through its board of directors), on the other hand, if the transactions
contemplated by this Agreement to take place at the Closing shall not have been
consummated by December 31, 1999, unless the failure of such transactions to be
consummated is due to the willful failure of the party seeking to terminate this
Agreement to perform any of its obligations under this Agreement to the extent
required to be performed by it prior to or on the Closing Date; (c) by the
Stockholders or the Company, on the one hand, or by Clarant, on the other hand,
after giving written notice to the other party that a breach or default of any
representation, warranty, or covenant contained in this Agreement which breach
has had or is reasonably foreseeable as having a Material Adverse Effect on the
Company or Clarant, as the case may be, has occurred and such breach has not
been cured on or before the Closing Date; (d)
61
pursuant to Section 7.11; or (e) by the Company (acting through its members) if,
by June 30, 1999,Clarant shall not have filed an initial registration statement
with the SEC reflecting an IPO price for Clarant Common Stock of $11.00 per
share.
12.2 LIABILITIES IN EVENT OF TERMINATION. The termination of this
Agreement will in no way limit any obligation or liability of any party based on
or arising from a breach or default by such party with respect to any of its
representations, warranties, covenants or agreements contained in this Agreement
including, but not limited to, legal and audit costs and out of pocket expenses.
13. NONCOMPETITION
13.1 PROHIBITED ACTIVITIES.
(a) Except for Xxxxxxx Xxxxxxxx and Xxxxxxx Xxxxx, the
Stockholders will not, for a period of three (3) years following the Closing
Date, for any reason whatsoever, directly or indirectly, for themselves or on
behalf of or in conjunction with any other Person, company, partnership,
corporation or business of whatever nature:
(i) engage, as an officer, director, shareholder,
option holder, lender, owner, partner, joint venturer, or in a managerial
capacity, whether as an employee, independent contractor, consultant or advisor,
or as a sales representative, in any business that is engaged in the Business
anywhere in the United States or Canada (the "Territory");
(ii) call upon any Person who is, at that time,
within the Territory, an employee of Clarant (including the subsidiaries
thereof) in a sales representative or managerial capacity for the purpose or
with the intent of enticing such employee away from or out of the employ of
Clarant (including the subsidiaries thereof), provided that each Stockholder
shall be permitted to call upon and hire any member of his or her immediate
family;
(iii) call upon any Person which is, at that time, or
which has been, within one (1) year prior to the Closing Date, a customer of
Clarant (including the subsidiaries thereof), of the Company or any Subsidiary
or of any of the Other Founding Companies within the Territory for the purpose
of soliciting or selling products or services in direct competition with Clarant
within the Territory;
(iv) call upon any prospective acquisition candidate,
on any Stockholder's behalf or on behalf of any competitor of Clarant, which
candidate, to the actual knowledge of such Stockholder after due inquiry, was
called upon by Clarant (including the subsidiaries thereof) or for which, to the
actual knowledge of such Stockholder after due inquiry, Clarant (or any
subsidiary thereof) made an acquisition analysis, for the purpose of acquiring
such entity; or
(v) disclose customers, whether in existence or
proposed, of the Company to any Person, firm, partnership, corporation or
business for any reason or purpose
62
whatsoever except to the extent that the Company has in the past disclosed such
information to the public for valid business reasons.
(b) Notwithstanding Section 13.1(a) the foregoing covenant
shall not be deemed to prohibit any Stockholder from acquiring as an investment
not more than one percent (1%) of the capital stock of a competing business
whose stock is traded on a national securities exchange or over-the-counter so
long as the Stockholder, other than Xxxxxxx Xxxxxxxx and Xxxxxxx Xxxxx, does not
consult with or is not employed by such competitor.
13.2 DAMAGES. Because of the difficulty of measuring economic losses to
Clarant as a result of a breach of the foregoing covenant, and because of the
immediate and irreparable damage that could be caused to Clarant for which it
would have no other adequate remedy, each Stockholder agrees that, in the event
of breach by such Stockholder, the foregoing covenant may be enforced by Clarant
by injunctions and restraining orders.
13.3 REASONABLE RESTRAINT. It is agreed by the parties hereto that the
foregoing covenants in this Article 13 impose a reasonable restraint on the
Stockholders in light of the activities and business of Clarant (including the
subsidiaries thereof) on the date of the execution of this Agreement and the
current plans of Clarant; but it is also the intent of Clarant and the
Stockholders that such covenants be construed and enforced in accordance with
the changing activities and business of Clarant (including the subsidiaries
thereof) throughout the term of this covenant.
It is further agreed by the parties hereto that, in the event that any
Stockholder who has entered into an employment agreement with Clarant and/or any
subsidiary thereof as set forth in Sections 8.11 and 9.11 hereto, shall
thereafter cease to be employed thereunder, and such Stockholder shall enter
into a business or pursue other activities not in competition with Clarant
and/or any subsidiary thereof, or similar activities or business in locations
the operations of which, under such circumstances, does not violate this Article
13 and in any event such new business, activities or location are not in
violation of this Article 13 or such Stockholder's obligations under this
Article 13, such Stockholder shall not be chargeable with a violation of this
Article 13 if Clarant and/or any subsidiary thereof shall thereafter enter the
same, similar or a competitive (i) business (ii) course of activities, or (iii)
location, as applicable.
13.4 SEVERABILITY; REFORMATION. The covenants in this Article 13 are
severable and separate, and the unenforceability of any specific covenant shall
not affect the provisions of any other covenant. Moreover, in the event any
court of competent jurisdiction shall determine that the scope, time or
territorial restrictions set forth are unreasonable, then it is the intention of
the parties that such restrictions be enforced to the fullest extent which the
court deems reasonable, and this Agreement shall thereby be reformed.
13.5 INDEPENDENT COVENANT. All of the covenants in this Article 13
shall be construed as an agreement independent of any other provision in this
Agreement, and the existence of any claim or cause of action of any Stockholder
against Clarant (including the subsidiaries thereof), whether predicated on this
Agreement or otherwise, shall not constitute a defense to the
63
enforcement by Clarant of such covenants. It is specifically agreed that the
period of three (3) years stated at the beginning of this Article 13, during
which the agreements and covenants of each Stockholder made in this Article 13
shall be effective, shall be computed by excluding from such computation any
time during which such Stockholder is in violation of any provision of this
Article 13. The covenants contained in Article 13 shall not be affected by any
breach of any other provision hereof by any party hereto and shall have no
effect if the transactions contemplated by this Agreement are not consummated.
13.6 MATERIALITY. The Company and the Stockholders hereby agree that
this covenant is a material and substantial part of this transaction and that it
is supported by adequate consideration.
14. NONDISCLOSURE OF CONFIDENTIAL INFORMATION
14.1 STOCKHOLDERS. The Stockholders recognize and acknowledge that they
had in the past, currently have, and in the future may have, access to certain
confidential information of the Company, the Other Founding Companies, and/or
Clarant, such as operational policies, and pricing and cost policies that are
valuable, special and unique assets of the Company's, the Other Founding
Companies' and/or Clarant's respective businesses. The Stockholders agree that
they will not disclose such confidential information to any Person, firm,
corporation, association or other entity for any purpose or reason whatsoever,
except (a) to authorized representatives of Clarant or the Other Founding
Companies who need to know information in connection with the transactions
contemplated hereby, who have been informed of the confidential nature of such
information and who have agreed to keep such information confidential as
provided hereby, (b) following the Closing, such information may be disclosed by
the Stockholders as is required in the course of performing their duties for
Clarant or the Surviving Corporation and (c) to counsel and other advisers,
provided that such advisers (other than counsel) agree to the confidentiality
provisions of this Section 14.1, unless (i) such information becomes known to
the public generally through no fault of any such Stockholders, (ii) disclosure
is required by law or the order of any governmental authority under color of
law, provided, that prior to disclosing any information pursuant to this clause
(ii), the Stockholders shall give prior written notice thereof to Clarant and
provide Clarant with the opportunity to contest such disclosure, or (iii) the
disclosing party reasonably believes that such disclosure is required in
connection with the defense of a lawsuit against the disclosing party. In the
event of a breach or threatened breach by any of the Stockholders of the
provisions of this Article 14, Clarant shall be entitled to an injunction
restraining such Stockholders from disclosing, in whole or in part, such
confidential information. Nothing herein shall be construed as prohibiting
Clarant from pursuing any other available remedy for such breach or threatened
breach, including the recovery of damages. In the event the transactions
contemplated by this Agreement are not consummated, the Stockholders shall have
none of the above-mentioned restrictions on their ability to disseminate
confidential information with respect to the Company.
64
14.2 CLARANT AND NEWCO. Clarant and Newco recognize and acknowledge
that they had in the past and currently have access to certain confidential
information of the Company, such as operational policies, and pricing and cost
policies that are valuable, special and unique assets of the Company's business.
Clarant and Newco agree that, prior to the Closing, or if the transactions
contemplated by this Agreement are not consummated, they will not disclose such
confidential information to any Person, firm, corporation, association or other
entity for any purpose or reason whatsoever, except (a) to the Stockholders and
to authorized representatives of the Company, (b) to counsel and other advisers,
provided that such advisors (other than counsel) agree to the confidentiality
provisions of this Section 14.2 and (c) to the Other Founding Companies and
their representatives pursuant to Section 7.1(a), unless (i) such information
becomes known to the public generally through no fault of Clarant or Newco, (ii)
disclosure is required by law or the order of any governmental authority under
color of law, provided, that prior to disclosing any information pursuant to
this clause (ii), Clarant and Newco shall, if possible, give prior written
notice thereof to the Company and the Stockholders and provide the Company and
the Stockholders with the opportunity to contest such disclosure, or (iii) the
disclosing party reasonably believes that such disclosure is required in
connection with the defense of a lawsuit against the disclosing party. In the
event of a breach or threatened breach by Clarant or Newco of the provisions of
this Section, the Company and the Stockholders shall be entitled to an
injunction restraining Clarant and Newco from disclosing, in whole or in part,
such confidential information. Nothing herein shall be construed as prohibiting
the Company and the Stockholders from pursuing any other available remedy for
such breach or threatened breach, including the recovery of damages.
14.3 DAMAGES. Because of the difficulty of measuring economic losses as
a result of the breach of the foregoing covenants in Sections 14.1 and 14.2, and
because of the immediate and irreparable damage that would be caused for which
they would have no other adequate remedy, the parties hereto agree that, in the
event of a breach by any of them of the foregoing covenants, the covenant may be
enforced against the other parties by injunctions and restraining orders.
14.4 SURVIVAL. The obligations of the parties under this Article 14
shall survive the termination of this Agreement for a period of five years from
the Closing Date.
15. TRANSFER RESTRICTIONS
15.1 TRANSFER RESTRICTIONS. Subject in all cases to compliance with
applicable federal and state securities laws, and in no case earlier than twelve
(12) months following the Closing Date, unless Clarant in its sole discretion
shall consent otherwise, except pursuant to Article 17 hereof, gratuitous
transfers to not-for-profit third parties and transfers to immediate family
members, in each case who agree to be bound by the restrictions set forth in
this Section 15.1 (or trusts for the benefit of the Stockholders or their
immediate family members, the trustees of which so agree), none of the
Stockholders shall (a) sell, assign, exchange, transfer, Encumber, pledge,
distribute, appoint or otherwise dispose of (i) any shares of Clarant Common
Stock received by the Stockholders in the Merger or (ii) any interest
(including, without limitation, an
65
option to buy or sell) in any such shares of Clarant Common Stock, in whole or
in part, and no such attempted transfer shall be treated as effective for any
purpose; or (b) engage in any transaction, whether or not with respect to any
shares of Clarant Common Stock or any interest therein, the intent or effect of
which is to reduce the risk of owning the shares of Clarant Common Stock
acquired pursuant to Article 2 hereof (including, by way of example and not
limitation, engaging in put, call, short-sale, straddle or similar market
transactions). Notwithstanding the foregoing, the Stockholders may encumber or
pledge any of such shares of Clarant Common Stock provided the pledgee or other
beneficiary of such encumbrance or pledge agrees to be bound by the provisions
of this Section as if a Stockholder and party hereto. The certificates
evidencing the Clarant Common Stock delivered to the Stockholders pursuant to
Article 3 of this Agreement will bear a legend substantially in the form set
forth below and containing such other information as Clarant may deem necessary
or appropriate:
THE SHARES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, ASSIGNED,
EXCHANGED, TRANSFERRED, ENCUMBERED, PLEDGED, DISTRIBUTED, APPOINTED OR
OTHERWISE DISPOSED OF, AND THE ISSUER SHALL NOT BE REQUIRED TO GIVE
EFFECT TO ANY ATTEMPTED SALE, ASSIGNMENT, EXCHANGE, TRANSFER,
ENCUMBRANCE, PLEDGE, DISTRIBUTION, APPOINTMENT OR OTHER DISPOSITION
[(PROVIDED, HOWEVER, THAT SUCH SHARES MAY BE ENCUMBERED OR PLEDGED
PROVIDED THE PLEDGEE OR OTHER BENEFICIARY OF SUCH ENCUMBRANCE OR PLEDGE
AGREES TO BE BOUND BY THE PROVISIONS OF THESE RESTRICTIONS TO THE SAME
EXTENT AS THE HOLDER THEREOF).
16. FEDERAL SECURITIES ACT REPRESENTATIONS
16.1 NON-REGISTRATION OF CLARANT COMMON STOCK. Each Stockholder
acknowledges that the shares of Clarant Common Stock delivered to the
Stockholder pursuant to this Agreement have not been and will not be registered
under the 1933 Act and therefore may not be resold without compliance with the
1933 Act. The Clarant Common Stock acquired by the Stockholder pursuant to this
Agreement is being acquired solely for their own respective accounts, for
investment purposes only, and with no present intention of distributing, selling
or otherwise disposing of it.
16.2 COMPLIANCE WITH LAW. Each Stockholder covenants, warrants and
represents that none of the shares of Clarant Common Stock issued to the
Stockholder will be offered, sold, assigned, pledged, hypothecated, transferred
or otherwise disposed of except after full compliance with all of the applicable
provisions of the 1933 Act and the rules and regulations of the SEC. The Clarant
Common Stock shall bear the following legend in addition to the legend required
under Article 15 of this Agreement:
THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
66
"ACT"). THE SHARES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY
NOT BE SOLD, ASSIGNED, EXCHANGED, TRANSFERRED, ENCUMBERED,
PLEDGED, DISTRIBUTED, APPOINTED OR OTHERWISE DISPOSED OF
EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT FOR
THE SHARES UNDER THE ACT OR AN EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE ACT AND ANY APPLICABLE
STATE SECURITIES LAWS AND, IF REQUIRED BY CLARANT, INC.,
DELIVERY BY THE HOLDER OF AN OPINION OF COUNSEL REASONABLY
ACCEPTABLE TO CLARANT, INC. STATING THAT REGISTRATION IS NOT
REQUIRED UNDER THE ACT.
16.3 ECONOMIC RISK; SOPHISTICATION. Each Stockholder represents and
warrants that it is able to bear the economic risk of an investment in the
Clarant Common Stock acquired pursuant to this Agreement, can afford to sustain
a total loss of such investment and have such knowledge and experience in
financial and business matters that they are capable of evaluating the merits
and risks of the investment in the Clarant Common Stock. Each Stockholder
represents and warrants that it has had an adequate opportunity to ask questions
and receive answers from the officers of Clarant concerning any and all matters
relating to the transactions described herein including, without limitation, the
background and experience of the current and proposed officers and directors of
Clarant, the plans for the operations of the business of Clarant, the business,
operations and financial condition of the Other Founding Companies, and any
plans for additional acquisitions and the like. Each Stockholder acknowledges
that it has asked any and all questions in the nature described in the preceding
sentence and all questions have been answered to its satisfaction. Each
Stockholder represents and warrants that such Stockholder has the requisite
knowledge and experience in financial and business matters to be capable of
evaluating the merits and risks of this investment and is an "accredited
investor" as defined in Regulation D under the 1933 Act.
17. REGISTRATION RIGHTS
17.1 PIGGYBACK REGISTRATION RIGHTS. At any time following the Closing
Date, whenever Clarant proposes to register any Clarant Common Stock for its own
or others' account under the 1933 Act for a public offering, other than (i) any
shelf registration of shares to be used as consideration for acquisitions of
additional businesses by Clarant, (ii) registrations relating to employee
benefit plans and (iii) registrations relating to rights offerings made to the
stockholders of Clarant, Clarant shall give each of the Stockholders prompt
written notice of its intent to do so. Upon the written request of any of the
Stockholders given within thirty (30) days after receipt of such notice, Clarant
shall cause to be included in such registration all of the Clarant Common Stock
issued to the Stockholders pursuant to this Agreement which any such Stockholder
requests, provided that Clarant shall have the right to reduce the number of
shares included in such registration to the extent that inclusion of such shares
could, in the opinion of tax counsel to Clarant or its independent auditors,
jeopardize the status of the transactions contemplated hereby and by the
Registration Statement as a tax-free organization. In addition, if Clarant is
advised in writing in good faith by any managing underwriter of an underwritten
offering of the securities
67
being offered pursuant to any registration statement under this Section 17.1
that the number of shares to be sold by Persons other than Clarant is greater
than the number of such shares which can be offered without adversely affecting
the offering, Clarant may reduce pro rata the number of shares offered for the
accounts of such Persons (based upon the number of shares proposed to be sold by
each such Person) to a number deemed satisfactory by such managing underwriter,
provided, that, for each such offering made by Clarant after the IPO, such
reduction shall be made first by reducing the number of shares to be sold by
Persons other than Clarant, the Stockholders and the stockholders of the Other
Founding Companies (collectively, the Stockholders and the stockholders of the
other Founding Companies being referred to herein as the "Founding
Stockholders"), and thereafter, if a further reduction is required, by reducing
the number of shares to be sold by the Founding Stockholders.
17.2 REGISTRATION PROCEDURES. All expenses incurred in connection with
the registrations under this Article 17 (including all registration, filing,
qualification, legal, printer and accounting fees, but excluding underwriting
commissions and discounts), shall be borne by Clarant. In connection with
registrations under Section 17.1, Clarant shall (i) use its commercially
reasonable best efforts to prepare and file with the SEC as soon as reasonably
practicable, a registration statement with respect to the Clarant Common Stock
and use its commercially reasonable best efforts to cause such registration to
promptly become and remain effective for a period of at least one hundred twenty
(120) days (or such shorter period during which Founding Stockholders shall have
sold all Clarant Common Stock which they requested to be registered); (ii) use
its commercially reasonable best efforts to register and qualify the Clarant
Common Stock covered by such registration statement under applicable state
securities laws as the holders shall reasonably request for the distribution of
the Clarant Common Stock; and (iii) take such other actions as are reasonable
and necessary to comply with the requirements of the 1933 Act and the
regulations thereunder.
17.3 UNDERWRITING AGREEMENT. In connection with each registration
pursuant to Sections 17.1 and 17.2 covering an underwritten registered public
offering, Clarant and each participating holder agree to enter into a written
agreement with the managing underwriters in such form and containing such
provisions as are customary in the securities business for such an arrangement
between such managing underwriters and companies of Clarant's size and
investment stature, including indemnification provisions.
17.4 AVAILABILITY OF RULE 144. Clarant shall not be obligated to
register shares of Clarant Common Stock held by any Stockholder at any time when
the resale provisions of Rule 144(k) (or any successor provision) promulgated
under the 1933 Act are available to such Stockholder for such shares.
17.5 MARKET STANDOFF. In consideration of the granting to the
Stockholders of the registration rights under this Article 17, the each of the
Stockholders agrees that he or she will not sell, transfer or otherwise dispose
of, including without limitation through put or short sale arrangements, shares
of Clarant Common Stock in the ten (10) days prior to the effectiveness of any
registration of Clarant Common Stock for sale to the public and for up to ninety
(90) days
68
following the effectiveness of such registration; provided that all directors,
executive officers and holders of more than five percent (5%) of the outstanding
Clarant Common Stock agree to the same restrictions; and further provided that,
with respect to the first public offering of shares of the Clarant Common Stock
within three years following the IPO, the Stockholders shall have been afforded
a meaningful opportunity to include shares in such registration after any
reduction by reason of underwriters' advice.
18. DEFINITIONS
Unless the context otherwise requires, capitalized terms used in this
Agreement or in any schedule attached hereto and not otherwise defined herein
shall have the following meanings for all purposes of this Agreement:
"Accredited Stockholders" shall have the meaning given to such term in
Section 2.1.
"Acquired Party" means the Company, any Subsidiary and any member of a
Relevant Group.
"Acquisition Companies" means Newco and each of the other Delaware
companies wholly-owned by Clarant prior to the Closing Date.
"Action" has the meaning set forth in Section 5.15.
"Affiliate Transactions" has the meaning set forth in Section 5.31.
"Affiliates" has the meaning set forth in Section 5.9.
"Agreement" means this Agreement and Plan of Organization.
"Applicable Contract" means any Contract (a) under which the Company or
any of its Subsidiaries has or may acquire any rights, (b) under which the
Company or any of its Subsidiaries has or may become subject to any obligation
or liability, or (c) by which the Company or any of its Subsidiaries or any of
the Assets used by it is or may become bound.
"A/R Aging Reports" has the meaning set forth in Section 5.12
"Articles of Merger" means those Articles or Certificates of Merger
with respect to the Merger substantially in the form[s] attached as EXHIBIT 1.1
hereto or with such changes therein as may be required by applicable state laws.
"Balance Sheet" means a consolidated balance sheet of the Company and
its Subsidiaries.
69
"Balance Sheet Date" means March 31, 1999.
"Business" has the meaning set forth in the recitals of this Agreement.
"Charter Documents" has the meaning set forth in Section 5.1.
"Claim" has the meaning set forth in Section 11.3.
"Closing" means the consummation of the transactions contemplated by
this Agreement on the Closing Date.
"Closing Date" has the meaning set forth in Section 4.2.
"Code" means the Internal Revenue Code of 1986, as amended, and
regulations issued by the Internal Revenue Service pursuant to the Internal
Revenue Code of 1986, as amended.
"Company" has the meaning set forth in the first paragraph of this
Agreement.
"Company Other Benefit Obligation" has the meaning set forth in Section
5.17.
"Company Plan" has the meaning set forth in Section 5.17.
"Company Stock" has the meaning set forth in Section 2.1(a).
"Company VEBA" has the meaning set forth in Section 5.17.
"Consents" has the meaning set forth in Section 5.4.
"Contingent Consideration" shall have the meaning given to such term in
Section 3.3.
"Contract" means any agreement, contract, obligation, promise, or
undertaking (whether written or oral and whether express or implied).
"Constituent Corporations" has the meaning set forth in the recitals of
this Agreement.
"Convertible Securities" has the meaning set forth in Section 5.3.
"Clarant" has the meaning set forth in the first paragraph of this
Agreement.
"Clarant Charter Documents" has the meaning set forth in Section 6.1.
"Clarant Common Stock" has the meaning set forth in Section 6.5.
70
"Clarant Expiration Date" means the date that is one year from the
Effective Time.
"Clarant Indemnified Party" has the meaning set forth in Section
11.1(a).
"Clarant Plan of Organization" has the meaning set forth in the
recitals of this Agreement.
"Clarant Preferred Stock" has the meaning set forth in Section 6.5.
"Clarant Stock" has the meaning set forth in Section 6.5.
"Defense Counsel" has the meaning set forth in Section 11.3.
"Defense Notice" has the meaning set forth in Section 11.3.
"Direct Claim" has the meaning set forth in Section 11.5.
"Effective Time" means the time as of which the Merger becomes
effective, which the parties hereto contemplate to occur at the Closing.
"Encumbrance" means any charge, claim, equity, judgment, lease,
liability, lien, mortgage, pledge, restriction, security interest, Tax lien, or
encumbrance of any kind.
"Environment" means soil, land surface or subsurface strata, surface
waters (including navigable waters, ocean waters, streams, ponds, drainage
basins, and wetlands) groundwaters, drinking water supply, stream sediments,
ambient air (including indoor air), plant and animal life, and any other
environmental medium or natural resource.
"Environmental Law" means any Legal Requirement that requires or
relates to:
(a) advising appropriate authorities, employees, and the
public of intended or actual releases of pollutants or hazardous
substances or materials, violations of discharge limits, or other
prohibitions and of the commencement of activities, such as resource
extraction or construction, that could have significant impact on the
Environment;
(b) preventing or reducing to acceptable levels the release of
pollutants or hazardous substances or materials into the Environment;
(c) reducing the quantities, preventing the release, or
minimizing the hazardous characteristics of wastes that are generated;
71
(d) assuring that products are designed, formulated, packaged,
and used so that they do not present unreasonable risks to human health
or the Environment when used or disposed of;
(e) protecting resources, species, or ecological amenities;
(f) reducing to acceptable levels the risks inherent in
transportation of hazardous substances or materials, pollutants, oil,
or other potentially harmful substances;
(g) cleaning up pollutants that have been released, preventing
the threat of release, or paying the costs of such clean up or
prevention; or
(h) making responsible parties pay a Governmental Authority or
private parties, or groups of them, for damages done to the
Environment, or permitting self-appointed representatives of the public
interest to recover for injuries done to public assets.
"ERISA Affiliate" has the meaning set forth in Section 5.17.
"Exhibit" means each Exhibit attached to this Agreement.
"Financial Statements" has the meaning set forth in Section 5.10(a).
"Founding Companies" has the meaning set forth in the recitals of this
Agreement.
"Founding Stockholders" has the meaning set forth in Section 17.1.
"GAAP" means generally accepted accounting principles as in effect on
the date hereof.
"Governmental Authority" means the United States or any state, local,
or foreign government, or any subdivision, agency, or authority of any thereof.
"Governmental Consents" has the meaning set forth in Section 5.4.
"Hazardous Materials" means any waste or other substance that is
listed, defined, designated, or classified as, or otherwise determined to be,
hazardous, radioactive, or toxic or a pollutant or a contaminant under or
pursuant to any Environmental Law, including any admixture or solution thereof,
and specifically including petroleum and all derivatives thereof or synthetic
substitutes therefor and asbestos or asbestos-containing materials.
"HSR ACT" means the Xxxx-Xxxxx-Xxxxxx Antitrust Improvements Act of
1976, as amended.
72
"Indemnified Party" has the meaning set forth in Section 11.3.
"Indemnifying Party" has the meaning set forth in Section 11.3.
"Intellectual Property" means all Trademarks, copyrights, and patents
and any registration or application for any of the foregoing, and any trade
secret, invention, process, know-how, computer software, technology systems,
product design or product packaging.
"Investor Questionnaire" means the form of document attached hereto as
EXHIBIT 5.29(a) and as completed and delivered to Clarant by the Stockholders.
"IPO" means the initial public offering of Clarant Common Stock
pursuant to the Registration Statement.
"Knowledge": an individual will be deemed to have "Knowledge" of a
particular fact if such individual is actually aware of such fact or other
matter. A Person (other than an individual) will be deemed to have "Knowledge"
of a particular fact or other matter if any individual listed in EXHIBIT 18 has,
or any time had, Knowledge of such fact or other matter.
"Laws" means, as applicable (a) all applicable statutes, rules,
regulations, Orders and restrictions relating to zoning, land use, safety,
health, employment and employment practices and access by the handicapped, (b)
all laws, rules, regulations, writs, injunctions, decrees, and Orders applicable
to the Company or to the operation of the Business, and (c) all statutes, rules,
regulations, ordinances, orders, writs, injunctions, judgments, decrees, awards
or restrictions of any government entity having jurisdiction over any portion of
the Real Property.
"Leases" has the meaning set forth in Section 5.23(d).
"Leased Real Property" has the meaning set forth in Section 5.23(d).
"Legal Requirement" means any federal, state, local, municipal,
foreign, or other administrative order, constitution, law, ordinance, principle
of common law, regulation, statute, or treaty.
"Losses" has the meaning set forth in Section 11.1.
"Material Adverse Effect" means with respect to any Person that is a
party to this Agreement, a material adverse change in (i) the business
operations, condition or prospects (financial or otherwise) of such Person, (ii)
the ability of such Person to consummate the transactions contemplated by the
Agreement, or (iii) the condition or value of the properties and assets of such
Person.
73
"Material Contract" means any Contract affecting or pertaining to the
Business that has a monetary obligation of at least $25,000 per year and that is
not cancelable by the Company without penalty upon notice of six (6) months or
less.
"Merger" means the merger of Newco with and into the Company pursuant
to this Agreement and the applicable provisions of the laws of the State of
[Delaware] [and other applicable state laws].
"Merger Consideration" shall have the meaning given to such term in
Section 3.1.
"Merger Documents" has the meaning set forth in Section 4.1.
"Xx. Xxxxxx" means Xxxxxxxxx X. Xxxxxx, the Chief Executive Officer of
Clarant.
"Multi-Employer Plan" has the meaning set forth in Section 5.17.
"Newco" has the meaning set forth in the first paragraph of this
Agreement.
"Newco Stock" has the meaning set forth in Section 1.4(c).
"1933 Act" means the Securities Act of 1933, as amended.
"1934 Act" means the Securities Exchange Act of 1934, as amended.
"Non-accredited Stockholders" shall have the meaning given to such term
in Section 2.1.
"Options" has the meaning set forth in Section 5.3.
"Order" means any award, decision, injunction, judgment, order, ruling,
subpoena, or verdict entered, issued, made, or rendered by any court,
administrative agency, or other Governmental Authority or by an arbitrator.
"Ordinary Course of Business" means an action taken by a Person only if:
a) such action is consistent with the past practices of such
Person and is taken in the ordinary course of the normal day-to-day
operations of such Person; or
(b) such action is similar in nature and magnitude to actions
customarily taken in the ordinary course of the normal day-to-day
operations of other Persons that are in the same line of business as
such Person.
"Other Agreements" has the meaning set forth in the recitals of this
Agreement.
74
"Other Benefit Obligations" has the meaning set forth in Section 5.17.
"Other Founding Companies" has the meaning set forth in the recitals of
this Agreement.
"Pension Plan" has the meaning set forth in Section 5.17
"Permits" has the meaning set forth in Section 5.16(b).
"Person" means any individual, corporation (including non-profit
corporation), general or limited partnership, limited liability company, joint
venture, estate, trust, association, organization, labor union, or other entity
or Governmental Authority.
"Plan" has the meaning set forth in Section 5.17.
"Plan Sponsor" has the meaning set forth in Section 5.17
"Plans" has the meaning set forth in Section 5.17.
"Pre-Closing" has the meaning set forth in Section 4.1.
"Pre-Closing Date" has the meaning set forth in Section 4.1.
"Pre-Closing Period" means any Taxable Period or portion thereof ending
on or before the Closing Date.
"Pricing" means the date of determination by Clarant and the
Underwriters of the public offering price of the shares of Clarant Common Stock
in the IPO.
"Proceeding" means any action, audit, hearing, investigation,
litigation, or suit (whether civil, criminal, administrative, investigative, or
informal) commenced, brought, conducted or heard by or before, or otherwise
involving, any Governmental Authority.
"Qualified Plan" has the meaning set forth in Section 5.17.
"Qualified Plans" has the meaning set forth in Section 5.17.
"Real Property" has the meaning set forth in Section 5.23(a).
"Registration Statement" means that certain registration statement of
Clarant on Form S-1 covering the shares of Clarant Common Stock to be issued in
the IPO and attached hereto as SCHEDULE 18.1.
75
"Reimbursement" has the meaning set forth in Section 11.7.
"Relevant Group" has the meaning set forth in Section 5.24.
"Returns" means any returns, reports or statements (including any
information returns) required to be filed for purposes of a particular Tax with
any Taxing Authority or governmental agency.
"Schedule" means each Schedule attached hereto and identified as a
Schedule, which shall reference the relevant sections of this Agreement, on
which parties hereto disclose information as part of their respective
representations, warranties and covenants.
"Securities Agreements" shall have the meaning given to such term in
Section 5.3.
"SEC" means the United States Securities and Exchange Commission.
"Significant Customer" has the meaning set forth in Section 5.22(a).
"State Corporation Law" has the meaning set forth in Section 1.2.
"Statutory Liens" has the meaning set forth in Section 7.3(e).
"Stockholders" has the meaning set forth in the first paragraph of this
Agreement.
"Stockholder Notes" has the meaning set forth in Section 3.3.
"Straddle Period" has the meaning set forth in Section 10.2(a).
"Subsidiary" means Resource Solutions International, LLC and any entity
the majority of voting shares or interests of which are owned by the Company
and/or by one or more Subsidiaries of the Company.
"Surviving Corporation" shall mean the Company as the surviving party
in the Merger.
"Tax" or "Taxes" means all Federal, state, local or foreign net or
gross income, gross receipts, net proceeds, transfer, sales, use, ad valorem,
value added, franchise, bank shares, withholding, payroll, employment, excise,
property, deed, stamp, alternative or add-on minimum, environmental or other
taxes, assessments, duties, fees, levies or other governmental charges of any
nature whatsoever, whether disputed or not, together with any interest,
penalties, additions to tax or additional amounts with respect thereto.
76
"Tax Proceeding" means any audit, examination, claim or other
administrative or judicial proceeding relating to Taxes or Returns.
"Taxable Period" means any taxable year or other period that is treated
as a taxable year with respect to which any Tax may be imposed under any
applicable statute, rule or regulation.
"Taxing Authority" means any governmental agency, board, bureau, body,
department or authority of any United States federal, state or local
jurisdiction or any foreign jurisdiction, having jurisdiction with respect to
any Tax.
"Third Party Claim" has the meaning set forth in Section 11.3.
"Threatened" means a claim, Proceeding, dispute, action, or other
matter will be deemed to have been "Threatened" if any demand or statement has
been made in writing or any notice has been given in writing that such a claim,
Proceeding, dispute, action or other matter is likely to be asserted, commenced,
taken, or otherwise pursued in the future.
"Title IV Plans" has the meaning set forth in Section 5.17.
"Trademarks" has the meaning set forth in Section 5.14.
"Underwriters" means the underwriters of the IPO, as identified in the
Registration Statement.
"Underwriting Agreement" means the Underwriting Agreement by and among
the Underwriters and the Company in respect of the IPO.
"VEBA" has the meaning set forth in Section 5.17.
"Welfare Plan" has the meaning set forth in Section 5.17.
"Year 2000 Compliant" has the meaning set forth in Section 5.27.
19. GENERAL
19.1 COOPERATION. The Company, the Subsidiary, the Stockholders,
Clarant and Newco shall each deliver or cause to be delivered to the other on
the Closing Date, and at such other times and places as shall be reasonably
agreed to, such additional instruments as the other may reasonably request for
the purpose of carrying out this Agreement. The Stockholders will cooperate and
use their reasonable efforts to have the present officers, directors and
employees of the Company cooperate with Clarant on and after the Closing Date in
furnishing information, evidence, testimony and other assistance in connection
with any Tax Return filing obligations,
77
actions, proceedings, arrangements or disputes of any nature with respect to
matters pertaining to all periods prior to the Closing Date.
19.2 SUCCESSORS AND ASSIGNS. This Agreement and the rights of the
parties hereunder may not be assigned (except by operation of law) and shall be
binding upon and shall inure to the benefit of the parties hereto, the
successors of Clarant, and the heirs and legal representatives of the
Stockholders.
19.3 ENTIRE AGREEMENT. This Agreement (including the Schedules,
Exhibits attached hereto which are incorporated by this reference) and the
documents delivered pursuant hereto constitute the entire agreement and
understanding among the Stockholders, the Company, Newco and Clarant and
supersede any prior agreement and understanding relating to the subject matter
of this Agreement. This Agreement, upon execution, constitutes a valid and
binding agreement of the parties hereto enforceable in accordance with its terms
and may be modified or amended only by a written instrument executed by the
Stockholders, the Company, the Subsidiary, Newco and Clarant, acting through
their respective officers or trustees, or members, as the case may be, duly
authorized by their respective boards of directors. Any disclosure made on any
Schedule delivered pursuant hereto shall be deemed to have been disclosed for
purposes of any other Schedule required hereby, provided that the Company and
the Stockholders shall make a good faith effort to cross reference disclosure,
as necessary or advisable, between related Schedules.
19.4 COUNTERPARTS. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original and all of which
together shall constitute but one and the same instrument.
19.5 EXPENSES.
(a) Whether or not the transactions herein contemplated shall
be consummated, Clarant will pay the fees, expenses and disbursements of Clarant
and its agents, representatives, accountants and counsel incurred in connection
with the subject matter of this Agreement and any amendments thereto, including
all costs and expenses incurred in the performance and compliance with all
conditions to be performed by Clarant under this Agreement, including the fees
and expenses of Clarant's public auditors, Xxxxxx Xxxxxx & Xxxxxxxxx, and any
other Person retained by Clarant, and the costs of preparing the Registration
Statement.
(b) If the transactions herein contemplated shall not be
consummated, the Company shall pay the fees, expenses and disbursements of the
Stockholders, the Company, the Subsidiary and their respective agents,
representatives, accountants and counsel incurred in connection with the subject
matter of this Agreement and any amendments thereto, including all costs and
expenses incurred in the performance and compliance with all conditions to be
performed by the Company and the Stockholders under this Agreement, including
the reasonable fees and expenses of legal counsel to the Company, the Subsidiary
and the Stockholders.
78
(c) If the transaction herein contemplated is consummated,
Clarant will pay the fees, expenses, and disbursements of the Stockholders and
the Company and their respective agents, representatives, accountants and
counsel as described in (b), above.
(d) Each Stockholder acknowledges that he, and not the
Company, the Subsidiary or Clarant, will pay all Taxes including, but not
limited to, income and transfer taxes due upon receipt of the consideration
payable pursuant to Article 2 hereof, and will assume all Tax or as a result of
risks and liabilities of such Stockholder in connection with the transactions
contemplated hereby.
19.6 NOTICES. All notices, requests, demands and other communications
made in connection with this Agreement shall be in writing and shall be deemed
to have been duly given on the date of delivery, if delivered to the persons
identified below, or on the second business day, if delivered by a reputable
overnight carrier, or on the date of the return receipt acknowledgment after
mailing if mailed by certified or registered mail, postage prepaid, return
receipt requested, or on the date such transmission is made and confirmation of
receipt obtained if a business day, or if not, then on the next following
business day, if sent by facsimile, telecopy, telegraph, telex or other similar
telegraphic communications equipment, addressed as follows:
(a) If to Clarant, or Newco, addressed to them at:
0000 Xxxxx Xxxxx Xxxxx
Xxxxx 000
Xxxxxx, Xxxxx 00000
Attention: Xxxxxxxxx X. Xxxxxx
Facsimile: (000) 000-0000
with copies to:
Xxxxxx, Xxxxxx & Xxxxxxxxx
0000 X Xxxxxx, X.X.
Xxxxxxxxxx, X.X. 00000
Attention: Xxxxxx X. Xxxxxx, Esq.
Facsimile: (000) 000-0000
(b) If to the Stockholders, addressed to them at their
addresses set forth on EXHIBIT 19.6, with copies to such counsel as is set forth
with respect to each Stockholder on such EXHIBIT 19.6;
(c) If to the Company or the Subsidiary, addressed to it at:
000 Xxxxxxx Xxxxxxx
Xxxxxxx, Xxxxxxxx 00000
Attn: Xx. Xxxxx X. Xxxxx
79
Facsimile: (000) 000-0000
and marked "Personal and Confidential"
with a copy to:
Stauffer, Mannix, Rommel, Xxxxxx & Xxxxxx, L.L.C.
Suite 100
0000 Xxxxxxxxxx Xxxxx
XxXxxx, Xxxxxxxx 00000-0000
Attn: Xxxxxxx X. Xxxxxxxx, Xx.
Facsimile: (000) 000-0000
or to such other address or counsel as any party hereto shall specify pursuant
to this Section 19.6 from time to time.
19.7 GOVERNING LAW. This Agreement shall be construed in accordance
with the laws of the State of Delaware without reference to conflicts of laws
principles.
19.8 EXERCISE OF RIGHTS AND REMEDIES. Except as otherwise provided
herein, no delay of or omission in the exercise of any right, power or remedy
accruing to any party as a result of any breach or default by any other party
under this Agreement shall impair any such right, power or remedy, nor shall it
be construed as a waiver of or acquiescence in any such breach or default, or of
any similar breach or default occurring later; nor shall any waiver of any
single breach or default be deemed a waiver of any other breach or default
occurring before or after that waiver.
19.9 TIME. Time is of the essence with respect to this Agreement.
19.10 REFORMATION AND SEVERABILITY. In case any provision of this
Agreement shall be invalid, illegal or unenforceable, it shall, to the extent
possible, be modified in such manner as to be valid, legal and enforceable but
so as to most nearly retain the intent of the parties, and if such modification
is not possible, such provision shall be severed from this Agreement, and in
either case the validity, legality and enforceability of the remaining
provisions of this Agreement shall not in any way be affected or impaired
thereby.
19.11 STOCKHOLDERS' REPRESENTATIVE.
80
(a) Each Stockholder, by signing this Agreement, designates
Xxxxx X. Xxxxx or, in the event that Xxxxx X. Xxxxx is unable or unwilling to
serve, now or in the future, Xxxxxxx Xxxxxxxx, to be the Stockholders'
Representative for purposes of this Agreement. The Stockholders shall be bound
by any and all actions taken by the Stockholders' Representative on their
behalf.
(b) Clarant and Newco shall be entitled to rely upon any
communication or writings given or executed by the Stockholders' Representative.
All notices to be sent to Stockholders pursuant to this Agreement may be
addressed to the Stockholders' Representative and any notice so sent shall be
deemed notice to all of the Stockholders hereunder. The Stockholders hereby
consent and agree that the Stockholders' Representative is authorized to accept
notice on behalf of the Stockholders pursuant hereto.
(c) The Stockholders' Representative is hereby appointed and
constituted the true and lawful attorney-in-fact of each Stockholder, with full
power in his or her name and on his or her behalf to act according to the terms
of this Agreement in the absolute discretion of the Stockholders'
Representative; and in general to do all things and to perform all acts
including, without limitation, executing and delivering all agreements,
certificates, receipts, instructions and other instruments contemplated by or
deemed advisable in connection with this Agreement. This power of attorney and
all authority hereby conferred is granted subject to the interest of the other
Stockholders hereunder and in consideration of the mutual covenants and
agreements made herein, and shall be irrevocable and shall not be terminated by
any act of either Stockholder, by operation of law, whether by the death or
other event.
19.12 CAPTIONS. The headings of this Agreement are inserted for
convenience only, shall not constitute a part of this Agreement or be used to
construe or interpret any provision hereof.
19.13 SURVIVAL. The representations and warranties set forth in this
Agreement shall survive the Closing and expire in accordance with Section 11.11.
The covenants of the parties to be performed offer the Closing shall survive the
Closing and expire in accordance with their respective terms.
19.14 ACCOUNTING TERMS. Except as otherwise expressly provided herein,
all accounting terms used in this Agreement shall be interpreted, and all
financial statements and certificates and reports as to financial matters
required to be delivered hereunder shall be prepared, in accordance with U.S.
GAAP consistently applied.
[this space left intentionally blank]
81
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as
of the day and year first above written.
CLARANT, INC., RSI I ACQUISITION CORP.,
a Delaware corporation a Texas corporation
By: /s/ Xxxxxxxxx X. Xxxxxx By: /s/ Xxxxxxxxx X. Xxxxxx
Name: Xxxxxxxxx X. Xxxxxx Name: Xxxxxxxxx X. Xxxxxx
Title: President Title: President
RSI GROUP, INC., RESOURCE SOLUTIONS
a Texas corporation INTERNATIONAL, LLC
By: /s/ Xxxxxxx Xxxxxxxx By: /s/ Xxxxxxx Xxxxxxxx
Name: Xxxxxxx Xxxxxxxx Name: Xxxxxxx Xxxxxxxx
Title: President and CEO Title: Manager
STOCKHOLDERS:
/s/ Xxxxxxx Xxxxxxxx /s/ Xxxxxxx Xxxxx
Xxxxxxx Xxxxxxxx Xxxxxxx Xxxxx
/s/ Xxxxx X. Xxxxx
Xxxxx X. Xxxxx
EXHIBIT 2.1(a)
CONSIDERATION
(a) At Closing, Clarant will deliver Merger Consideration to the Members and
holders of vested Options and Convertible Securities equal to:
(i) if the IPO price per share of Clarant Common Stock is equal to or
greater than $11.00,
(A) One Million Ninety-Four Thousand Five Hundred Forty-Five
(1,094,545) shares of Clarant Common Stock (the "Stock Consideration") plus
(B) Four Hundred Sixty-Nine Thousand Ninety-One and 71/100
U.S. Dollars ($469,091.71) times the IPO price per share of Clarant Common
Stock; provided that, for purposes of this calculation, the IPO price per share
of Clarant Common Stock shall not be less than $11.00 provided that in no event
shall the amount of cash delivered to the Stockholders be less than Five Million
One Hundred Sixty Thousand Eight and 81/100 U.S. Dollars ($5,160,008.81) (the
"Cash Consideration"); or
(ii) if the IPO price per share of Clarant Common Stock is less than
$11.00:
(A) the Stock Consideration plus a sufficient number of
additional shares of Clarant Common Stock (the "Additional Shares") such that
the aggregate value of the Stock Consideration plus the Additional Shares plus
the mimimum Cash Consideration under (a)(i)(B) above shall be Seventeen Million
Two Hundred Thousand and 00/100 U.S. Dollars ($17,200,000.00)
(b) At Closing, the Merger Consideration shall be distributed among the
Stockholders so that Xxxxx X. Xxxxx receives twenty percent (20%) of the Merger
Consideration and Xxxxxxx Xxxxxxxx and Xxxxxxx Xxxxx receive their pro rata
allocation of the remaining eighty percent (80%) of the Merger Consideration,
such distribution to be made to each of the Stockholders in the ratio of seventy
percent (70%) Clarant Common Stock and thirty percent (30%) cash.
(c) The minimum IPO price per share of Clarant Common Stock is $9.90.
EXHIBIT 3.3
(a) Contingent Consideration will be paid to the Stockholder(s)
contingent on the financial performance of the Company and Clarant during the
periods July 1, 1999 through December 31, 1999, and January 1, 2000 through June
30, 2000 (each such period a "Measurement Period"). The following tables set
forth the projections and formulas for determining the Contingent Consideration
payable to the Stockholder(s):
PROJECTIONS FOR DETERMINING CONTINGENT CONSIDERATION
PROJECTED PROJECTED PROJECTED PROJECTED
MEASUREMENT COMPANY COMPANY PRE-TAX COMBINED COMBINED
PERIOD REVENUES INCOME REVENUES PRE-TAX INCOME
------ -------- ------ -------- --------------
Jul. 1, 1999 - $8,664,000 $1,049,000 n/a n/a
Dec. 31, 1999
Jan. 1, 2000 - n/a n/a $75,216,000 $13,810,000
Jun. 30, 2000
FORMULAS FOR DETERMINING CONTINGENT CONSIDERATION
MAXIMUM
PRE-TAX POOL FOR CAP ON
MEASUREMENT REVENUE INCOME POOL FORMULA FOR CALCULATING CONTINGENT CONTINGENT
PERIOD MULTIPLE MULTIPLE SHARE CONTINGENT CONSIDERATION CONSIDERATION CONSIDERATION
------ -------- -------- ----- ------------------------ ------------- -------------
Jul. 1, 1999 - 3 15 n/a [50% (Revenue Multiple) x $78,700,000 $4,300,000
Dec. 31, 1999 (Actual Company Revenues -
Projected Company Revenues)]
+
[50% (Pre-Tax Income Multiple)
x (Actual Pre-Tax Income -
Projected Pre-Tax Income)]
Jan. 1, 2000 - 3 15 5.46% [(Pool Share) x 50% (Revenue $78,700,000 $4,300,000
Jun. 30, 2000 Multiple) x (Actual Combined
Revenues - Projected
Combined Revenues)]
+
[(Pool Share) x 50% (Pre-Tax
Income Multiple) x (Actual
Combined Pretax Income -
Projected Combined Pretax
Income)]
(b) For purposes of determining the amount of Contingent Consideration
payable to the Stockholder(s):
(i) Pre-Tax Income shall mean net revenues less direct costs
less indirect costs and expenses, but including all taxes other than Federal and
state income taxes, provided, that, Pre-Tax Income expressly excludes
amortization of acquisition goodwill incident to the transactions contemplated
by the Agreement;
(ii) Combined Revenues shall mean the total revenues of the
Founding Companies only, without giving effect to acquisitions by Clarant or any
Founding Company after the Closing Date, unless otherwise agreed to in writing
by Clarant;
(iii) Combined Pre-Tax Income shall mean the total Pre-Tax
Income of the Founding Companies only, without giving effect to acquisitions by
Clarant or any Founding Company after the Closing Date, unless otherwise agreed
to in writing by Clarant; and
(iv) except as otherwise expressly provided herein, all
accounting terms shall be interpreted in accordance with U.S. GAAP, based upon
consistent use of accounting principles and policies, revenue recognition
methods and reserve methodologies for the Measurement Period and the relevant
audited financial statements.
(c) The Contingent Consideration payable for a Measurement Period shall
be made in cash and shares of Clarant Common Stock, with the amount paid in cash
to be determined by Clarant in its sole and absolute discretion, PROVIDED, THAT,
such amount represents no less than twenty-five percent (25%), nor more than
fifty percent (50%), of the total amount of the Contingent Consideration for the
Measurement Period. For these purposes, each share of Clarant Common Stock will
be valued at the trailing 30-day average closing price, ending on the day before
the date of issuance.
(d) Within forty-five (45) days following the end of each Measurement
Period, Clarant shall cause Xxxxxx Xxxxxxxx to review Clarant's and each
Founding Company's books and records to determine, as applicable, the Company's
actual revenues ("Actual Company Revenues") and actual Pre-Tax Income ("Actual
Company Pre-Tax Income"), and the actual Combined Revenues ("Actual Combined
Revenues") and actual Combined Pre-Tax Income ("Actual Combined Pre-Tax
Income"), for the Measurement Period. Within sixty (60) days following the end
of each Measurement Period, Clarant shall deliver a written notice (a
"Contingent Consideration Notice") to the Stockholder's Representative setting
forth (i) the determination made by Xxxxxx Xxxxxxxx of the Actual Company
Revenues, Actual Company Pre-Tax Income, Actual Combined Revenues and Actual
Combined Pre-Tax Income, if applicable, (ii) the total amount of the Contingent
Consideration payable to the Stockholder(s) for the Measurement Period and (iii)
the amount of cash and shares of Clarant Common Stock that will be paid to the
Stockholder(s) as Contingent Consideration for the Measurement Period. As soon
as practicable after delivering the Contingent Consideration Notice, Clarant
shall issue
the shares of Clarant Common Stock to be paid as Contingent Consideration and
deliver such shares, along with the cash to be paid as Contingent Consideration,
to [Clarant's Bank] to hold in escrow until final resolution of any disputes
regarding the Contingent Consideration.
(e) The Stockholders' Representative shall have fifteen (15) days from
the receipt of the Contingent Consideration Notice to notify Clarant if there is
a dispute about such Contingent Consideration Notice. If Clarant has not
received notice of such a dispute within such 15-day period, Clarant shall
direct [Clarant's Bank] to pay the cash portion of the Contingent Consideration
by wire transfer of immediately available funds to the Stockholder(s) at the
account(s) identified on SCHEDULE 19.6 and deliver the shares of Clarant Common
Stock to the Stockholder(s) at the address(es) set forth on SCHEDULE 19.6. If,
however, the Stockholders' Representative has delivered notice of such a dispute
to Clarant within such 15-day period, then Clarant's chief financial officer and
the Stockholders' Representative shall meet (by conference telephone call or in
person at a mutually agreeable site) within one week after notice of a
disagreement is given as provided herein. Clarant's chief financial officer and
the Stockholders' Representative shall attempt to make a final determination of
the Contingent Consideration payable for the Measurement Period. If Clarant's
chief financial officer and the Stockholders' Representative do not reach
agreement within a reasonable time, either or both of them shall give notice of
an impasse, in which case they shall mutually agree on an independent accounting
firm to review the Contingent Consideration Notice (and related information) to
determine the amount of the Contingent Consideration. In the event that
Clarant's chief financial officer and the Stockholders' Representative cannot
agree on an independent accounting firm, Xxxxxx Xxxxxxxx shall select such
independent accounting firm. The determination of such independent accounting
firm shall be final and binding on the parties hereto and promptly upon such
determination Clarant shall direct [Clarant's Bank] to deliver the Contingent
Consideration to the Stockholder(s). The costs of the independent accounting
firm shall be borne by the party whose determination of the Contingent
Consideration was furthest from the determination of the independent accounting
firm, or equally by the parties in the event that the determination by the
independent accounting firm is equidistant between the Contingent Consideration
as calculated by Clarant and the Stockholders' Representative.
(f) Any adjustments to the Contingent Consideration required to be made
as a result of the process described in paragraph (e) shall be made in either
cash or Clarant Common Stock, notwithstanding any other limitations contained
herein to the contrary.
(g) The amounts payable as Contingent Consideration shall be deemed to
include interest, if any, that would be imputed under the Code. No additional
payments shall be made to the Stockholder(s) for such imputed interest.
(h) The right to receive the Contingent Consideration shall not be
assignable by the Stockholder(s).
(i) The parties acknowledge that Clarant intends to integrate the
businesses of the Founding Companies and implement policies applicable to
Clarant and its subsidiaries as a whole after the Closing Date. In integrating
the Founding Companies and implementing such
policies, Clarant shall not take any action intended to prejudice the
Stockholders' rights with respect to the Contingent Consideration. In the event
that Clarant merges, consolidates, reorganizes, restructures or disposes of a
material portion of the assets of, or takes any similar action with respect to,
any one or more of the Founding Companies, Clarant shall maintain sufficient
records and recordkeeping procedures as is commercially practicable and
reasonably necessary to calculate the amount of Contingent Consideration payable
to the Stockholder in accordance with the Agreement and the terms set forth in
this EXHIBIT 3.3.
(j) For purposes of calculating the Contingent Consideration during the
first Measurement Period, the Company's Actual Pre-tax Income shall be increased
by ten percent (10%) of any revenues of any one of the Other Founding Companies
from any Referred Work. The term "Referred Work" means work relating to a
project obtained from a client by the Company that the Company requests Clarant
to assign to one of the Other Founding Companies and which assignment request is
approved by Xx. Xxxxxx (or an officer of Clarant designated by Xx. Xxxxxx)
according to procedures established by Clarant.
